US20050075680A1 - Methods and systems for intracranial neurostimulation and/or sensing - Google Patents
Methods and systems for intracranial neurostimulation and/or sensing Download PDFInfo
- Publication number
- US20050075680A1 US20050075680A1 US10/891,834 US89183404A US2005075680A1 US 20050075680 A1 US20050075680 A1 US 20050075680A1 US 89183404 A US89183404 A US 89183404A US 2005075680 A1 US2005075680 A1 US 2005075680A1
- Authority
- US
- United States
- Prior art keywords
- contact portion
- electrical contact
- patient
- shaft
- electrical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0539—Anchoring of brain electrode systems, e.g. within burr hole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0531—Brain cortex electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
Definitions
- the present invention relates to intracranial electrodes and methods for implanting and using intracranial electrodes. These electrodes and methods may be suited for neurostimulation systems and may also be used in electroencephalography and other recording systems, e.g., evoked potential recordings.
- a wide variety of mental and physical processes are known to be controlled or influenced by neural activity in the central and peripheral nervous systems.
- the neural functions in some areas of the brain e.g., the sensory or motor cortices
- the neural functions in some areas of the brain are organized according to physical or cognitive functions.
- Several other areas of the brain also appear to have distinct functions in most individuals.
- the areas of the occipital lobes relate to vision
- the regions of the left inferior frontal lobes relate to language
- the regions of the cerebral cortex appear to be involved with conscious awareness, memory, and intellect.
- stimulating neurons at selected locations of the central nervous system can be used to effectuate changes in cognitive and/or motor functions throughout the body.
- neural functions are treated by electrical or magnetic stimulation powered by a neural stimulator that has a plurality of therapy electrodes and a pulse system coupled to the therapy electrodes.
- the therapy electrodes can be implanted into the patient at a target site for stimulating the desired portions of the brain.
- one existing technique for masking pain in a patient is to apply an electrical stimulus to a target stimulation site of the brain.
- TES transcranial electrical stimulation
- TMS transcranial magnetic stimulation
- TES transcranial magnetic stimulation
- TMS does not cause the painful side effects of TES.
- TMS is not presently effective for treating many patients because the existing delivery systems are not practical for applying stimulation over an adequate period of time.
- TMS systems for example, are relatively complex and require stimulation treatments to be performed by a healthcare professional in a hospital or physician's office.
- the efficacy of TMS in longer-term therapies may be limited because it is difficult to (a) accurately localize the region of stimulation in a reproducible manner, (b) hold the device in the correct position over the cranium for the requisite period, and (c) provide stimulation for extended periods of time.
- King discloses a device for cortical surface stimulation having electrodes mounted on a paddle that is implanted under the skull of the patient. These electrodes are placed in contact with the surface of the cortex to create “paresthesia,” which is a vibrating or buzzing sensation.
- Implanting the paddle typically requires removal of a relatively large (e.g., thumbnail-sized or larger) window in the skull via a full craniotomy. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
- a physician may employ electroencephalography (EEG) to monitor neural functions of a patient. Sometimes this is done alone, e.g., in diagnosing epileptic conditions, though it may also be used in conjunction with neurostimulation.
- electroencephalography involves monitoring electrical activity of the brain, manifested as potential differences at the scalp surfaces, using electrodes placed on the scalp. The electrodes are typically coupled to an electroencephalograph to generate an electroencephalogram. Diagnosis of some neurological diseases and disorders, e.g., epilepsy, may best be conducted by monitoring neural function over an extended period of time. For this reason, ambulatory electroencephalography (AEEG) monitoring is becoming more popular.
- AEEG ambulatory electroencephalography
- disc electrodes are applied to the patient's scalp. The scalp with the attached electrodes may be wrapped in gauze and the lead wires attached to the electrodes may be taped to the patient's scalp to minimize the chance of displacement.
- EEG conducted with scalp-positioned electrodes requires amplification of the signals detected by the electrodes. In some circumstances, it can be difficult to pinpoint the origin of a particular signal because of the signal dissipation attributable to the scalp and the skull.
- EEG may be conducted using “deep brain” electrodes. Such electrodes extend through the patient's scalp and skull to a target location within the patient's brain. Typically, these deep brain electrodes comprise lengths of relatively thin wire that are advanced through a bore through the patient's skull to the desired location. If the electrodes are to be monitored over an extended period of time, the electrodes typically are allowed to extend out of the patient's skull and scalp and are coupled to the electroencephalograph using leads clipped or otherwise attached to the electrodes outside the scalp.
- the electrodes typically are taped down or held in place with a biocompatible cementitious material.
- the patient's head typically must be wrapped in gauze to protect the exposed electrodes and the associated leads, and the patient is uncomfortable during the procedure. This may be suitable for limited testing purposes-deep brain encephalography typically is limited to tests conducted in hospital settings over a limited period of time, usually no more than a few days-but could be problematic for longer-term monitoring, particularly in nonclinical settings.
- FIG. 1 schematically illustrates a conventional cranial reconstruction to repair a fracture 50 or other trauma.
- a plate 60 is attached to the outer cortex 12 of the skull 10 by cortical bone screws 62 .
- the plate 60 spans the fracture 50 , helping fix the skull in place on opposite sides of the fracture 50 .
- the screws 62 do not extend through the entire thickness of the skull. Instead, the screws 62 are seated in the outer cortex 12 and do not extend into the cancellous 18 or the inter cortex 14 . In some related applications, the screws 62 may be longer and extend into or even through the cancellous 18 . Physicians typically take significant care to ensure that the screws 62 do not extend through the entire thickness of the skull, though, because penetrating the skull can increase the likelihood of trauma to or infection in the patient's brain.
- FIG. 1 is a schematic illustration of a conventional cranial reconstruction.
- FIG. 2A is a schematic view in partial cross section of an intracranial electrode in accordance with one embodiment of the invention implanted in a patient.
- FIG. 2B is a schematic top elevation view of the implanted intracranial electrode of FIG. 2A .
- FIG. 3A is a schematic illustration in partial cross section of an intracranial electrode in accordance with another embodiment of the invention implanted in a patient.
- FIG. 3B is a schematic top elevation view of the implanted intracranial electrode of FIG. 3A .
- FIG. 4A is a schematic illustration in partial cross section of an intracranial electrode in accordance with yet another embodiment of the invention implanted in a patient.
- FIG. 4B is a side view of a dielectric member of the electrode of FIG. 4A .
- FIG. 5 is a schematic illustration in partial cross section of an intracranial electrode in accordance with still another embodiment of the invention implanted in a patient.
- FIG. 6A is a schematic illustration in partial cross section of an intracranial electrode in accordance with a further embodiment of the invention implanted in a patient.
- FIG. 6B is a schematic top elevation view of the implanted intracranial electrode of FIG. 6A .
- FIG. 7 is a schematic illustration in partial cross section of an intracranial electrode in accordance with still another embodiment of the invention implanted in a patient.
- FIG. 8 is a schematic side view of a broken-away portion of a patient's skull in which an intracranial electrode in accordance with another embodiment of the invention has been implanted.
- FIG. 9 is a schematic partial cross-sectional view taken along line 9 - 9 of FIG. 8 .
- FIG. 10 is an isolation view of a portion of the implanted electrode of FIG. 9 .
- FIG. 11 is a perspective view of selected components of the intracranial electrode of FIGS. 8-10 .
- FIG. 12 is a schematic illustration in partial cross section of an intracranial electrode in accordance with yet another embodiment of the invention implanted in a patient.
- FIG. 13 is a schematic illustration in partial cross section of an intracranial electrode in accordance with one more embodiment of the invention implanted in a patient.
- FIG. 14 is a schematic illustration in partial cross section of an intracranial electrode in accordance with a further embodiment of the invention implanted in a patient.
- FIG. 15 is a schematic partial cross-sectional view of the intracranial electrode of FIG. 13 with a retaining collar of the electrode in a radially compressed state.
- FIG. 16 is a schematic partial cross-sectional view of the intracranial electrode of FIG. 14 with the retaining collar in a radially expanded state.
- FIG. 17 is a schematic illustration in partial cross section of a deep brain intracranial electrode in accordance with an alternative embodiment of the invention implanted in a patient.
- FIG. 18 is a schematic illustration in partial cross section of a deep brain intracranial electrode in accordance with still another embodiment of the invention implanted in a patient.
- FIG. 19 is a schematic overview of a neurostimulation system in accordance with a further embodiment of the invention.
- FIG. 20 is a schematic overview of a neurostimulation system in accordance with another embodiment of the invention.
- FIG. 21 is a schematic illustration of one pulse system suitable for use in the neurostimulation system of FIG. 17 or FIG. 18 .
- FIG. 22 is a schematic top view of the array of electrodes in FIG. 17 .
- FIGS. 23-26 are schematic top views of alternative electrode arrays in accordance with other embodiments of the invention.
- FIG. 27 is a schematic view in partial cross section of an intracranial electrode implanted in a patient in accordance with another embodiment of the invention.
- FIG. 28 is a schematic view in partial cross section of an intracranial electrode implanted in a patient in accordance with another embodiment of the invention.
- FIG. 29 is a schematic view in partial cross section of an intracranial electrode implanted in a patient in accordance with another embodiment of the invention.
- FIG. 30 is a schematic view in partial cross section of an intracranial electrode having an adjunct depth-penetrating electrode implanted in a patient in accordance with another embodiment of the invention.
- FIG. 31 is a schematic view in partial cross section of another intracranial electrode having an adjunct depth-penetrating electrode implanted in a patient in accordance with another embodiment of the invention.
- FIG. 32 is a schematic view in partial cross section of a neural stimulation system implanted in a patient in accordance with an alternative embodiment of the invention.
- FIG. 33 is a schematic view in partial cross section of a neural stimulation system implanted in a patient in accordance with yet another embodiment of the invention.
- FIG. 34A is a schematic view in partial cross section of an intracranial electrode system implanted in a patient in accordance with another embodiment of the invention.
- FIG. 34B is a schematic illustration of an electrical energy transfer mechanism in accordance with an embodiment of the invention.
- FIG. 35 is a schematic view in partial cross section of portions of intracranial electrode system implanted in a patient in accordance with an embodiment of the invention.
- FIG. 36 is a schematic overview of an intracranial electrode system implanted in a patient in accordance with an embodiment of the invention.
- FIG. 37 is a schematic view in partial cross section of a set of intracranial electrodes implanted in a patient in accordance with a further embodiment of the invention.
- FIG. 38 is a schematic view in partial cross section of an intracranial electrode in accordance with a further embodiment of the invention.
- FIG. 39 is a schematic view in partial cross section of an intracranial electrode in accordance with an embodiment of the invention.
- FIG. 40 is a schematic overview of an intracranial electrode system having RFID capabilities in accordance with a further embodiment of the invention.
- FIG. 41 illustrates a depth measurement procedure employing a depth acquisition stick according to an embodiment of the present invention.
- FIG. 42 is a flowchart illustrating depth measurement procedures in accordance with an embodiment of the invention.
- FIGS. 1-42 Various embodiments of the present invention provide intracranial electrodes and methods for implanting and using intracranial electrodes. It will be appreciated that several of the details set forth below are provided to describe the following embodiments in a manner sufficient to enable a person skilled in the art to make and use the disclosed embodiments. Several of the details and advantages described below, however, may not be necessary to practice certain embodiments of the invention. Additionally, the invention can also include additional embodiments that are not described in detail with respect to FIGS. 1-42 .
- One aspect of the invention is directed to an intracranial signal transmission system that includes a generally electrically insulating support body having a head portion configured to be positioned at least proximate to an outer surface of a patient's skull.
- the support body can further have a shaft portion configured to extend into an aperture in the patient's skull.
- At least one electrical contact portion is carried by the support body and can be positioned to transfer electrical signals to, from, or both to and from the patient's brain via the aperture in the patient's skull.
- An intracranial signal transmission system in accordance with another aspect of the invention includes an electrical contact portion configured to be positioned in an aperture of a patient's skull, and an electrical energy transfer device configured to be releasably positioned external to the patient's scalp.
- the energy transfer device can be coupleable to a signal transmitter to transmit signals to the electrical contact portion while the electrical contact portion is positioned beneath the patient's scalp, and while the energy transfer device is positioned external to the patient's scalp.
- the electrical energy transfer device can include a flexible outer layer, an adhesive gel layer positioned to contact the patient's scalp, a conductive layer positioned between the outer layer and the adhesive gel layer, and a conductive lead connected to the conductive layer.
- An intracranial signal transmission system in accordance with still another aspect of the invention includes a shaft configured to extend through an aperture in a patient's skull, and a head connected to the shaft.
- the head can be configured to be positioned adjacent to an external surface of the patient's skull and can be eccentrically positioned relative to the shaft. Accordingly, the head can have a first portion extending outwardly from the shaft by a first distance, and a second portion extending outwardly from the shaft by a second distance different from the first distance.
- the system can further include an electrical contact portion carried by at least one of the shaft and the head.
- a method in accordance with one aspect of the invention includes drilling a hole in a patient's skull, and determining a distance from an outer surface of the patient's skull to a feature beneath the outer surface of the patient's skull by inserting an elongated member having graduation markings into the pilot hole.
- the method can further include selecting a size of an intracranial electrode based on the distance determined with the elongated member, and inserting the intracranial electrode into the hole.
- the method can still further include securing the intracranial electrode to the patient's skull.
- a method in accordance with another aspect of the invention includes forming an aperture in a patient's skull, with the aperture having a first generally conical portion with a first diameter at an external surface of the patient's skull, and a second portion having a second diameter smaller than the first diameter, located beneath the external surface.
- the method can further include disposing proximate to the aperture an electrical contact portion carried by a support body having a shaft and a head depending from the shaft.
- the head can have a generally conical shape, with an angle between an external surface of the shaft and an external surface of the head being obtuse.
- the method can still further include inserting the support body into the aperture so that the shaft extends through the second portion of the aperture and the head engages a wall of the aperture at the first portion of the aperture.
- a method in accordance with yet another aspect of the invention includes forming an aperture in the patient's skull, disposing proximate to the aperture an electrical contact portion carried by a support body having a shaft and a head depending from the shaft, with the shaft having an external surface and a plurality of surface features.
- the method can still further include inserting the support body into the aperture so that the shaft extends into the aperture, and then allowing the patient's bone tissue to grow into interengagement with the surface features.
- the first section discusses certain intracranial electrodes; the second section relates to select embodiments of neurostimulation systems; and the third section outlines methods in accordance with other embodiments of the invention.
- FIGS. 2-15 illustrate intracranial electrodes in accordance with various embodiments of the invention. Like reference numbers are used throughout these figures to designate like or analogous elements.
- FIGS. 2 A-B illustrate an intracranial electrode 100 in accordance with one embodiment of the invention.
- This electrode 100 includes a head 102 attached to a threaded shaft 110 .
- the head 102 and shaft 110 may be integrally formed of an electrically conductive material, e.g., titanium or another biocompatible, electrical conductive metal.
- the head 102 may include one or more slots 104 , an allen head recess (not shown), or other structure (e.g., a square drive or TORXTM drive recess) adapted to facilitate turning the electrode 100 .
- the threads 112 of the threaded shaft 110 will advance a generally distally positioned contact surface 115 of the electrode 100 toward the dura mater 20 .
- the length of the shaft 110 may be selected so that the contact surface 115 of the electrode 100 electrically engages the surface of the dura mater 20 without causing undue harm to the dura mater 20 or the underlying cerebral cortex.
- the contact surface 115 may comprise a relatively blunt end to reduce trauma to the dura mater and the underlying brain tissue 25 .
- the intracranial electrode 100 is adapted to be electrically connected to a pulse system ( 1050 in FIG. 18 , for example), as described below.
- the electrode 100 may be connected to the pulse system in any desired fashion.
- the electrode 100 is coupled to such a pulse system by means of an electrical lead 120 .
- the electrical lead 120 shown in FIGS. 2A and 2B comprises an elongated, subcutaneously implantable body 124 , which may have an insulative sheath.
- An electrically conductive ring or washer 122 may be attached to an end of the body 124 .
- an opposite end of the body 124 is physically attached to a component of the pulse system.
- the leads may be operatively connected to one or more components of the pulse system without being physically attached thereto, e.g., using a transmitter and antenna or a magnetic coupling.
- a transmitter and antenna or a magnetic coupling Embodiments of pulse systems incorporating such wireless links are disclosed in U.S. Patent Application Publication No. US 2002/0087201, the entirety of which is incorporated herein by reference.
- the head 102 of the electrode 100 is adapted to be implanted subcutaneously beneath the patient's scalp 30 (shown schematically in FIG. 2A ). As explained below, the electrode 100 may be used to deliver an electrical signal to the brain tissue 25 adjacent the contact surface 115 . At higher stimulus levels, electrical contact between the patient's scalp 30 and the head 102 of the electrode 100 may be uncomfortable for the patient. If so desired, the scalp 30 may be electrically insulated from the head 102 . This may be accomplished by applying on the head 102 a quantity of a dielectric, biocompatible, cementitious material (not shown), which may be cured or dried in place. In another embodiment, the head 102 may be covered with a separate cap 130 (shown in dashed lines in FIG. 2A ) formed of a dielectric material, e.g., a dielectric, biocompatible plastic, that may be glued, press-fit, or otherwise attached to the head 102 and/or the lead 120 .
- a separate cap 130 shown in dashed lines in FIG.
- the dimensions of the electrode 100 can be varied to meet various design objectives. In one embodiment, however, the electrode 100 is longer than the thickness of the patient's skull. More specifically, the head 102 is adapted to be seated at an extracranial subcutaneous site while the threaded shaft 110 is only slightly longer than the skull thickness at the intended treatment site. Lengths on the order of 4-50 mm, for example, may be appropriate in certain applications. The diameter of the head 102 and the threaded shaft 110 may also be varied. For most applications, shafts 110 having diameters (typically excluding the width of the threads 112 ) of no greater than 4 mm will suffice. Shaft diameters of about 1-4 mm are likely, with diameters of 1.5-2.5 mm being well suited for most applications. FIGS.
- FIGS. 2 A-B illustrate an electrode 100 having a constant diameter shaft 110 , but it should be understood that the shaft diameter may vary.
- the shaft 110 may taper distally to improve the ability of the shaft 110 to be self-tapping.
- the head 102 typically will have a larger diameter than an adjoining portion of the shaft 110 .
- FIGS. 2-15 are not drawn to scale. In particular, the aspect ratio of the electrodes is significantly reduced to better illustrate certain functional aspects of the designs.
- FIG. 3A illustrates an intracranial electrode 150 in accordance with another embodiment of the invention.
- This intracranial electrode 150 is similar in many respects to the intracranial electrode 100 of FIGS. 2 A-B.
- the electrode 150 includes an electrically conductive threaded shaft 110 defining a blunt, atraumatic contact surface 115 adjacent a distal end.
- connection of the electrode 150 to the lead 160 in FIGS. 3 A-B differs somewhat from the connection of the electrode 100 and lead 120 in FIGS. 2 A-B, however.
- the electrode 100 is electrically coupled to the lead 120 by compressively engaging the electrically conductive ring 122 of the lead 120 between the electrode head 102 and the skull 10 .
- the electrode 150 includes a head 152 including slots 154 or other structure for engaging a screwdriver, wrench, or the like.
- the head 152 is adapted to engage a cap 162 carried by the lead 160 that electrically couples the body 164 of the lead 160 to the head 152 of the electrode 150 .
- the cap 162 comprises a dielectric body (e.g., a dielectric plastic material with some resilience) having an electrically conductive inner surface 163 , which may be provided by coating an interior surface of the cap 162 with a metal.
- the cap 162 is adapted to resiliently deform to be press-fitted on the head 152 .
- the body 164 of the lead 160 may be coupled to the electrically conductive inner surface 163 of the cap 162 , thereby providing an electrical pathway between the electrode 150 and a pulse system (not shown) operatively coupled to the lead 160 .
- the cap 162 is sized to be subcutaneously implanted beneath the patient's scalp 30 .
- the head 152 and the cap 162 both extend outwardly beyond the outer cortex 12 of the patient's skull 10 .
- some or all of the length of the head 152 and/or the cap 162 may be countersunk into a recess formed through the outer cortex 12 and/or an outer portion of the cancellous 18 . This can improve patient comfort, which can be useful if the intracranial electrode 150 is intended to be implanted permanently or for an extended period of time.
- FIGS. 4 A-B schematically illustrate aspects of an intracranial electrode 200 in accordance with another embodiment.
- the electrode 200 may comprise an electrically conductive inner portion 205 and an electrically insulative outer portion 206 .
- the electrically conductive portion 205 of the electrode 200 includes a head 202 and a threaded shaft 210 defining a contact surface 215 for electrically contacting the patient's dura mater 20 .
- These elements of the electrode 200 and their electrical connection to the lead 120 are directly analogous to the electrode 100 shown in FIGS. 2 A-B.
- the electrically insulative outer portion 206 of the electrode 200 shown in FIG. 4A comprises a dielectric member 240 that is disposed between the threaded shaft 210 and the patient's skull 10 .
- this dielectric member 240 may take the form of a tapered sleeve.
- the sleeve 240 may have an upper ring-like portion 242 and a plurality of deformable flanges 244 extending distally therefrom.
- the flanges 244 may be adapted to be urged outwardly into compressive contact with a bore formed in the patient's skull 10 when the threaded shaft 210 is advanced into the interior of the sleeve 240 .
- ribs or teeth may be provided on the exterior surfaces of the flanges 244 to further anchor the sleeve 240 in the cancellous 18 .
- the sleeve 240 is formed of a dielectric plastic and the threads of the threaded member 210 may be self-tapping in the inner wall of the sleeve 240 .
- the dielectric sleeve 240 When implanted in a skull 10 as shown in FIG. 4A , the dielectric sleeve 240 will electrically insulate the skull 10 from the electrically conductive shaft 210 of the electrode 200 . (The sleeve 240 need not completely electrically isolate the skull and shaft 210 ; it merely serves to reduce electrical conduction to the skull 10 .) As explained below, some embodiments of the invention employ an array comprising a plurality of intracranial electrodes implanted at various locations in a patient's skull 10 . The use of a dielectric member such as the dielectric sleeve 240 can help electrically isolate each of the electrodes 200 from other electrodes 200 in the array (not shown).
- the electrode 200 may be provided with a dielectric cap 230 sized and shaped to be implanted subcutaneously beneath the patient's scalp 30 (not shown in FIG. 4A ). Much like the cap 130 of FIG. 2A , this cap 230 may electrically insulate the patient's scalp from the electrically conductive head 202 . This may further improve electrical isolation of the electrodes 200 in an array.
- FIG. 5 illustrates an intracranial electrode 250 in accordance with yet another embodiment of the invention.
- This electrode 250 includes an electrically conductive shaft 260 electrically coupled to a subcutaneously implantable head 262 and a distally positioned contact surface 265 .
- the shaft 260 is received in the interior of an externally threaded dielectric layer 280 .
- the shaft 260 may be operatively coupled to the dielectric layer 280 for rotation therewith as the electrode is threadedly advanced through the patient's skull 10 . In one embodiment, this may be accomplished by a spline connection between the shaft 260 and the dielectric layer 280 .
- the dielectric layer 280 may be molded or otherwise formed about the shaft 260 .
- the dielectric layer 280 comprises an electrically insulative ceramic material. In another embodiment, the dielectric layer 280 comprises an electrically insulative plastic or other biocompatible polymer that has sufficient structural integrity to adequately anchor the electrode 250 to the skull 10 for the duration of its intended use. If so desired, the dielectric layer 280 may be porous or textured to promote osseointegration of long-term implants. For shorter-term applications, the dielectric layer 280 may be formed of or covered with a material that will limit osseointegration.
- the intracranial electrode 100 , 150 , 200 , or 250 has a fixed length.
- the distance between the base of the head 102 and the contact surface 115 remains fixed.
- the threaded shaft 110 is sunk into the skull 10 to a depth sufficient to compress the conductive ring 122 of the lead 120 between the head 102 and the skull 10 , this will also fix the distance from the exterior surface of the outer cortex 12 of the skull 10 to the contact surface 115 .
- the thickness of the skull 10 can vary from patient to patient and from site to site on a given patient's skull.
- the pressure exerted by the contact surface 115 against the dura mater 20 will vary depending on the thickness of the skull. If the electrode 100 is selected to be long enough to make adequate electrical contact with the dura mater adjacent the thickest site on a skull, the pressure exerted by the contact surface 115 against the dura mater 20 may cause undue damage at sites where the skull is thinner. Consequently, it can be advantageous to provide a selection of electrode sizes from which the physician can choose in selecting an electrode 100 for a particular site of a specific patient's skull.
- FIGS. 6-12 illustrate embodiments of electrodes with adjustable lengths.
- FIGS. 6 A-B for example, illustrate an intracranial electrode 300 that is adapted to adjust a distance between the outer surface of the skull 10 and a contact surface 315 of the electrode 300 . This, in turn, enables the contact force between the contact surface 315 and the surface of the dura mater 20 to be varied without requiring multiple electrode lengths.
- the intracranial electrode 300 of FIGS. 6A and 6B includes a probe or shaft 310 that has a blunt distal surface defining the contact surface 315 of the electrode 300 .
- the shaft 310 has a proximal end 312 that may include a torque drive recess 314 or the like to facilitate rotation of the shaft 310 relative to a head 320 of the electrode 300 .
- At least a portion of the length of the shaft 310 is externally threaded.
- the shaft has an externally threaded proximal length and an unthreaded surface along a distal length.
- the head 320 of the electrode 300 comprises a body 322 and a tubular length 324 that extends from the body 322 .
- the body 322 may be adapted to be rotated by hand or by an installation tool.
- the body 322 is generally hexagonal to facilitate rotation with an appropriately sized wrench.
- the body 322 has a pair of recesses 323 in its outer face sized and shaped to interface with a dedicated installation tool (not shown) having projections adapted to fit in the recesses 323 .
- the installation tool may be a torque wrench or other tool adapted to limit the amount of torque an operator may apply to the head 320 of the electrode 300 during installation.
- the tubular length 324 may be externally threaded so the head 320 may be anchored to the skull 10 by screwing the tubular length 324 into the skull 10 .
- the head 320 includes an internally threaded bore 326 that extends through the thickness of the body 322 and the tubular length 324 .
- the bore 326 has threads sized to mate with the external threads on the shaft 310 .
- a biocompatible sealant e.g., a length of polytetrafluoroethylene tape
- Rotation of the shaft 310 with respect to the head 320 will, therefore, selectively advance or retract the shaft 310 with respect to the head 320 . This will, in turn, increase or decrease, respectively, the distance between the lower face 323 of the head body 322 and the contact surface 315 of the shaft 310 . As suggested in FIG. 6A , this may be accomplished by inserting a tip 344 of a torque driver 340 into the torque drive recess 314 in the shaft 310 and rotating the torque driver 340 .
- the tip 344 of the torque driver 340 may be specifically designed to fit the torque drive recess 314 . In the embodiment shown in FIGS.
- the torque drive recess 314 is generally triangular in shape and is adapted to receive a triangular tip 344 of the torque driver 340 .
- the torque driver 340 may comprise a torque wrench or the like that will limit the maximum torque and operator can apply to the shaft 310 of the electrode 300 .
- the torque driver 340 may include graduations 342 to inform the physician how far the shaft 310 has been advanced with respect to the head 320 .
- the thickness of the skull at the particular treatment site may be gauged before the electrode 300 is implanted. Using this information and the graduations 342 on the torque driver 340 , the physician can fairly reliably select an appropriate length for the electrode 300 to meet the conditions present at that particular site.
- the head 320 and the shaft 310 are both formed of an electrically conductive material.
- the conductive ring 122 of the lead 120 may be received in a slot formed in the lower face 323 of the body 322 .
- the ring 122 may be internally threaded, permitting it to be threaded over the external threads of the tubular length 324 before the head 320 is implanted. If so desired, the ring 122 can instead be compressively engaged by the lower face 323 of the head 320 in a manner analogous to the engagement of the head 102 with the ring 122 in FIG. 2A , for example.
- the head 320 is formed of a dielectric material, such as a dielectric ceramic or plastic. This may necessitate a different connection between the lead 120 and the shaft 310 , such as by electrically contacting the lead 120 to the proximal end 312 of the shaft 310 .
- Employing a dielectric head 320 can help electrically insulate the skull 10 from the electrodes 300 , improving signal quality and reducing interference between the various electrodes 300 in an array, as noted above.
- FIG. 7 schematically illustrates an intracranial electrode 350 in accordance with a further embodiment of the invention.
- the electrode 350 includes a shaft or probe 360 having a proximal end 362 and a distally located contact surface 365 .
- the shaft 360 may include a first threaded portion 360 a and a second threaded portion 360 c .
- the first and second threaded portions 360 a and 360 c are separated by an unthreaded intermediate portion 360 b .
- the two threaded portions 360 a and 360 c directly abut one another.
- the intracranial electrode 350 of this embodiment also includes a head 370 having an internally threaded bore 376 extending through its thickness.
- the threads of the bore 376 are adapted to mate with the threads of the first threaded portion 360 a .
- the head 320 of the electrode 300 in FIGS. 6 A-B has an externally threaded tubular length 324 that extends into the skull 10 and helps anchor the electrode 300 to the skull 10 .
- the shaft 310 may then move with respect to the skull by rotating the shaft 310 with respect to the head 320 .
- the head 370 is not directly anchored to the skull 10 . Instead, the threads of the second threaded portion 360 c are adapted to threadedly engage the skull 10 to anchor the electrode 350 with respect to the skull 10 and the head 370 is attached to the first threaded portion 360 a of the shaft 360 .
- the shaft 360 may be threaded into a pilot hole in the skull 10 .
- the head 370 may be screwed onto the first threaded portion 360 a of the shaft 360 to help fix the shaft 360 with respect to the skull and provide a less traumatic surface to engage the patient's scalp (not shown) when the scalp is closed over the electrode 350 .
- the length of the electrode 350 may first be adjusted by rotating the shaft 360 with respect to the head 370 . Once the electrode 350 has the desired length, the shaft 360 may be advanced into the skull 10 . The shaft 360 may be graduated to facilitate adjustment to the appropriate length.
- first threaded portion 360 a may be threaded in a direction opposite the second threaded portion 360 c and/or the pitch of the threads in the first threaded portion 360 a may be different from the pitch of the threads in the second threaded portion 360 c.
- the shaft 360 of the electrode 350 extends through the dura mater 20 and the contact surface 365 of the electrode 350 is in direct contact with the cerebral cortex of the patient's brain.
- the length of the electrode 350 may be selected so that the contact surface 365 electrically contacts the dura mater 20 without extending therethrough, much as illustrated in FIG. 6A , for example.
- FIGS. 8-11 illustrate an intracranial electrode 400 in accordance with another embodiment of the invention.
- the intracranial electrode 400 includes a shaft or probe 410 that is slidably received by a head 420 .
- the shaft 410 comprises an electrically conductive material and defines an electrical contact surface 415 , e.g., on its distal end.
- some or a majority of the head of the electrode extends outwardly beyond the outer surface of the skull 10 .
- the head 420 is received entirely within the thickness of the skull 10 . It should be understood, though, that this is not necessary for operation of the device, and this is shown simply to highlight that the position of the head 420 with respect to the skull 10 can be varied. In another embodiment, at least a portion of the head 420 extends outwardly beyond the outer surface of the skull 10 .
- the head 420 includes a base 430 and an actuator 422 .
- the base 430 includes an externally threaded body 432 and a tubular length 434 that extends from the body 432 .
- a portion of the tubular length 434 carries external threads 436 .
- the tubular length 434 may also include one or more locking tabs 440 , each of which includes an actuating surface 442 .
- the actuator 422 has an internally threaded bore 424 that is adapted to matingly engage the threads 436 on the base 430 .
- Rotating the actuator 422 with respect to the base 430 in a first direction will advance the actuator 422 toward the actuating surface 442 of each of the tabs 440 .
- the actuator 422 may urge against the actuating surfaces 442 , pushing the tabs 440 inwardly into engagement with the shaft 410 . This will help lock the shaft 410 in place with respect to the base 430 .
- Rotating the actuator 422 in the opposite direction will allow the tabs 440 to resiliently return toward a rest position wherein they do not brake movement of the shaft 410 .
- the force with which the shaft 410 engages the dura mater 20 then can be adjusted to a desired level by moving the shaft 410 with respect to the base 430 .
- the actuator 422 may be moved into engagement with the tabs 440 to hold the shaft 410 in the desired position.
- FIG. 12 illustrates an adjustable-length intracranial electrode 450 in accordance with another embodiment.
- the intracranial electrode 450 includes an axially slidable probe or shaft 452 and a head 460 .
- the head 460 includes a body 462 and an externally threaded tubular length 464 .
- the tubular length 464 includes an axially extending recess 466 sized to slidably receive a portion of the shaft 452 .
- An O-ring 465 or the like may provide a sliding seal between the head 460 and the shaft 452 .
- the contact surface 455 of the shaft 452 is pushed against the surface of the dura mater 20 with a predictable force by means of a spring 454 received in the recess 466 .
- the spring 454 is typified as a compressed coil spring formed of a helically wound wire or the like.
- an electrical contact 469 of the lead 468 may be electrically coupled to the wire of the spring 454 . Electrical potential may then be conducted to the shaft 452 by the wire of the spring 454 .
- the spring 454 comprises a compressed elastomer, which may take the form of a column that fills some or all of the diameter of the recess 466 .
- the elastomer may comprise a biocompatible polymeric material, for example.
- the elastomer may be electrically conductive, e.g., by filling a polymeric material with a suitable quantity of a conductive metal powder or the like.
- one or more wires may be embedded in the elastomeric material to conduct an electrical signal across the elastomer to the shaft 452 .
- the head 460 may be formed of a dielectric material, helping electrically insulate the skull 10 from the shaft 452 .
- the head 460 may be formed of an electrically conductive material. Even though the other structural elements of the electrode 450 may remain largely the same, this would avoid the necessity of having the lead 468 extend through the head 460 ; an electrically conducive ring 122 or the like instead may be employed in a manner analogous to that shown in FIG. 6A , for example.
- FIG. 13 depicts and adjustable-length intracranial electrode 475 in accordance with a different embodiment.
- the intracranial electrode 475 includes an axially slidable probe or shaft 480 that is slidably received in an axially extending recess 488 in a tubular length 492 of a head 490 .
- a proximal face of the body 490 may include a pair of tool-receiving recesses 494 , which may be analogous to the tool-receiving recesses 323 noted above in connection with FIG. 6A , to aid in the installation of the body 490 .
- one or more seals may be provided between the shaft 480 and the body 490 .
- the body 490 carries a first O-ring 493 and the shaft 480 and carries a second O-ring 484 sealed against the interior of the recess 488 .
- These O-rings may also serve as abutments to limit axial travel of the shaft 480 in the recess 488 .
- the contact surface 481 of the shaft 480 is pushed against the surface of the dura mater 20 with a predictable force by means of a spring 486 .
- the spring 486 may be substantially the same as the spring 454 shown in FIG. 12 , and the various materials suggested above for the spring 454 may also be employed in the spring 486 of FIG. 13 .
- the spring 454 provides the electrical connection between the lead 468 and the shaft 452 .
- the lead 496 may be connected directly to the shaft 480 through a lumen 495 in the body 490 .
- This lumen 495 is sized to slidably receive a reduced-diameter neck 482 of the shaft 480 .
- the electrode 475 of FIG. 13 may facilitate delivering a highly reproducible contact force of the contact surface 481 of the shaft 480 against the dura mater 20 .
- the position of the reduced-diameter neck 482 of the shaft 480 within the lumen 495 will vary in a fixed relationship with the force exerted on the spring 486 by the shaft 480 . Since the force of the shaft 480 against the spring 486 is essentially the same as the force of the shaft 480 against the dura mater 20 , knowing the position of the neck 482 within the lumen 495 can give the operator an indication of the force exerted against the dura mater 20 .
- the interior of the lumen 495 may be graduated to mark off the depth of the neck 482 in the lumen 495 .
- the body 490 may be driven into the skull 10 until the height of the neck 482 in the lumen 495 reaches a predetermined point, e.g., when the top of the neck 482 is flush with the top of the body 490 .
- FIG. 14 illustrates an intracranial electrode 500 in accordance with still another embodiment of the invention.
- This electrode 500 includes an electrically conductive probe or shaft 510 having a head 512 and a contact surface 515 .
- a radially compressible retaining collar 540 extends along a portion of the length of the shaft 510 .
- the retaining collar 540 may be adapted to assume a radially reduced configuration in response to a compressive force, indicated schematically by the arrows F.
- This compressive force F may be generated by collapsing the retaining collar 540 and restraining it in the lumen of an introducing sheath (not shown) sized to be received in a bore through the skull 10 .
- this force F is removed (e.g., by retracting the introducing sheath), the retaining collar 540 may expand radially outwardly away from the shaft 510 , as illustrated in FIG. 16 .
- the shaft 510 may be advanced into a bore in the skull until the contact surface 515 exerts the desired contact force against the dura mater 20 . Once the shaft 510 is in the desired position, the compressive force F on the collar 540 may be released, allowing the collar 540 to expand outwardly into compressive engagement with the lumen of the bore in the skull 10 . This will help hold the electrode 500 in place with respect to the skull without requiring permanent anchoring of the shaft 510 to the skull 10 .
- the shaft 510 may be electrically coupled to a pulse system (not shown) by a lead 520 .
- the lead 520 may include a cap 522 having an electrically conductive inner surface 524 coupled to a body 526 of the lead.
- the lead 520 may be analogous to the lead 160 shown in FIGS. 3 A-B. Any other suitable electrical connection between the shaft 510 and the pulse system may be employed.
- the collar 540 comprises a dielectric material. This will help electrically insulate the skull 10 from the shaft 510 .
- the collar 540 is electrically conductive and the lead 520 may be electrically coupled to the shaft 510 via the collar 540 .
- the shaft 510 may have a length only a little longer than the thickness of the patient's skull 10 and the contact surface 515 may be relatively blunt. Such a design is useful for relatively atraumatic contact with the dura mater 20 .
- the electrode 500 may instead have a substantially longer shaft 510 a and a relatively sharp contact surface 515 a . Such an embodiment may be useful for directly stimulating a particular location within the cerebral cortex or some other location within the deeper tissues of the brain.
- FIG. 17 schematically illustrates how certain principles of the invention can be embodied in a subcortical or deep brain intracranial electrode 550 .
- the electrode 550 generally includes a threaded shaft 560 having a head 562 .
- the head 562 may be coupled to a pulse system or a sensing unit (as described below) via a lead 160 in the same manner lead 160 is attached to the head 152 of electrode 150 in FIGS. 3 A-B.
- the electrode 550 also includes an elongate conductive member 570 that extends inwardly from the skull 10 to a selected target site 28 .
- the conductive member 570 which may comprise a length of a conductive wire, may be electrically shielded by a dielectric sheath along much of its length and have an exposed, electrically conductive tip 574 .
- the conductive member 570 may be slid freely through a pilot hole 11 formed through the skull to position the tip 574 at the target site 28 in a known manner.
- the pilot hole 11 may be larger than the conductive member 570 or be tapped to receive the threads of the shaft 560 .
- the shaft 560 may be threaded into the pilot hole 11 , crimping the conductive member 570 against an interior of the pilot hole 11 . This will fix the conductive member 570 in place.
- a proximal length 572 of the conductive member 570 may extend outwardly of the skull and be held in place by the head 562 .
- the threads of the threaded shaft 560 may also cut through the dielectric sheath of the conductive member 570 as the shaft 560 is screwed into place, making electrical contact with the conductive wire therein.
- FIG. 18 schematically illustrates a subcortical or deep brain intracranial electrode 600 in accordance with an alternative embodiment of the invention.
- This electrode 600 includes a head 610 having a threaded shaft 620 with an axially-extending opening 622 extending through the length of the head 610 .
- the head 610 may also include a gimbal fitting 630 adapted to slidably receive a length of a conductive member, which may comprise the same type of elongate conductive member 570 discussed above in connection with FIG. 17 .
- the gimbal fitting 630 is adapted to allow an operator greater control over the placement of the electrically conductive tip 574 of the conductive member 570 .
- the tip 574 of the conductive member 570 will be threaded through an opening in the gimbal fitting 630 .
- the angular orientation of the conductive member 570 with respect to the pilot hole 11 in the skull 10 can be accurately controlled.
- the operator may advance the conductive member 570 to position the conductive tip 574 at the target site 28 .
- the cap 162 of a lead 160 may be press-fitted on the body 610 of the electrode 600 . This will crimp the proximal length 572 of the connective member 570 between the body 610 and the conductive inner surface 163 of the cap 162 , providing an effective electrical connection between the conductive member 570 and the body 164 of the lead 160 .
- FIGS. 27-29 schematically illustrate intracranial electrodes that form portions of signal transmission systems in accordance with further embodiments of the invention.
- an electrode 700 comprises a body (e.g., a support body) that includes a head 702 coupled to a shaft 710 .
- the body of the electrode 700 may be integrally formed of an electrically conductive inner core 708 clad with a biocompatible electrically insulating material 712 .
- the electrically conductive portion 708 of the electrode 700 extends along the length of both the head 702 and the shaft 710 .
- An electrical lead 720 may be coupled to the electrode core 708 to facilitate electrical signal transfer, for example, for electrical stimulation and/or monitoring.
- the lead 720 may be coupled to a pulse generator.
- An electrical contact or contact portion 704 transmits electrical signals to and/or from the brain tissue 25 .
- the electrical contact portion 704 can be integral with or connected to the conductive inner core 708 .
- the electrical contact portions are housed within an insulative body. Electrical contact portions in accordance with other embodiments of the invention can have other arrangements (e.g., they can form part of a larger, generally conductive element).
- FIG. 28 illustrates another intracranial electrode 750 in accordance with an embodiment of the invention.
- the body of electrode 750 may comprise a biocompatible electrically insulating material 765 containing a set of biocompatible, electrically conductive contacts 760 a and 760 b .
- the electrically conductive contacts 760 a and 760 b may be carried by different portions of the electrode 750 to facilitate production of particular types of electric field distributions.
- a first contact 760 a may be carried by the head 762
- a second contact 760 b may be carried by a distal portion of the shaft 755 , which may be configured to be in electrical contact with a stimulation site.
- a lead 770 may comprise lead wires or links 772 and 774 to provide electrical signal pathways to the contacts 760 a and 760 b.
- FIG. 29 illustrates yet another embodiment of an intracranial electrode 780 .
- the intracranial electrode 780 may comprise electrical contacts 796 and 798 that are carried by a distal portion of a shaft 785 .
- a head 782 can stabilize the shaft 785 relative to the skull 10 .
- a lead 790 may comprise lead wires or links 792 and 794 that are electrically coupled to one or more contacts 796 and 798 .
- Such lead wires 792 and 794 may facilitate electrical stimulation and/or monitoring using one or both contacts 796 and 798 .
- the shaft 785 can carry two contacts 796 , 798 , and in other embodiments, the shaft 785 can carry more or fewer contacts.
- the diameter of the shaft 785 can be selected based on factors that include the number of contacts carried by the shaft 785 .
- the shaft 785 can have a diameter of from about 0.5 millimeters to about 3.0 centimeters. In other embodiments, the diameter of the shaft 785 can have other values.
- the shaft 785 can be inserted into the skull in a manner that is consistent with the diameter of the shaft 785 . For example, smaller shafts 785 can be inserted through a burr hole in the skull 10 , and larger shafts 785 can be inserted using a craniotomy procedure.
- FIGS. 30 and 31 schematically illustrate other embodiments of the invention that may be applicable to cortical, subcortical, and/or deep brain stimulation and/or monitoring situations. Such embodiments may facilitate stimulation and/or monitoring involving surface or cortical tissues and/or subcortical or deep brain tissues.
- like reference numbers may correspond to identical, essentially identical, or analogous elements.
- One embodiment of a combined intracranial electrode assembly 800 is shown in FIG. 30 .
- the combined intracranial electrode assembly 800 comprises a first electrode 810 and a second electrode 820 .
- the first and second electrodes 810 and 820 may be configured and dimensioned for placement relative to physically distinct locations of the brain. For example, the first electrode 810 may be in contact with the dura 20 , while the second electrode 820 may be positioned relative to a subcortical or deep brain location.
- the first electrode 810 comprises at least one electrical contact 815 carried by a distal portion of a shaft 816 .
- a first lead wire 830 may be coupled to the first electrode's contact 815 .
- the second electrode 820 may comprise an elongate member 822 that carries one or more conductive portions, sections, segments, and/or contacts 825 , in a manner identical, essentially identical, or analogous to that described above.
- a second lead wire 835 may be coupled to the second electrode's contact(s) 825 .
- each electrode 810 , 820 can provide independently controlled stimulation signals.
- one of the electrodes 810 , 820 can be coupled to a transmitter to provide stimulation signals to the patient, and the other can be coupled to a sensor to receive diagnostic signals from the patient.
- the electrodes 810 , 820 can be coupled to a common ground, or can be coupled to independent grounds.
- FIG. 31 illustrates an embodiment of an intracranial electrode assembly 800 wherein a first electrode 810 comprises at least one electrical contact 817 carried by a head 812 .
- the contact 817 is shown spanning a proximal surface portion of the head 812 , it is to be appreciated that the contact 817 may be located along, upon, and/or within various portions of the head 812 .
- the first electrode 810 comprises a shaft 816 that need not touch or rest against neural tissue such as the dura 20 . Rather, the shaft 816 may be shorter than in an embodiment such as shown in FIG. 30 .
- a first electrode 810 may include a contact 815 ( FIG. 30 ) carried by the shaft 816 in addition to the contact 817 carried by the head 812 . Such an embodiment may include an additional lead wire (not shown).
- a combined electrode assembly 800 may be comprised of one or more electrically nonconductive portions along with one or more electrically conductive portions.
- nonconductive portions 814 and 822 of the first and second electrodes 810 and 820 may be formed from one or more biocompatible materials (e.g., plastic, silicone, and/or other materials), and conductive portions such as the first and second sets of contacts 815 and 825 may be formed from one or more biocompatible conductive materials (e.g., Titanium, Platinum, and/or other materials).
- one or more contacts 815 may be configured as an anode or a cathode, while other contacts 825 may respectively be configured as a cathode or an anode to facilitate bipolar and/or unipolar stimulation as further described below.
- a combined electrode assembly 800 may be implanted into a patient such that a local contact portion, which may comprise a distal portion of a shaft 816 , resides at, upon, or proximate to a stimulation site; while a remote contact portion, which may comprise a distal portion 826 of an elongate member 822 , provides a remote or distant circuit completion site.
- intracranial electrode embodiments may depend upon the location, depth, and/or spatial boundaries of target neural structures and/or target neural populations under consideration, which may depend upon the nature of a patient's neurological condition or disorder.
- the extent to which an electric field reaches, penetrates, and/or travels into and/or through target neural structures and/or a target neural population may affect neural stimulation efficiency and/or efficacy.
- Various intracranial electrode embodiments in accordance with the invention for example, those described above with reference to FIGS. 27-31 , may have conducting portions in various positions or locations, which may facilitate establishment of particular types of electric field distributions at one or more times.
- FIG. 19 is a schematic illustration of a neurostimulation system 1000 in accordance with one embodiment of the invention.
- This neurostimulation system 1000 includes an array 1010 of intracranial electrodes and an internally implantable pulse system 1050 .
- the array 1010 of electrodes may employ one or more electrodes in accordance with any one or more of the embodiments described above in connection with FIGS. 2-18 and/or 27 - 31 and/or any other suitable design.
- the array 1010 (shown schematically in FIG. 20 ) includes a first implantable intracranial electrode 100 a and a second implantable intracranial electrode 100 b , each of which may be substantially the same as the electrode 100 shown in FIGS. 2 A-B.
- These electrodes 100 b and 100 b extend through the skull 10 into contact with the dura mater 20 at two spaced-apart locations.
- the pulse system 1050 may be implanted in the body of the patient P at a location remote from the array 1010 of electrodes 100 .
- the pulse system 1050 is adapted to be implanted subclavicularly.
- the pulse system 1050 is adapted to be implanted in a recess formed in the patient's skull 10 .
- each of the electrodes 100 in the array 1010 is electrically coupled to the pulse system 1050 by means of a separate lead ( 120 in FIGS. 2 A-B) having an elongate, subcutaneously implantable body 124 .
- electrode 100 a is coupled to the pulse system 1050 by the elongate body 124 a of a first lead and the other electrode 100 b is coupled to the pulse system 1050 by the elongate body 124 b of another lead.
- the elongate bodies 124 a - b are combined into a single subcutaneously implantable cable or ribbon.
- FIG. 21 schematically illustrates one pulse system 1050 suitable for use in the neurostimulation system 1000 shown in FIG. 19 .
- the pulse system 1050 generally includes a power supply 1055 , an integrated controller 1060 , a pulse generator 1065 , and a pulse transmitter 1070 .
- the power supply 1055 can be a primary battery, such as a rechargeable battery or other suitable device for storing electrical energy.
- the power supply 1055 can be an RF transducer or a magnetic transducer that receives broadcast energy emitted from an external power source and converts the broadcast energy into power for the electrical components of the pulse system 1050 .
- the controller 1060 includes a processor, a memory, and a programmable computer medium.
- the controller 1060 can be a computer, and the programmable computer medium can be software loaded into the memory of the computer and/or hardware that performs the requisite control functions.
- the controller 1060 may include an integrated RF or magnetic controller 1064 that communicates with an external controller 1062 via an RF or magnetic link. In such a circumstance, many of the functions of the controller 1060 may be resident in the external controller 1062 and the integrated portion 1064 of the controller 1060 may comprise a wireless communication system.
- the controller 1060 is operatively coupled to and provides control signals to the pulse generator 1065 , which may include a plurality of channels that send appropriate electrical pulses to the pulse transmitter 1070 .
- the pulse generator 1065 may have N channels, with at least one channel associated with each of N electrodes 100 in the array 1010 .
- the pulse generator 1065 sends appropriate electrical pulses to the pulse transmitter 1070 , which is coupled to a plurality of electrodes 1080 .
- each of these electrodes is adapted to be physically connected to the body 124 of a separate lead, allowing each electrode 1080 to electrically communicate with a single electrode 100 in the array 1010 on a dedicated channel of the pulse generator 1065 .
- Suitable components for the power supply 1055 , the integrated controller 1060 , the pulse generator 1065 , and the pulse transmitter 1070 are known to persons skilled in the art of implantable medical devices.
- the array 1010 of electrodes 100 in FIG. 19 comprises a simple pair of electrodes 100 a and 100 b implanted in the patient's skull at spaced-apart locations.
- FIGS. 23-26 illustrate alternative arrays that may be useful in other embodiments.
- the array 1010 a includes four electrodes 100 arranged in a rectangular array.
- the array 1010 b of FIG. 24 includes sixteen electrodes 100 , also arranged in a rectangular array.
- the array 1010 c shown in FIG. 25 includes nine electrodes 100 arranged in a radial array.
- FIG. 26 illustrates an array 1010 d that includes four electrodes 100 ⁇ arranged in a rectangular pattern and a fifth electrode 100 y at a location spaced from the other four electrodes 100 x .
- the four proximate electrodes 100 ⁇ may be provided with the same polarity and the fifth electrode 100 y may have a different polarity.
- the housing ( 1052 in FIG. 19 ) of the pulse system 1050 may serve the function of the fifth electrode 100 y .
- the precise shape, size, and location of the array 1010 and the number of electrodes 100 in the array 110 can be optimized to meet the requirements of any particular application.
- One or more electrodes 100 of arrays 1010 such as those described herein may be provided with electrical signals in a variety of spatially and/or temporally different manners. In some circumstances, one electrode 100 or a subset of the electrodes 100 may have one electrical potential and a different electrode 100 or subset of the electrodes 100 (or, in some embodiments, the housing 1052 of the pulse system 1050 ) may have a different electrical potential.
- U.S. patent application Ser. No. 09/978,134 entitled “Systems and Methods for Automatically Optimizing Stimulus Parameters and Electrode Configurations for Neuro-Stimulators” and filed 15 Oct.
- neural stimulation efficiency and/or efficacy may be influenced by an extent to and/or manner in which neural stimulation reaches and/or travels into and/or through target neural structures and/or a target neural population, which may be affected by stimulation signal polarity, electrode configuration, and/or electrical contact configuration considerations.
- the particular neural structures and/or neural populations targeted at any time in a neural stimulation situation, and hence such considerations, may depend upon the nature, severity, and/or spatial boundaries of a patient's neurologic dysfunction.
- Various embodiments in accordance with the present invention may be configured to provide bipolar and/or unipolar stimulation at one or more times.
- Neural stimulation in which both an anode and a cathode are positioned, located, or situated within, essentially across, or proximate to a stimulation site may be defined as bipolar stimulation.
- Neural stimulation in which one of an anode and a cathode is positioned, located, or situated within or proximate to a stimulation site while a respective corresponding cathode or anode is positioned, located, or situated remote from the stimulation site to provide electrical continuity may be defined as unipolar, monopolar, or isopolar stimulation.
- Unipolar stimulation may alternatively or additionally be characterized by a biasing configuration in which an anode and a cathode are positioned, located, or situated in different neurofunctional areas or functionally distinct anatomical regions.
- an anode and a cathode may be defined in accordance with a first phase polarity of a biphasic or polyphasic signal.
- a pulse system 1050 may apply an identical polarity signal to each electrode or electrical contact positioned upon or proximate to one or more stimulation sites.
- Unipolar stimulation may be defined as anodal unipolar stimulation when an anode is positioned upon or proximate to a stimulation site or a target neural population; and as cathodal unipolar stimulation when a cathode is positioned upon or proximate to a stimulation site or a target neural population.
- neural stimulation having particular stimulation signal and/or spatial and/or temporal characteristics (e.g., bipolar stimulation, cathodal or anodal unipolar stimulation, mixed-polarity stimulation, varying duty cycle stimulation, varying frequency stimulation, varying amplitude stimulation, spatially or topographically varying stimulation, theta burst stimulation, and/or other types of stimulation applied or delivered in a predetermined, pseudo-random, and/or aperiodic manner at one or more times and/or locations), possibly in association or conjunction with one or more adjunctive or synergistic therapies, may facilitate enhanced symptomatic relief and/or at least partial recovery from neurologic dysfunction.
- stimulation signal and/or spatial and/or temporal characteristics e.g., bipolar stimulation, cathodal or anodal unipolar stimulation, mixed-polarity stimulation, varying duty cycle stimulation, varying frequency stimulation, varying amplitude stimulation, spatially or topographically varying stimulation, theta burst stimulation, and/or other types of stimulation applied or delivered in a
- An adjunctive or synergistic therapy may comprise a behavioral therapy such as a physical therapy activity, a movement and/or balance exercise, an activity of daily living (ADL), a vision exercise, a reading task, a speech task, a memory or concentration task, a visualization or imagination exercise, an auditory activity, an olfactory activity, a relaxation activity, and/or another type of behavior, task, or activity; a drug or chemical substance therapy; and/or another therapy that may be relevant to a patient's functional state, development, and/or recovery.
- a behavioral therapy such as a physical therapy activity, a movement and/or balance exercise, an activity of daily living (ADL), a vision exercise, a reading task, a speech task, a memory or concentration task, a visualization or imagination exercise, an auditory activity, an olfactory activity, a relaxation activity, and/or another type of behavior, task, or activity
- a drug or chemical substance therapy and/or another therapy that may be relevant to a patient's functional state, development,
- Neurologic dysfunction to which various embodiments of the present invention may be directed may correspond to, for example, motor, sensory, language, visual, cognitive, neuropsychiatric, auditory, and/or other types of deficits or symptoms associated with stroke, traumatic brain injury, cerebral palsy, Multiple Sclerosis, Parkinson's Disease, essential tremor, a memory disorder, dementia, Alzheimer's disease, depression, bipolar disorder, anxiety, obsessive/compulsive disorder, Post Traumatic Stress Disorder, an eating disorder, schizophrenia, Tourette's Syndrome, Attention Deficit Disorder, a drug addiction, autism, epilepsy, a sleep disorder, a hearing disorder, and/or one or more other states, conditions, and/or disorders.
- At least partial symptomatic relief, functional recovery, and/or functional development may occur through mechanisms corresponding or analogous to Long Term Potentiation (LTP), Long Term Depression (LTD), neuroplastic change, and/or compensatory processes.
- LTP Long Term Potentiation
- LTD Long Term Depression
- FIG. 32 is a schematic illustration of an exemplary implantation configuration for a neural stimulation system 1000 according to an embodiment of the invention.
- a neural stimulation system 1000 may comprise a set of intracranial electrodes 100 c and 100 d coupled by lead wires 124 c and 124 d to a pulse system 1050 .
- the intracranial electrodes 100 c and 100 d may be surgically implanted at or relative to a set of target sites, and the pulse system 1050 may be implanted beneath the scalp 30 and adjacent to and/or partially within the skull 10 .
- a particular separation between and/or relative positioning of two or more intracranial electrodes 100 c and 100 d may be established, such that target electrode implantation or stimulation sites may correspond to anatomically remote and/or distinct regions. This may facilitate unipolar stimulation and/or stimulation of neural populations in different neural association areas, for example, different neurofunctional areas associated with motor skills or abilities; neurofunctional areas associated with motor and language skills; and/or neurofunctional areas associated with other skills.
- FIG. 33 is a schematic illustration of another exemplary implantation configuration for a neural stimulation system 1000 according to an embodiment of the invention.
- like reference numbers may indicate like, corresponding, and/or analogous elements.
- a set of intracranial electrodes 100 e and 100 f may be implanted or positioned relative to particular neurofunctional areas.
- the set of electrodes 100 e and 100 f may exhibit multiple types of electrical contact configurations, orientations, and/or geometries.
- a particular electrode 100 e may carry an electrical contact C e that is distinctly different from one or more contacts C f carried by another electrode 100 f .
- differences in contact configuration may facilitate establishment of particular types of electric field distributions, which may influence neural stimulation efficiency and/or efficacy.
- intracranial electrodes e.g., electrodes 100 , 150 , 200 , 250 , 300 , 350 , 400 , 450 , 475 , 500 , 550 , or 600
- intracranial electrodes may additionally or alternatively be used to monitor electrical potentials, for example, in situations involving electroencephalography or electrocorticography.
- a suitable electroencephalograph may incorporate a system similar to the neurostimulation system 1000 shown in FIG. 19 , but a sensing unit (not shown) may be used in place of the pulse system 1050 . Suitable components for such a sensing unit are known to those skilled in the art of electroencephalography.
- FIG. 34A illustrates an intracranial electrode system 900 in accordance with an embodiment of the invention.
- the electrode system 900 comprises an electrical energy transfer mechanism (ETM) 910 externally placed adjacent to a patient's scalp 30 to couple electrical energy from a pulse generator 1050 to an intracranial electrode 920 .
- a lead wire 915 may couple the ETM 910 to the pulse generator 1050 .
- the pulse generator 1050 may be of an identical, essentially identical, analogous, or different type relative to a pulse generator 1050 shown in FIGS. 19-21 .
- the ETM 910 may comprise a conventional adhesive patch electrode commonly used for providing an electrical coupling to a particular location on a patient.
- the intracranial electrode 920 may comprise a head 922 coupled to a shaft 924 .
- the head 922 and shaft 924 may be integrally formed of an electrically conductive material forming a conductive core 925 that forms an electrical energy conduit.
- the conductive core 925 may extend throughout a portion or along the entire length of the electrode 920 .
- the conductive core 925 may be carried by or encased in an electrically insulating material or cladding 921 .
- the conductive core 925 may extend from an upper or proximal contact surface 925 a to a lower or distal contact surface 925 b .
- Contact surfaces 925 a and 925 b provide a signal exchange interface of the conductive core 925 .
- the conductive core 925 and the insulating material 921 may vary in proportionate dimensions with one another accordingly.
- FIG. 34B is a cross sectional illustration of an ETM 910 according to an embodiment of the invention.
- the ETM 910 comprises an energy transfer patch 912 that may have several layers.
- an ETM 910 may comprise an outer flexible, insulating, and/or articulated layer 916 , an electrically conductive layer 914 , and a gel layer 912 .
- the conductive layer 914 may be comprised of a conductive material, such as aluminum for example, for carrying or conveying an electrical signal.
- the conductive layer 914 may be appropriately shaped (e.g., oval or elliptical) for conforming to a portion of the skull's rounded surface, and may be coupled to the lead wire 915 .
- the conductive layer 914 forms a portion of a conductive circuit between the lead wire 915 and the conductive core 925 ( FIG. 34A ).
- the outer layer 916 may be comprised of essentially any appropriate insulating nonconductive material as is known in the art (e.g., foam).
- the outer layer 916 may be smooth and flexible to facilitate contouring to the patient's skin surface 30 .
- the gel layer 912 which may be placed in contact with scalp 30 , may comprise one or more of an electrically conductive coupling gel 912 a (such as a hydrogel or wet gel), an adhesive gel 912 b , and/or an anesthetic gel 912 c .
- Electrical coupling gel 912 a may be comprised of a saline composition for enhancing electrical conductivity and decreasing losses between the conductive layer 914 and scalp 30 .
- the adhesive gel 912 b aids in keeping the ETM 910 in place.
- An anesthetic gel 912 c may be incorporated to possibly reduce or retard sensations that may result from the transfer of electrical signals from the ETM 910 through scalp tissues 30 to the electrode 920 .
- FIG. 35 illustrates yet another embodiment of portions of an intracranial electrode system 900 .
- an intracranial electrode 930 comprises a head 932 and a shaft 934 forming a body of the electrode 930 .
- the electrode 930 may contain a conductive core 925 having contact surfaces 935 a and 935 b for conducting electrical energy through the scalp 30 to a stimulation site such as the dura 20 .
- the conductive core 935 may be clad with an electrically insulating material 931 .
- a portion of the insulating material 931 may form one or more portions of the shaft 934 , which may contain threads 935 for tapping into the cancellous 18 .
- intracranial electrode 930 may be tapped into the skull 10 to a desired depth.
- a bore, notch or groove 933 may be formed in a proximal portion of the head 932 to facilitate tapping the electrode 930 into place.
- FIG. 36 is an illustration of an intracranial electrode system 900 according to an embodiment of the invention.
- a set of intracranial electrodes 920 may be implanted relative to one or more target sites within cancellous 18 .
- electrodes 920 may be implanted relative to one or more target sites within cancellous 18 .
- ETMs 910 shown as ETMs 910 a , 910 b
- ETMs 910 a and 920 b may be placed proximate to each electrode 920 a and 920 b , external to the body and adjacent the scalp 30 .
- Such a set of ETMs 910 may be coupled to the pulse generator 1050 via leads 915 a and 915 b .
- the intracranial electrode system 900 may be configured to provide bipolar stimulation, as a first electrode 920 a may have a first polarity and a second electrode 920 b may have an opposing polarity as determined by electrical signals transmitted via corresponding lead wires 915 a and 915 b , respectively.
- each of the electrodes 920 may be biased with the same polarity in a unipolar configuration.
- a return electrode (not shown) may be placed in another location upon the patient's body; or one or more portions of the pulse generator's case may serve as a return electrode.
- the leads 915 a , 915 b can be generally continuous (e.g., they can extend from the corresponding ETM 910 a , 910 b to the pulse generator 1050 without a break, except for an optional releasable connection at the pulse generator 1050 ).
- FIG. 37 is an illustration of a set of implanted intracranial electrodes 940 a and 940 b according to an embodiment of the invention.
- the intracranial electrodes 940 a and 940 b may comprise heads 942 a and 942 b that are eccentrically offset relative to a center axis A 1 and A 2 of an electrode shaft 944 a and 944 b , respectively.
- a first offset may be defined for a first electrode 940 a by a first radius L1 and a second radius R1, where L1>R1.
- a second offset may be defined for a second electrode 940 b having a head 942 b with radii L2 and R2 where R2>L2.
- the offset radii may facilitate the placement of intracranial electrodes 940 a and 940 b in close or generally close proximity to one another at a distance D, while keeping D at a minimum due to the shorter radii R1 and L2.
- the offset radii provide maximum distancing between the ETMs 910 a and 910 b .
- having electrodes with off center heads 942 a and 942 b may provide better and/or more placement options when a plurality of electrodes are to be placed in close proximity to one another.
- the electrodes 940 a , 940 b can be secured relative to the skull 10 by inserting each of the electrodes 940 a , 940 b into a corresponding collar, e.g., a collar 540 generally similar to that described above with reference to FIG. 14 .
- the collar can be secured to the skull with one or more securement elements (e.g., threads).
- FIG. 38 illustrates an intracranial electrode 950 according to another embodiment of the invention.
- electrode 950 comprises a body formed of a head 952 and shaft 954 , wherein the head 952 and the shaft 954 are formed with an obtuse angle ⁇ at their juncture.
- the obtuse angle ⁇ provides the body of the electrode with a tapered, frustoconical shape that facilitates a more contoured, conformal implant within the cancellous 18 .
- the head 952 may also be formed with a protrusion or protruded upper portion E.
- the protrusion E may be rounded for a more contoured abutment with scalp tissues 30 to enhance patient comfort.
- the head 952 may be contoured and/or tapered, and may be at least partially recessed within the skull 10 to facilitate a more conformal positioning within the patient's skull 10 . Furthermore, a recessed, contoured placement within the skull 10 may provide a more aesthetically pleasing implant.
- An outer portion of the electrode 950 may be comprised of an insulating cladding 956 disposed around a conductive core 955 .
- the conductive core 955 can include a first electrical contact portion 955 a and a second conductive contact portion 955 b .
- the cladding 956 may be comprised of any suitable biocompatible electrically insulating material, such as, but not limited to, polymers and/or ceramic materials.
- the cladding 956 may contain a plurality of pores 957 . Pores 957 may encourage bone regeneration within and about the pores for a more friction enhanced and/or lasting placement within the skull 10 .
- an exterior portion of the cladding 956 in contact with body tissues may also be formed with a roughened surface (not shown) that may encourage bone growth and/or regeneration.
- a roughened surface not shown
- Such enhanced friction and intergrowth between the cladding 956 and the cancellous 18 may provide for a more secure and/or conformal placement, which may reduce or minimize positional migration of the implanted electrodes 950 .
- inventions may include variations of the cladding 957 having combinations of compatible insulative materials comprising the exterior; such as for example, an upper proximal portion of the cladding 967 being comprised of a ring-like polymer insulator; and/or a distal or generally distal portion of the cladding 967 being comprised of a ceramic insulator.
- FIG. 39 illustrates yet another intracranial electrode 960 according to an embodiment of the invention.
- the intracranial electrode 960 comprises a body having a head 962 and a shaft 964 .
- One or more portions of the head 962 and/or the shaft 964 may form a tapered transition region, such that a juncture of the head 962 and the shaft 964 form an obtuse angle 0 .
- the intracranial electrode 960 may be surgically implanted within a patient's skull 10 such that a proximal portion (e.g., an end surface) of the head 962 is flush or substantially flush with an outer portion or layer 12 of the skull 10 .
- the entirety of the electrode 960 may be countersunk into a recess formed through the outer skull 12 and cancellous 18 .
- the intracranial electrode 960 may also comprise a cladding 966 surrounding a conductive core 965 .
- the cladding 966 comprised of any suitable biocompatible material, may in some embodiments include recesses 967 which may encourage surrounding cancellous tissue 18 to grow within and/or around the recesses 967 , thus forming an enhanced bonding between the implanted electrode 960 and the skull 10 . This modified bonding may discourage migration of the electrode 960 .
- FIG. 40 illustrates an intracranial electrode system 900 according to another embodiment of the invention.
- the intracranial electrode system 900 comprises at least one intracranial electrode 970 that includes a radio frequency identification (RFID) element, tag, or transponder 971 and/or another type of proximity sensing and/or detecting device.
- RFID element 971 may be embedded within or carried by a portion of the head 972 and/or shaft 974 , for example, within an insulating non-conductive material 973 forming a portion of the head 972 . Insulating material 973 may electrically insulate the RFID element 971 from a conductive core 975 .
- the conductive core 975 may include contact surface areas 975 a and 975 b that couple to and/or comprise a portion of an electrical conduit that facilitates signal transfer or electrical communication between an ETM 910 and intended target tissues.
- the ETM 910 is electrically coupled to a pulse generator 1050 .
- the pulse generator 1050 may include an RFID unit 1063 comprising an RFID reader configured to identify one or more RFID elements 971 to either allow/enable or disallow/disable electrical signal transmissions to particular intracranial electrodes 970 at one or more times.
- the RFID unit 1063 may comprise an RFID reader that may include a transmitter and a receive module, a control unit, and a coupling element (e.g., an antenna).
- the reader may have three functions: energizing, demodulating, and decoding.
- a reader can include or be fitted with an interface that converts RF signals returned from an RFID element 971 into a form that can be passed on to and/or processed by other elements (e.g., a controller 1060 ) associated with the system 900 .
- the RFID element 971 may comprise an integrated circuit that is activated when placed in a transmitting field of the RFID unit 1063 .
- the transmitting field may vary depending on specifications of the RFID element 971 and/or RFID unit 1063 .
- the RFID unit 1063 may emit an RF signal that may used to power up the electrode's RFID element 971 .
- electrical signal transmission between the pulse generator 1050 and the ETM 910 , and hence to the electrode 970 may be allowed. Such an embodiment may facilitate enhanced security neural stimulation.
- an adjunct sleeve may serve as an anchor surrounding an electrode as discussed with reference to FIG. 4B ;
- a dielectric member may be included with an insulating layer as discussed with reference to FIGS.
- one or more mechanisms for adjusting the overall length of the electrode as discussed with reference to FIGS. 6-13 may be included; an electrode may have a compressible retaining collar as discussed with reference to FIG. 14 ; an electrode may have a sharper contact surface as discussed with reference to FIGS. 14 and 15 ; and/or the second electrode 820 of the intracranial electrode system of FIGS. 30 and 31 may have a gimbal type fitting, as discussed with reference to FIG. 18 .
- FIGS. 2 A-B the particular intracranial electrode 100 illustrated in FIGS. 2 A-B and to the neurostimulation system 1000 shown in FIG. 19 . It should be understood, though, that reference to this particular embodiment is solely for purposes of illustration and that the methods outlined below are not limited to any particular apparatus shown in the drawings or discussed in detail above.
- implanting conventional cortical electrodes typically requires a full craniotomy under general anesthesia to remove a relatively large (e.g., thumbnail-sized or larger) window in the skull.
- Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
- the diameter of the electrode shaft 110 is sufficiently small to permit implantation under local anesthetic without requiring a craniotomy.
- a relatively small (e.g., 4 mm or smaller) pilot hole may be formed through at least part of the thickness of the patient's skull adjacent a selected stimulation or monitoring site of the brain.
- an initial estimate of skull thickness can be made from MRI, CT, or other imaging information.
- a hand-held drill may be used to form a bore shallow enough to avoid extending through the entire skull.
- a stylus may be inserted into the pilot hole to confirm that it strikes relatively rigid bone. The drill may then be used to deepen the pilot hole in small increments, checking with the stylus after each increment to detect when the hole passes through the thickness of the inner cortex 14 of the skull 10 . If so desired, the stylus may be graduated to allow a physician to measure the distance to the springy dura mater and this information can be used to select an electrode 100 of appropriate length or, if an adjustable-length electrode (e.g., electrode 300 of FIGS. 6 A-B) is used, to adjust the electrode to an appropriate length.
- an adjustable-length electrode e.g., electrode 300 of FIGS. 6 A-B
- the location of the pilot hole (and, ultimately the electrode 100 received therein) can be selected in a variety of fashions.
- U.S. Patent Application Publication No. US 2002/0087201 and U.S. application Ser. No. 09/978,134 both of which are incorporated hereinabove, suggest approaches for selecting an appropriate stimulation site.
- the physician can bore the pilot hole to guide the contact surface 115 of the electrode 100 to that site.
- the physician may use anatomical landmarks, e.g., cranial landmarks such as the bregma or the sagittal suture, to guide placement and orientation of the pilot hole.
- a surgical navigation system may be employed to inform the physician during the procedure.
- such systems may employ real-time imaging and/or proximity detection to guide a physician in placing the pilot hole and in placing the electrode 100 in the pilot hole.
- fiducials are positioned on the patient's scalp or skull prior to imaging and those fiducials are used as reference points in subsequent implantation.
- real-time MRI or the like may be employed instead of or in conjunction with such fiducials.
- suitable navigation systems are commercially available, such as the STEALTHSTATION TREON TGS sold by Medtronic Surgical Navigation Technologies of Louisville, Colo., US.
- the threaded electrode 100 may be advanced along the pilot hole until the contact surface 115 electrically contacts a desired portion of the patient's brain. If the electrode 100 is intended to be positioned epidurally, this may comprise relatively atraumatically contacting the dura mater 20 ; if the electrode is to contact a site on the cerebral cortex, the electrode will be advanced to extend through the dura mater.
- the electrodes 100 may also be implanted to a selected depth within the cerebral cortex or at a deeper location in the brain.
- the length of the electrode 100 is selected (or adjusted for electrode 300 , for example) to achieve the desired level of contact and the electrode will be advanced until a known relationship with the skull is achieved, e.g., when the head 102 compresses the contact ring 122 of the lead 120 against the exterior of the skull 10 .
- the thickness of the skull 10 need not be known to any significant accuracy before the electrode 100 is implanted.
- the electrode 100 may be connected, e.g., via the lead 120 , to an impedance monitor and the impedance may be monitored as the electrode 100 is being implanted. It is anticipated that the measured impedance will change when the electrode 100 contacts the dura mater 20 . Once this contact is detected, the physician may advance the electrode a small, fixed distance to ensure reliable electrical contact over time.
- the electrode 100 may be coupled to a lead 120 .
- the timing of this coupling may vary with the nature of the coupling.
- the lead may be coupled to the electrode before the electrode is introduced into the skull.
- the lead (e.g., lead 160 of FIGS. 3 A-B) may be coupled to the electrode after the electrode is properly positioned with respect to the selected site of the brain.
- the lead, or at least a length thereof may be implanted subcutaneously, e.g., by guiding it through a tunnel formed between the implant site and the intended site of a subclavicularly implanted pulse system 1050 .
- the patient's scalp may then be closed over the head 102 of the electrode 100 so the electrode is completely enclosed. This can materially improve patient comfort compared to more conventional systems wherein epilepsy monitoring electrodes or the like extend through the scalp to an extracorporeal connection.
- FIG. 41 is a schematic illustration of a depth measurement apparatus 175 (e.g., a depth acquisition stick or DAS) and a set of intracranial electrodes I 1 -I 4 .
- an appropriate electrode length may be determined by performing a depth measurement procedure using the device 175 .
- the device 175 may be inserted into a surgically formed pilot hole 11 .
- the device 175 may contain indicia comprising a plurality of calibrated indicators d 1 -d 4 , which provide linear measurements as to the depth of the pilot hole 11 .
- the device 175 may have a retainer cuff and/or sleeve 176 that aids in keeping the device 175 in an upright position for accurate depth measurements.
- intracranial electrodes 11 - 14 may have shafts of varying lengths S 1 -S 4 that correspond to the demarcated indicators d 1 -d 4 .
- the shaft of intracranial electrode I 1 may have a length S 1 associated with a distance d, indicated on the device 175 .
- intracranial electrodes I 2 , I 3 and I 4 may be associated with distances d 2 , d 3 , and d 4 , respectively.
- the depths of the pilot holes 11 may vary from patient to patient depending on such variables as the age of the patient and/or an implant location in the skull 10 .
- FIG. 42 is a flowchart illustrating a depth acquisition procedure 2000 according to an embodiment of the invention.
- a depth acquisition procedure 2000 may comprise an accessing procedure 2010 that involves surgically accessing an implantation or stimulation site.
- An accessing procedure may utilize a surgical navigational system and/or anatomical landmarks, as discussed above, to aid in making a pilot hole 11 in one or more appropriate locations.
- the depth acquisition procedure 2000 may further comprise an insertion procedure 2020 that may involve insertion of a depth acquisition apparatus such as device 175 ( FIG. 41 ) into a pilot hole 11 .
- the device 175 may be provided with indicia corresponding to demarcations or units of length (e.g., millimeters).
- the depth acquisition procedure 2000 may additionally comprise a measurement procedure 2030 that involves measuring or comparing the depth of a hole 11 relative to a calibrated indicia on a measurement device, e.g., the device 175 . As discussed above, the device 175 may have calibrations corresponding to a set of shaft lengths of a series of electrodes.
- the depth acquisition procedure 2000 may also comprise a mapping procedure 2040 that involves mapping or correlating a measurement depth associated with a pilot hole 11 to a corresponding electrode, for example, one of intracranial electrodes I 1 -I 4 .
- a depth acquisition procedure 2000 may additionally comprise a selection procedure 2050 that involves selecting an electrode characterized by an appropriate length or dimension for implantation.
- an electrical stimulus may be delivered from a pulse system 1050 to the patient's brain via a lead 120 and the electrode 100 .
- a plurality of electrodes 100 may be implanted in an array (e.g., array 1010 , 1010 a , 1010 b , or 1010 c ) in the patient's skull and each of the electrodes 100 may be coupled to the pulse system 1050 by an electrically separate lead 120 .
- the precise nature of the stimulus delivered via the electrode(s) 100 can be varied as desired to diagnose or treat a variety of conditions.
- the type, pattern, and/or frequency of stimulus may be selected in a manner identical, essentially identical, or analogous to or different from that outlined in U.S. Patent Application Publication No. US 2002 / 0087201 , for example, and/or may be optimized in a manner described in U.S. application Ser. No. 09/978,134.
Abstract
Description
- This application is a continuation-in-part of pending U.S. application Ser. No. 10/418,796, filed Apr. 18, 2003, and incorporated herein in its entirety by reference.
- The present invention relates to intracranial electrodes and methods for implanting and using intracranial electrodes. These electrodes and methods may be suited for neurostimulation systems and may also be used in electroencephalography and other recording systems, e.g., evoked potential recordings.
- A wide variety of mental and physical processes are known to be controlled or influenced by neural activity in the central and peripheral nervous systems. For example, the neural functions in some areas of the brain (e.g., the sensory or motor cortices) are organized according to physical or cognitive functions. Several other areas of the brain also appear to have distinct functions in most individuals. In the majority of people, for example, the areas of the occipital lobes relate to vision, the regions of the left inferior frontal lobes relate to language, and the regions of the cerebral cortex appear to be involved with conscious awareness, memory, and intellect. Because of the location-specific functional organization of the brain, in which neurons at discrete locations are statistically likely to control particular mental or physical functions in normal individuals, stimulating neurons at selected locations of the central nervous system can be used to effectuate changes in cognitive and/or motor functions throughout the body.
- In several existing applications, neural functions are treated by electrical or magnetic stimulation powered by a neural stimulator that has a plurality of therapy electrodes and a pulse system coupled to the therapy electrodes. The therapy electrodes can be implanted into the patient at a target site for stimulating the desired portions of the brain. For example, one existing technique for masking pain in a patient is to apply an electrical stimulus to a target stimulation site of the brain.
- The brain can be stimulated in several known fashions. One type of treatment is referred to as transcranial electrical stimulation (TES), which involves placing an electrode on the exterior of the patient's scalp and delivering an electrical current to the brain through the scalp and the skull. TES, however, is not widely used because the delivery of the electrical stimulation through the scalp and the skull causes patients a great amount of pain and the electrical field is difficult to direct or focus accurately.
- Another type of treatment is transcranial magnetic stimulation (TMS), which involves using a high-powered magnetic field adjacent the exterior of the scalp over an area of the cortex. TMS does not cause the painful side effects of TES. Unfortunately, TMS is not presently effective for treating many patients because the existing delivery systems are not practical for applying stimulation over an adequate period of time. TMS systems, for example, are relatively complex and require stimulation treatments to be performed by a healthcare professional in a hospital or physician's office. The efficacy of TMS in longer-term therapies may be limited because it is difficult to (a) accurately localize the region of stimulation in a reproducible manner, (b) hold the device in the correct position over the cranium for the requisite period, and (c) provide stimulation for extended periods of time.
- Another device for stimulating a region of the brain is disclosed by King in U.S. Pat. No. 5,713,922, the entirety of which is incorporated herein by reference. King discloses a device for cortical surface stimulation having electrodes mounted on a paddle that is implanted under the skull of the patient. These electrodes are placed in contact with the surface of the cortex to create “paresthesia,” which is a vibrating or buzzing sensation. Implanting the paddle typically requires removal of a relatively large (e.g., thumbnail-sized or larger) window in the skull via a full craniotomy. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
- A physician may employ electroencephalography (EEG) to monitor neural functions of a patient. Sometimes this is done alone, e.g., in diagnosing epileptic conditions, though it may also be used in conjunction with neurostimulation. Most commonly, electroencephalography involves monitoring electrical activity of the brain, manifested as potential differences at the scalp surfaces, using electrodes placed on the scalp. The electrodes are typically coupled to an electroencephalograph to generate an electroencephalogram. Diagnosis of some neurological diseases and disorders, e.g., epilepsy, may best be conducted by monitoring neural function over an extended period of time. For this reason, ambulatory electroencephalography (AEEG) monitoring is becoming more popular. In AEEG applications, disc electrodes are applied to the patient's scalp. The scalp with the attached electrodes may be wrapped in gauze and the lead wires attached to the electrodes may be taped to the patient's scalp to minimize the chance of displacement.
- EEG conducted with scalp-positioned electrodes requires amplification of the signals detected by the electrodes. In some circumstances, it can be difficult to pinpoint the origin of a particular signal because of the signal dissipation attributable to the scalp and the skull. For more precise determinations, EEG may be conducted using “deep brain” electrodes. Such electrodes extend through the patient's scalp and skull to a target location within the patient's brain. Typically, these deep brain electrodes comprise lengths of relatively thin wire that are advanced through a bore through the patient's skull to the desired location. If the electrodes are to be monitored over an extended period of time, the electrodes typically are allowed to extend out of the patient's skull and scalp and are coupled to the electroencephalograph using leads clipped or otherwise attached to the electrodes outside the scalp. To avoid shifting of the electrodes over time, the electrodes typically are taped down or held in place with a biocompatible cementitious material. The patient's head typically must be wrapped in gauze to protect the exposed electrodes and the associated leads, and the patient is uncomfortable during the procedure. This may be suitable for limited testing purposes-deep brain encephalography typically is limited to tests conducted in hospital settings over a limited period of time, usually no more than a few days-but could be problematic for longer-term monitoring, particularly in nonclinical settings.
- Screws have been used to attach plates or the like to patients' skulls.
FIG. 1 , for example, schematically illustrates a conventional cranial reconstruction to repair afracture 50 or other trauma. In this application, aplate 60 is attached to theouter cortex 12 of theskull 10 bycortical bone screws 62. Theplate 60 spans thefracture 50, helping fix the skull in place on opposite sides of thefracture 50. As can be seen inFIG. 1 , thescrews 62 do not extend through the entire thickness of the skull. Instead, thescrews 62 are seated in theouter cortex 12 and do not extend into thecancellous 18 or theinter cortex 14. In some related applications, thescrews 62 may be longer and extend into or even through thecancellous 18. Physicians typically take significant care to ensure that thescrews 62 do not extend through the entire thickness of the skull, though, because penetrating the skull can increase the likelihood of trauma to or infection in the patient's brain. -
FIG. 1 is a schematic illustration of a conventional cranial reconstruction. -
FIG. 2A is a schematic view in partial cross section of an intracranial electrode in accordance with one embodiment of the invention implanted in a patient. -
FIG. 2B is a schematic top elevation view of the implanted intracranial electrode ofFIG. 2A . -
FIG. 3A is a schematic illustration in partial cross section of an intracranial electrode in accordance with another embodiment of the invention implanted in a patient. -
FIG. 3B is a schematic top elevation view of the implanted intracranial electrode ofFIG. 3A . -
FIG. 4A is a schematic illustration in partial cross section of an intracranial electrode in accordance with yet another embodiment of the invention implanted in a patient. -
FIG. 4B is a side view of a dielectric member of the electrode ofFIG. 4A . -
FIG. 5 is a schematic illustration in partial cross section of an intracranial electrode in accordance with still another embodiment of the invention implanted in a patient. -
FIG. 6A is a schematic illustration in partial cross section of an intracranial electrode in accordance with a further embodiment of the invention implanted in a patient. -
FIG. 6B is a schematic top elevation view of the implanted intracranial electrode ofFIG. 6A . -
FIG. 7 is a schematic illustration in partial cross section of an intracranial electrode in accordance with still another embodiment of the invention implanted in a patient. -
FIG. 8 is a schematic side view of a broken-away portion of a patient's skull in which an intracranial electrode in accordance with another embodiment of the invention has been implanted. -
FIG. 9 is a schematic partial cross-sectional view taken along line 9-9 ofFIG. 8 . -
FIG. 10 is an isolation view of a portion of the implanted electrode ofFIG. 9 . -
FIG. 11 is a perspective view of selected components of the intracranial electrode ofFIGS. 8-10 . -
FIG. 12 is a schematic illustration in partial cross section of an intracranial electrode in accordance with yet another embodiment of the invention implanted in a patient. -
FIG. 13 is a schematic illustration in partial cross section of an intracranial electrode in accordance with one more embodiment of the invention implanted in a patient. -
FIG. 14 is a schematic illustration in partial cross section of an intracranial electrode in accordance with a further embodiment of the invention implanted in a patient. -
FIG. 15 is a schematic partial cross-sectional view of the intracranial electrode ofFIG. 13 with a retaining collar of the electrode in a radially compressed state. -
FIG. 16 is a schematic partial cross-sectional view of the intracranial electrode ofFIG. 14 with the retaining collar in a radially expanded state. -
FIG. 17 is a schematic illustration in partial cross section of a deep brain intracranial electrode in accordance with an alternative embodiment of the invention implanted in a patient. -
FIG. 18 is a schematic illustration in partial cross section of a deep brain intracranial electrode in accordance with still another embodiment of the invention implanted in a patient. -
FIG. 19 is a schematic overview of a neurostimulation system in accordance with a further embodiment of the invention. -
FIG. 20 is a schematic overview of a neurostimulation system in accordance with another embodiment of the invention. -
FIG. 21 is a schematic illustration of one pulse system suitable for use in the neurostimulation system ofFIG. 17 orFIG. 18 . -
FIG. 22 is a schematic top view of the array of electrodes inFIG. 17 . -
FIGS. 23-26 are schematic top views of alternative electrode arrays in accordance with other embodiments of the invention. -
FIG. 27 is a schematic view in partial cross section of an intracranial electrode implanted in a patient in accordance with another embodiment of the invention. -
FIG. 28 is a schematic view in partial cross section of an intracranial electrode implanted in a patient in accordance with another embodiment of the invention. -
FIG. 29 is a schematic view in partial cross section of an intracranial electrode implanted in a patient in accordance with another embodiment of the invention. -
FIG. 30 is a schematic view in partial cross section of an intracranial electrode having an adjunct depth-penetrating electrode implanted in a patient in accordance with another embodiment of the invention. -
FIG. 31 is a schematic view in partial cross section of another intracranial electrode having an adjunct depth-penetrating electrode implanted in a patient in accordance with another embodiment of the invention. -
FIG. 32 is a schematic view in partial cross section of a neural stimulation system implanted in a patient in accordance with an alternative embodiment of the invention. -
FIG. 33 is a schematic view in partial cross section of a neural stimulation system implanted in a patient in accordance with yet another embodiment of the invention. -
FIG. 34A is a schematic view in partial cross section of an intracranial electrode system implanted in a patient in accordance with another embodiment of the invention. -
FIG. 34B is a schematic illustration of an electrical energy transfer mechanism in accordance with an embodiment of the invention. -
FIG. 35 is a schematic view in partial cross section of portions of intracranial electrode system implanted in a patient in accordance with an embodiment of the invention. -
FIG. 36 is a schematic overview of an intracranial electrode system implanted in a patient in accordance with an embodiment of the invention. -
FIG. 37 is a schematic view in partial cross section of a set of intracranial electrodes implanted in a patient in accordance with a further embodiment of the invention. -
FIG. 38 is a schematic view in partial cross section of an intracranial electrode in accordance with a further embodiment of the invention. -
FIG. 39 is a schematic view in partial cross section of an intracranial electrode in accordance with an embodiment of the invention. -
FIG. 40 is a schematic overview of an intracranial electrode system having RFID capabilities in accordance with a further embodiment of the invention. -
FIG. 41 illustrates a depth measurement procedure employing a depth acquisition stick according to an embodiment of the present invention. -
FIG. 42 is a flowchart illustrating depth measurement procedures in accordance with an embodiment of the invention. - A. Overview
- Various embodiments of the present invention provide intracranial electrodes and methods for implanting and using intracranial electrodes. It will be appreciated that several of the details set forth below are provided to describe the following embodiments in a manner sufficient to enable a person skilled in the art to make and use the disclosed embodiments. Several of the details and advantages described below, however, may not be necessary to practice certain embodiments of the invention. Additionally, the invention can also include additional embodiments that are not described in detail with respect to
FIGS. 1-42 . - One aspect of the invention is directed to an intracranial signal transmission system that includes a generally electrically insulating support body having a head portion configured to be positioned at least proximate to an outer surface of a patient's skull. The support body can further have a shaft portion configured to extend into an aperture in the patient's skull. At least one electrical contact portion is carried by the support body and can be positioned to transfer electrical signals to, from, or both to and from the patient's brain via the aperture in the patient's skull.
- An intracranial signal transmission system in accordance with another aspect of the invention includes an electrical contact portion configured to be positioned in an aperture of a patient's skull, and an electrical energy transfer device configured to be releasably positioned external to the patient's scalp. The energy transfer device can be coupleable to a signal transmitter to transmit signals to the electrical contact portion while the electrical contact portion is positioned beneath the patient's scalp, and while the energy transfer device is positioned external to the patient's scalp. In particular embodiments, the electrical energy transfer device can include a flexible outer layer, an adhesive gel layer positioned to contact the patient's scalp, a conductive layer positioned between the outer layer and the adhesive gel layer, and a conductive lead connected to the conductive layer.
- An intracranial signal transmission system in accordance with still another aspect of the invention includes a shaft configured to extend through an aperture in a patient's skull, and a head connected to the shaft. The head can be configured to be positioned adjacent to an external surface of the patient's skull and can be eccentrically positioned relative to the shaft. Accordingly, the head can have a first portion extending outwardly from the shaft by a first distance, and a second portion extending outwardly from the shaft by a second distance different from the first distance. The system can further include an electrical contact portion carried by at least one of the shaft and the head.
- Other aspects of the invention are directed to methods for installing electrodes and/or transmitting intracranial electrical signals. A method in accordance with one aspect of the invention includes drilling a hole in a patient's skull, and determining a distance from an outer surface of the patient's skull to a feature beneath the outer surface of the patient's skull by inserting an elongated member having graduation markings into the pilot hole. The method can further include selecting a size of an intracranial electrode based on the distance determined with the elongated member, and inserting the intracranial electrode into the hole. The method can still further include securing the intracranial electrode to the patient's skull.
- A method in accordance with another aspect of the invention includes forming an aperture in a patient's skull, with the aperture having a first generally conical portion with a first diameter at an external surface of the patient's skull, and a second portion having a second diameter smaller than the first diameter, located beneath the external surface. The method can further include disposing proximate to the aperture an electrical contact portion carried by a support body having a shaft and a head depending from the shaft. The head can have a generally conical shape, with an angle between an external surface of the shaft and an external surface of the head being obtuse. The method can still further include inserting the support body into the aperture so that the shaft extends through the second portion of the aperture and the head engages a wall of the aperture at the first portion of the aperture.
- A method in accordance with yet another aspect of the invention includes forming an aperture in the patient's skull, disposing proximate to the aperture an electrical contact portion carried by a support body having a shaft and a head depending from the shaft, with the shaft having an external surface and a plurality of surface features. The method can still further include inserting the support body into the aperture so that the shaft extends into the aperture, and then allowing the patient's bone tissue to grow into interengagement with the surface features.
- For ease of understanding, the following discussion is subdivided into three areas of emphasis. The first section discusses certain intracranial electrodes; the second section relates to select embodiments of neurostimulation systems; and the third section outlines methods in accordance with other embodiments of the invention.
- B. Intracranial Electrodes
-
FIGS. 2-15 illustrate intracranial electrodes in accordance with various embodiments of the invention. Like reference numbers are used throughout these figures to designate like or analogous elements. - FIGS. 2A-B illustrate an
intracranial electrode 100 in accordance with one embodiment of the invention. Thiselectrode 100 includes ahead 102 attached to a threadedshaft 110. Thehead 102 andshaft 110 may be integrally formed of an electrically conductive material, e.g., titanium or another biocompatible, electrical conductive metal. Thehead 102 may include one ormore slots 104, an allen head recess (not shown), or other structure (e.g., a square drive or TORX™ drive recess) adapted to facilitate turning theelectrode 100. As theelectrode 100 is turned, thethreads 112 of the threadedshaft 110 will advance a generally distally positionedcontact surface 115 of theelectrode 100 toward thedura mater 20. The length of theshaft 110 may be selected so that thecontact surface 115 of theelectrode 100 electrically engages the surface of thedura mater 20 without causing undue harm to thedura mater 20 or the underlying cerebral cortex. Thecontact surface 115 may comprise a relatively blunt end to reduce trauma to the dura mater and theunderlying brain tissue 25. - In one embodiment, the
intracranial electrode 100 is adapted to be electrically connected to a pulse system (1050 inFIG. 18 , for example), as described below. Theelectrode 100 may be connected to the pulse system in any desired fashion. In the illustrated embodiment, theelectrode 100 is coupled to such a pulse system by means of anelectrical lead 120. Theelectrical lead 120 shown inFIGS. 2A and 2B comprises an elongated, subcutaneouslyimplantable body 124, which may have an insulative sheath. An electrically conductive ring orwasher 122 may be attached to an end of thebody 124. In one embodiment, an opposite end of thebody 124 is physically attached to a component of the pulse system. In other embodiments, the leads may be operatively connected to one or more components of the pulse system without being physically attached thereto, e.g., using a transmitter and antenna or a magnetic coupling. Embodiments of pulse systems incorporating such wireless links are disclosed in U.S. Patent Application Publication No. US 2002/0087201, the entirety of which is incorporated herein by reference. - The
head 102 of theelectrode 100 is adapted to be implanted subcutaneously beneath the patient's scalp 30 (shown schematically inFIG. 2A ). As explained below, theelectrode 100 may be used to deliver an electrical signal to thebrain tissue 25 adjacent thecontact surface 115. At higher stimulus levels, electrical contact between the patient'sscalp 30 and thehead 102 of theelectrode 100 may be uncomfortable for the patient. If so desired, thescalp 30 may be electrically insulated from thehead 102. This may be accomplished by applying on the head 102 a quantity of a dielectric, biocompatible, cementitious material (not shown), which may be cured or dried in place. In another embodiment, thehead 102 may be covered with a separate cap 130 (shown in dashed lines inFIG. 2A ) formed of a dielectric material, e.g., a dielectric, biocompatible plastic, that may be glued, press-fit, or otherwise attached to thehead 102 and/or thelead 120. - The dimensions of the
electrode 100 can be varied to meet various design objectives. In one embodiment, however, theelectrode 100 is longer than the thickness of the patient's skull. More specifically, thehead 102 is adapted to be seated at an extracranial subcutaneous site while the threadedshaft 110 is only slightly longer than the skull thickness at the intended treatment site. Lengths on the order of 4-50 mm, for example, may be appropriate in certain applications. The diameter of thehead 102 and the threadedshaft 110 may also be varied. For most applications,shafts 110 having diameters (typically excluding the width of the threads 112) of no greater than 4 mm will suffice. Shaft diameters of about 1-4 mm are likely, with diameters of 1.5-2.5 mm being well suited for most applications. FIGS. 2A-B illustrate anelectrode 100 having aconstant diameter shaft 110, but it should be understood that the shaft diameter may vary. For example, theshaft 110 may taper distally to improve the ability of theshaft 110 to be self-tapping. Thehead 102 typically will have a larger diameter than an adjoining portion of theshaft 110. (It should be recognized thatFIGS. 2-15 are not drawn to scale. In particular, the aspect ratio of the electrodes is significantly reduced to better illustrate certain functional aspects of the designs.) -
FIG. 3A illustrates anintracranial electrode 150 in accordance with another embodiment of the invention. Thisintracranial electrode 150 is similar in many respects to theintracranial electrode 100 of FIGS. 2A-B. For example, theelectrode 150 includes an electrically conductive threadedshaft 110 defining a blunt,atraumatic contact surface 115 adjacent a distal end. - The connection of the
electrode 150 to thelead 160 in FIGS. 3A-B differs somewhat from the connection of theelectrode 100 and lead 120 in FIGS. 2A-B, however. In FIGS. 2A-B, theelectrode 100 is electrically coupled to thelead 120 by compressively engaging the electricallyconductive ring 122 of thelead 120 between theelectrode head 102 and theskull 10. In FIGS. 3A-B, theelectrode 150 includes ahead 152 includingslots 154 or other structure for engaging a screwdriver, wrench, or the like. Thehead 152 is adapted to engage acap 162 carried by thelead 160 that electrically couples thebody 164 of thelead 160 to thehead 152 of theelectrode 150. In the illustrated embodiment, thecap 162 comprises a dielectric body (e.g., a dielectric plastic material with some resilience) having an electrically conductiveinner surface 163, which may be provided by coating an interior surface of thecap 162 with a metal. In one embodiment, thecap 162 is adapted to resiliently deform to be press-fitted on thehead 152. Thebody 164 of thelead 160 may be coupled to the electrically conductiveinner surface 163 of thecap 162, thereby providing an electrical pathway between theelectrode 150 and a pulse system (not shown) operatively coupled to thelead 160. - In one embodiment, the
cap 162 is sized to be subcutaneously implanted beneath the patient'sscalp 30. In the illustrated embodiment, thehead 152 and thecap 162 both extend outwardly beyond theouter cortex 12 of the patient'sskull 10. In another embodiment (discussed in more detail below with respect toFIGS. 38 and 39 ) some or all of the length of thehead 152 and/or thecap 162 may be countersunk into a recess formed through theouter cortex 12 and/or an outer portion of the cancellous 18. This can improve patient comfort, which can be useful if theintracranial electrode 150 is intended to be implanted permanently or for an extended period of time. - FIGS. 4A-B schematically illustrate aspects of an
intracranial electrode 200 in accordance with another embodiment. Theelectrode 200 may comprise an electrically conductiveinner portion 205 and an electrically insulativeouter portion 206. In the illustrated embodiment, the electricallyconductive portion 205 of theelectrode 200 includes ahead 202 and a threadedshaft 210 defining acontact surface 215 for electrically contacting the patient'sdura mater 20. These elements of theelectrode 200 and their electrical connection to thelead 120 are directly analogous to theelectrode 100 shown in FIGS. 2A-B. The electrically insulativeouter portion 206 of theelectrode 200 shown inFIG. 4A comprises adielectric member 240 that is disposed between the threadedshaft 210 and the patient'sskull 10. As shown inFIG. 4B , thisdielectric member 240 may take the form of a tapered sleeve. Thesleeve 240 may have an upper ring-like portion 242 and a plurality ofdeformable flanges 244 extending distally therefrom. Theflanges 244 may be adapted to be urged outwardly into compressive contact with a bore formed in the patient'sskull 10 when the threadedshaft 210 is advanced into the interior of thesleeve 240. Although not shown inFIG. 4B , ribs or teeth may be provided on the exterior surfaces of theflanges 244 to further anchor thesleeve 240 in the cancellous 18. In one embodiment, thesleeve 240 is formed of a dielectric plastic and the threads of the threadedmember 210 may be self-tapping in the inner wall of thesleeve 240. - When implanted in a
skull 10 as shown inFIG. 4A , thedielectric sleeve 240 will electrically insulate theskull 10 from the electricallyconductive shaft 210 of theelectrode 200. (Thesleeve 240 need not completely electrically isolate the skull andshaft 210; it merely serves to reduce electrical conduction to theskull 10.) As explained below, some embodiments of the invention employ an array comprising a plurality of intracranial electrodes implanted at various locations in a patient'sskull 10. The use of a dielectric member such as thedielectric sleeve 240 can help electrically isolate each of theelectrodes 200 fromother electrodes 200 in the array (not shown). If so desired, theelectrode 200 may be provided with adielectric cap 230 sized and shaped to be implanted subcutaneously beneath the patient's scalp 30 (not shown inFIG. 4A ). Much like thecap 130 ofFIG. 2A , thiscap 230 may electrically insulate the patient's scalp from the electricallyconductive head 202. This may further improve electrical isolation of theelectrodes 200 in an array. -
FIG. 5 illustrates anintracranial electrode 250 in accordance with yet another embodiment of the invention. Thiselectrode 250 includes an electricallyconductive shaft 260 electrically coupled to a subcutaneouslyimplantable head 262 and a distally positionedcontact surface 265. Theshaft 260 is received in the interior of an externally threaded dielectric layer 280. Theshaft 260 may be operatively coupled to the dielectric layer 280 for rotation therewith as the electrode is threadedly advanced through the patient'sskull 10. In one embodiment, this may be accomplished by a spline connection between theshaft 260 and the dielectric layer 280. In other embodiments, the dielectric layer 280 may be molded or otherwise formed about theshaft 260. - In one particular embodiment, the dielectric layer 280 comprises an electrically insulative ceramic material. In another embodiment, the dielectric layer 280 comprises an electrically insulative plastic or other biocompatible polymer that has sufficient structural integrity to adequately anchor the
electrode 250 to theskull 10 for the duration of its intended use. If so desired, the dielectric layer 280 may be porous or textured to promote osseointegration of long-term implants. For shorter-term applications, the dielectric layer 280 may be formed of or covered with a material that will limit osseointegration. - In at least some of the preceding embodiments, the
intracranial electrode head 102 and thecontact surface 115 remains fixed. When the threadedshaft 110 is sunk into theskull 10 to a depth sufficient to compress theconductive ring 122 of thelead 120 between thehead 102 and theskull 10, this will also fix the distance from the exterior surface of theouter cortex 12 of theskull 10 to thecontact surface 115. The thickness of theskull 10 can vary from patient to patient and from site to site on a given patient's skull. Hence, the pressure exerted by thecontact surface 115 against thedura mater 20 will vary depending on the thickness of the skull. If theelectrode 100 is selected to be long enough to make adequate electrical contact with the dura mater adjacent the thickest site on a skull, the pressure exerted by thecontact surface 115 against thedura mater 20 may cause undue damage at sites where the skull is thinner. Consequently, it can be advantageous to provide a selection of electrode sizes from which the physician can choose in selecting anelectrode 100 for a particular site of a specific patient's skull. -
FIGS. 6-12 illustrate embodiments of electrodes with adjustable lengths. FIGS. 6A-B, for example, illustrate anintracranial electrode 300 that is adapted to adjust a distance between the outer surface of theskull 10 and acontact surface 315 of theelectrode 300. This, in turn, enables the contact force between thecontact surface 315 and the surface of thedura mater 20 to be varied without requiring multiple electrode lengths. - The
intracranial electrode 300 ofFIGS. 6A and 6B includes a probe orshaft 310 that has a blunt distal surface defining thecontact surface 315 of theelectrode 300. Theshaft 310 has aproximal end 312 that may include atorque drive recess 314 or the like to facilitate rotation of theshaft 310 relative to ahead 320 of theelectrode 300. At least a portion of the length of theshaft 310 is externally threaded. In the illustrated embodiment, the shaft has an externally threaded proximal length and an unthreaded surface along a distal length. - The
head 320 of theelectrode 300 comprises abody 322 and atubular length 324 that extends from thebody 322. Thebody 322 may be adapted to be rotated by hand or by an installation tool. In one embodiment thebody 322 is generally hexagonal to facilitate rotation with an appropriately sized wrench. In the particular embodiment shown in FIGS. 6A-B, thebody 322 has a pair ofrecesses 323 in its outer face sized and shaped to interface with a dedicated installation tool (not shown) having projections adapted to fit in therecesses 323. If so desired, the installation tool may be a torque wrench or other tool adapted to limit the amount of torque an operator may apply to thehead 320 of theelectrode 300 during installation. Thetubular length 324 may be externally threaded so thehead 320 may be anchored to theskull 10 by screwing thetubular length 324 into theskull 10. - The
head 320 includes an internally threaded bore 326 that extends through the thickness of thebody 322 and thetubular length 324. Thebore 326 has threads sized to mate with the external threads on theshaft 310. If so desired, a biocompatible sealant (e.g., a length of polytetrafluoroethylene tape) may be provided between the threads of thebore 326 and the threads of theshaft 310 to limit passage of fluids or infectious agents through thebore 326. - Rotation of the
shaft 310 with respect to thehead 320 will, therefore, selectively advance or retract theshaft 310 with respect to thehead 320. This will, in turn, increase or decrease, respectively, the distance between thelower face 323 of thehead body 322 and thecontact surface 315 of theshaft 310. As suggested inFIG. 6A , this may be accomplished by inserting atip 344 of atorque driver 340 into thetorque drive recess 314 in theshaft 310 and rotating thetorque driver 340. Thetip 344 of thetorque driver 340 may be specifically designed to fit thetorque drive recess 314. In the embodiment shown in FIGS. 6A-B, thetorque drive recess 314 is generally triangular in shape and is adapted to receive atriangular tip 344 of thetorque driver 340. If so desired, thetorque driver 340 may comprise a torque wrench or the like that will limit the maximum torque and operator can apply to theshaft 310 of theelectrode 300. - If so desired, the
torque driver 340 may includegraduations 342 to inform the physician how far theshaft 310 has been advanced with respect to thehead 320. As noted below, in certain methods of the invention, the thickness of the skull at the particular treatment site may be gauged before theelectrode 300 is implanted. Using this information and thegraduations 342 on thetorque driver 340, the physician can fairly reliably select an appropriate length for theelectrode 300 to meet the conditions present at that particular site. - In the embodiment shown in FIGS. 6A-B, the
head 320 and theshaft 310 are both formed of an electrically conductive material. Theconductive ring 122 of thelead 120 may be received in a slot formed in thelower face 323 of thebody 322. Alternatively, thering 122 may be internally threaded, permitting it to be threaded over the external threads of thetubular length 324 before thehead 320 is implanted. If so desired, thering 122 can instead be compressively engaged by thelower face 323 of thehead 320 in a manner analogous to the engagement of thehead 102 with thering 122 inFIG. 2A , for example. - In another embodiment, the
head 320 is formed of a dielectric material, such as a dielectric ceramic or plastic. This may necessitate a different connection between the lead 120 and theshaft 310, such as by electrically contacting thelead 120 to theproximal end 312 of theshaft 310. Employing adielectric head 320 can help electrically insulate theskull 10 from theelectrodes 300, improving signal quality and reducing interference between thevarious electrodes 300 in an array, as noted above. -
FIG. 7 schematically illustrates anintracranial electrode 350 in accordance with a further embodiment of the invention. Theelectrode 350 includes a shaft or probe 360 having aproximal end 362 and a distally locatedcontact surface 365. Theshaft 360 may include a first threadedportion 360 a and a second threadedportion 360 c. In the embodiment shown inFIG. 7 , the first and second threadedportions intermediate portion 360 b. In an alternative embodiment, the two threadedportions - The
intracranial electrode 350 of this embodiment also includes ahead 370 having an internally threadedbore 376 extending through its thickness. The threads of thebore 376 are adapted to mate with the threads of the first threadedportion 360 a. By rotating theshaft 360 with respect to the head 370 (e.g., with a screwdriver 340), the distance between thehead 370 and thecontact surface 365 can be adjusted in much the same manner described above in connection with FIGS. 6A-B. - The
head 320 of theelectrode 300 in FIGS. 6A-B has an externally threadedtubular length 324 that extends into theskull 10 and helps anchor theelectrode 300 to theskull 10. Theshaft 310 may then move with respect to the skull by rotating theshaft 310 with respect to thehead 320. In the embodiment shown inFIG. 7 , thehead 370 is not directly anchored to theskull 10. Instead, the threads of the second threadedportion 360 c are adapted to threadedly engage theskull 10 to anchor theelectrode 350 with respect to theskull 10 and thehead 370 is attached to the first threadedportion 360 a of theshaft 360. In one embodiment, theshaft 360 may be threaded into a pilot hole in theskull 10. Once theshaft 360 is positioned at the desired depth, thehead 370 may be screwed onto the first threadedportion 360 a of theshaft 360 to help fix theshaft 360 with respect to the skull and provide a less traumatic surface to engage the patient's scalp (not shown) when the scalp is closed over theelectrode 350. In another embodiment, the length of theelectrode 350 may first be adjusted by rotating theshaft 360 with respect to thehead 370. Once theelectrode 350 has the desired length, theshaft 360 may be advanced into theskull 10. Theshaft 360 may be graduated to facilitate adjustment to the appropriate length. If so desired, the first threadedportion 360 a may be threaded in a direction opposite the second threadedportion 360 c and/or the pitch of the threads in the first threadedportion 360 a may be different from the pitch of the threads in the second threadedportion 360 c. - In the embodiment of
FIG. 7 , theshaft 360 of theelectrode 350 extends through thedura mater 20 and thecontact surface 365 of theelectrode 350 is in direct contact with the cerebral cortex of the patient's brain. This is simply intended to illustrate one alternative application. In other embodiments, the length of theelectrode 350 may be selected so that thecontact surface 365 electrically contacts thedura mater 20 without extending therethrough, much as illustrated inFIG. 6A , for example. -
FIGS. 8-11 illustrate anintracranial electrode 400 in accordance with another embodiment of the invention. Theintracranial electrode 400 includes a shaft or probe 410 that is slidably received by ahead 420. Theshaft 410 comprises an electrically conductive material and defines anelectrical contact surface 415, e.g., on its distal end. - In the preceding embodiments, some or a majority of the head of the electrode extends outwardly beyond the outer surface of the
skull 10. In the particular implementation shown inFIGS. 8-10 , thehead 420 is received entirely within the thickness of theskull 10. It should be understood, though, that this is not necessary for operation of the device, and this is shown simply to highlight that the position of thehead 420 with respect to theskull 10 can be varied. In another embodiment, at least a portion of thehead 420 extends outwardly beyond the outer surface of theskull 10. - The
head 420 includes abase 430 and anactuator 422. Thebase 430 includes an externally threadedbody 432 and atubular length 434 that extends from thebody 432. A portion of thetubular length 434 carriesexternal threads 436. Thetubular length 434 may also include one ormore locking tabs 440, each of which includes anactuating surface 442. - The
actuator 422 has an internally threaded bore 424 that is adapted to matingly engage thethreads 436 on thebase 430. Rotating theactuator 422 with respect to the base 430 in a first direction will advance theactuator 422 toward theactuating surface 442 of each of thetabs 440. Theactuator 422 may urge against the actuating surfaces 442, pushing thetabs 440 inwardly into engagement with theshaft 410. This will help lock theshaft 410 in place with respect to thebase 430. Rotating theactuator 422 in the opposite direction will allow thetabs 440 to resiliently return toward a rest position wherein they do not brake movement of theshaft 410. The force with which theshaft 410 engages the dura mater 20 (not shown) then can be adjusted to a desired level by moving theshaft 410 with respect to thebase 430. When theshaft 410 is in the desired position, theactuator 422 may be moved into engagement with thetabs 440 to hold theshaft 410 in the desired position. -
FIG. 12 illustrates an adjustable-lengthintracranial electrode 450 in accordance with another embodiment. Theintracranial electrode 450 includes an axially slidable probe orshaft 452 and ahead 460. Thehead 460 includes abody 462 and an externally threadedtubular length 464. Thetubular length 464 includes an axially extendingrecess 466 sized to slidably receive a portion of theshaft 452. An O-ring 465 or the like may provide a sliding seal between thehead 460 and theshaft 452. - The
contact surface 455 of theshaft 452 is pushed against the surface of thedura mater 20 with a predictable force by means of aspring 454 received in therecess 466. InFIG. 12 , thespring 454 is typified as a compressed coil spring formed of a helically wound wire or the like. In this embodiment, anelectrical contact 469 of the lead 468 may be electrically coupled to the wire of thespring 454. Electrical potential may then be conducted to theshaft 452 by the wire of thespring 454. - In another embodiment (not shown), the
spring 454 comprises a compressed elastomer, which may take the form of a column that fills some or all of the diameter of therecess 466. The elastomer may comprise a biocompatible polymeric material, for example. In such an embodiment, the elastomer may be electrically conductive, e.g., by filling a polymeric material with a suitable quantity of a conductive metal powder or the like. In another embodiment, one or more wires may be embedded in the elastomeric material to conduct an electrical signal across the elastomer to theshaft 452. - In the illustrated embodiment and the alternative embodiment wherein the
spring 454 comprises an elastomer, thehead 460 may be formed of a dielectric material, helping electrically insulate theskull 10 from theshaft 452. In an alternative embodiment, thehead 460 may be formed of an electrically conductive material. Even though the other structural elements of theelectrode 450 may remain largely the same, this would avoid the necessity of having the lead 468 extend through thehead 460; an electricallyconducive ring 122 or the like instead may be employed in a manner analogous to that shown inFIG. 6A , for example. -
FIG. 13 depicts and adjustable-lengthintracranial electrode 475 in accordance with a different embodiment. Some aspects of theintracranial electrode 475 are similar to theintracranial electrode 450 shown inFIG. 12 . In particular, theintracranial electrode 475 includes an axially slidable probe orshaft 480 that is slidably received in an axially extendingrecess 488 in atubular length 492 of ahead 490. A proximal face of thebody 490 may include a pair of tool-receivingrecesses 494, which may be analogous to the tool-receivingrecesses 323 noted above in connection withFIG. 6A , to aid in the installation of thebody 490. If so desired, one or more seals may be provided between theshaft 480 and thebody 490. In the embodiment shown inFIG. 13 , thebody 490 carries a first O-ring 493 and theshaft 480 and carries a second O-ring 484 sealed against the interior of therecess 488. These O-rings may also serve as abutments to limit axial travel of theshaft 480 in therecess 488. - The
contact surface 481 of theshaft 480 is pushed against the surface of thedura mater 20 with a predictable force by means of aspring 486. Thespring 486 may be substantially the same as thespring 454 shown inFIG. 12 , and the various materials suggested above for thespring 454 may also be employed in thespring 486 ofFIG. 13 . - In
FIG. 12 , thespring 454 provides the electrical connection between the lead 468 and theshaft 452. In the embodiment ofFIG. 13 , however, thelead 496 may be connected directly to theshaft 480 through alumen 495 in thebody 490. Thislumen 495 is sized to slidably receive a reduced-diameter neck 482 of theshaft 480. As thebody 490 is screwed into theskull 10 and moves toward thebrain 25, contact between theshaft 480 and thedura mater 20 will urge theshaft 480 upwardly, moving theneck 482 upwardly within thelumen 495. - The
electrode 475 ofFIG. 13 may facilitate delivering a highly reproducible contact force of thecontact surface 481 of theshaft 480 against thedura mater 20. The position of the reduced-diameter neck 482 of theshaft 480 within thelumen 495 will vary in a fixed relationship with the force exerted on thespring 486 by theshaft 480. Since the force of theshaft 480 against thespring 486 is essentially the same as the force of theshaft 480 against thedura mater 20, knowing the position of theneck 482 within thelumen 495 can give the operator an indication of the force exerted against thedura mater 20. In one particular embodiment, the interior of thelumen 495 may be graduated to mark off the depth of theneck 482 in thelumen 495. In another embodiment, thebody 490 may be driven into theskull 10 until the height of theneck 482 in thelumen 495 reaches a predetermined point, e.g., when the top of theneck 482 is flush with the top of thebody 490. -
FIG. 14 illustrates anintracranial electrode 500 in accordance with still another embodiment of the invention. Thiselectrode 500 includes an electrically conductive probe orshaft 510 having ahead 512 and acontact surface 515. A radiallycompressible retaining collar 540 extends along a portion of the length of theshaft 510. As shown inFIG. 15 , the retainingcollar 540 may be adapted to assume a radially reduced configuration in response to a compressive force, indicated schematically by the arrows F. This compressive force F may be generated by collapsing the retainingcollar 540 and restraining it in the lumen of an introducing sheath (not shown) sized to be received in a bore through theskull 10. When this force F is removed (e.g., by retracting the introducing sheath), the retainingcollar 540 may expand radially outwardly away from theshaft 510, as illustrated inFIG. 16 . - To implant the
electrode 500 in theskull 10, theshaft 510 may be advanced into a bore in the skull until thecontact surface 515 exerts the desired contact force against thedura mater 20. Once theshaft 510 is in the desired position, the compressive force F on thecollar 540 may be released, allowing thecollar 540 to expand outwardly into compressive engagement with the lumen of the bore in theskull 10. This will help hold theelectrode 500 in place with respect to the skull without requiring permanent anchoring of theshaft 510 to theskull 10. - The
shaft 510 may be electrically coupled to a pulse system (not shown) by alead 520. Thelead 520 may include acap 522 having an electrically conductiveinner surface 524 coupled to abody 526 of the lead. Thelead 520 may be analogous to thelead 160 shown in FIGS. 3A-B. Any other suitable electrical connection between theshaft 510 and the pulse system may be employed. - In one embodiment, the
collar 540 comprises a dielectric material. This will help electrically insulate theskull 10 from theshaft 510. In another embodiment, thecollar 540 is electrically conductive and thelead 520 may be electrically coupled to theshaft 510 via thecollar 540. - In the embodiment shown in
FIG. 14 , theshaft 510 may have a length only a little longer than the thickness of the patient'sskull 10 and thecontact surface 515 may be relatively blunt. Such a design is useful for relatively atraumatic contact with thedura mater 20. In another embodiment suggested in dashed lines inFIGS. 15 and 16 , theelectrode 500 may instead have a substantiallylonger shaft 510 a and a relativelysharp contact surface 515 a. Such an embodiment may be useful for directly stimulating a particular location within the cerebral cortex or some other location within the deeper tissues of the brain. -
FIG. 17 schematically illustrates how certain principles of the invention can be embodied in a subcortical or deep brainintracranial electrode 550. Theelectrode 550 generally includes a threadedshaft 560 having ahead 562. Thehead 562 may be coupled to a pulse system or a sensing unit (as described below) via alead 160 in the same manner lead 160 is attached to thehead 152 ofelectrode 150 in FIGS. 3A-B. (Like reference numbers are used in these figures to indicate like elements.) Theelectrode 550 also includes an elongateconductive member 570 that extends inwardly from theskull 10 to a selectedtarget site 28. Theconductive member 570, which may comprise a length of a conductive wire, may be electrically shielded by a dielectric sheath along much of its length and have an exposed, electricallyconductive tip 574. - In use, the
conductive member 570 may be slid freely through apilot hole 11 formed through the skull to position thetip 574 at thetarget site 28 in a known manner. Thepilot hole 11 may be larger than theconductive member 570 or be tapped to receive the threads of theshaft 560. With theconductive member 570 in place, theshaft 560 may be threaded into thepilot hole 11, crimping theconductive member 570 against an interior of thepilot hole 11. This will fix theconductive member 570 in place. If so desired, aproximal length 572 of theconductive member 570 may extend outwardly of the skull and be held in place by thehead 562. The threads of the threadedshaft 560 may also cut through the dielectric sheath of theconductive member 570 as theshaft 560 is screwed into place, making electrical contact with the conductive wire therein. -
FIG. 18 schematically illustrates a subcortical or deep brainintracranial electrode 600 in accordance with an alternative embodiment of the invention. Thiselectrode 600 includes ahead 610 having a threadedshaft 620 with an axially-extendingopening 622 extending through the length of thehead 610. Thehead 610 may also include a gimbal fitting 630 adapted to slidably receive a length of a conductive member, which may comprise the same type of elongateconductive member 570 discussed above in connection withFIG. 17 . - The gimbal fitting 630 is adapted to allow an operator greater control over the placement of the electrically
conductive tip 574 of theconductive member 570. In use, thetip 574 of theconductive member 570 will be threaded through an opening in thegimbal fitting 630. By pivoting the gimbal fitting 630 with respect to the threadedshaft 620 of thehead 610, the angular orientation of theconductive member 570 with respect to thepilot hole 11 in theskull 10 can be accurately controlled. Once the operator determines that theconductive member 570 is at the appropriate angle, e.g., using a surgical navigation system such as that noted below, the operator may advance theconductive member 570 to position theconductive tip 574 at thetarget site 28. Once thetip 574 is in position, thecap 162 of a lead 160 may be press-fitted on thebody 610 of theelectrode 600. This will crimp theproximal length 572 of theconnective member 570 between thebody 610 and the conductiveinner surface 163 of thecap 162, providing an effective electrical connection between theconductive member 570 and thebody 164 of thelead 160. -
FIGS. 27-29 schematically illustrate intracranial electrodes that form portions of signal transmission systems in accordance with further embodiments of the invention. InFIG. 27 , an electrode 700 comprises a body (e.g., a support body) that includes ahead 702 coupled to ashaft 710. The body of the electrode 700 may be integrally formed of an electrically conductiveinner core 708 clad with a biocompatible electrically insulating material 712. In the illustrated embodiment, the electricallyconductive portion 708 of the electrode 700 extends along the length of both thehead 702 and theshaft 710. Anelectrical lead 720 may be coupled to theelectrode core 708 to facilitate electrical signal transfer, for example, for electrical stimulation and/or monitoring. In certain embodiments, thelead 720 may be coupled to a pulse generator. An electrical contact orcontact portion 704 transmits electrical signals to and/or from thebrain tissue 25. Theelectrical contact portion 704 can be integral with or connected to the conductiveinner core 708. In the particular embodiments shown inFIGS. 27-29 , the electrical contact portions are housed within an insulative body. Electrical contact portions in accordance with other embodiments of the invention can have other arrangements (e.g., they can form part of a larger, generally conductive element). -
FIG. 28 illustrates anotherintracranial electrode 750 in accordance with an embodiment of the invention. In this embodiment, the body ofelectrode 750 may comprise a biocompatibleelectrically insulating material 765 containing a set of biocompatible, electricallyconductive contacts 760 a and 760 b. The electricallyconductive contacts 760 a and 760 b may be carried by different portions of theelectrode 750 to facilitate production of particular types of electric field distributions. In one embodiment, afirst contact 760 a may be carried by thehead 762, and a second contact 760 b may be carried by a distal portion of theshaft 755, which may be configured to be in electrical contact with a stimulation site. A lead 770 may comprise lead wires orlinks contacts 760 a and 760 b. -
FIG. 29 illustrates yet another embodiment of an intracranial electrode 780. In the embodiment shown, the intracranial electrode 780 may compriseelectrical contacts shaft 785. Ahead 782 can stabilize theshaft 785 relative to theskull 10. A lead 790 may comprise lead wires orlinks 792 and 794 that are electrically coupled to one ormore contacts lead wires 792 and 794 may facilitate electrical stimulation and/or monitoring using one or bothcontacts - In an embodiment shown in
FIG. 29 , theshaft 785 can carry twocontacts shaft 785 can carry more or fewer contacts. The diameter of theshaft 785 can be selected based on factors that include the number of contacts carried by theshaft 785. In particular embodiments, theshaft 785 can have a diameter of from about 0.5 millimeters to about 3.0 centimeters. In other embodiments, the diameter of theshaft 785 can have other values. Theshaft 785 can be inserted into the skull in a manner that is consistent with the diameter of theshaft 785. For example,smaller shafts 785 can be inserted through a burr hole in theskull 10, andlarger shafts 785 can be inserted using a craniotomy procedure. -
FIGS. 30 and 31 schematically illustrate other embodiments of the invention that may be applicable to cortical, subcortical, and/or deep brain stimulation and/or monitoring situations. Such embodiments may facilitate stimulation and/or monitoring involving surface or cortical tissues and/or subcortical or deep brain tissues. InFIGS. 30 and 31 , like reference numbers may correspond to identical, essentially identical, or analogous elements. One embodiment of a combinedintracranial electrode assembly 800 is shown in FIG. 30. The combinedintracranial electrode assembly 800 comprises afirst electrode 810 and asecond electrode 820. The first andsecond electrodes first electrode 810 may be in contact with thedura 20, while thesecond electrode 820 may be positioned relative to a subcortical or deep brain location. - In one embodiment, the
first electrode 810 comprises at least oneelectrical contact 815 carried by a distal portion of ashaft 816. Afirst lead wire 830 may be coupled to the first electrode'scontact 815. Thesecond electrode 820 may comprise anelongate member 822 that carries one or more conductive portions, sections, segments, and/orcontacts 825, in a manner identical, essentially identical, or analogous to that described above. Asecond lead wire 835 may be coupled to the second electrode's contact(s) 825. The length of thesecond electrode 820, the position of one ormore contacts 825 carried by thesecond electrode 820, and/or theparticular contacts 825 that are electrically active at any given time may depend upon a targeted tissue type or location and/or establishment of a desired type of stimulation and/or monitoring configuration. In one embodiment, eachelectrode electrodes electrodes -
FIG. 31 illustrates an embodiment of anintracranial electrode assembly 800 wherein afirst electrode 810 comprises at least oneelectrical contact 817 carried by ahead 812. Although thecontact 817 is shown spanning a proximal surface portion of thehead 812, it is to be appreciated that thecontact 817 may be located along, upon, and/or within various portions of thehead 812. In one embodiment, thefirst electrode 810 comprises ashaft 816 that need not touch or rest against neural tissue such as thedura 20. Rather, theshaft 816 may be shorter than in an embodiment such as shown inFIG. 30 . In another embodiment, afirst electrode 810 may include a contact 815 (FIG. 30 ) carried by theshaft 816 in addition to thecontact 817 carried by thehead 812. Such an embodiment may include an additional lead wire (not shown). - In a manner identical, essentially identical, or analogous to other embodiments described herein, a combined
electrode assembly 800 may be comprised of one or more electrically nonconductive portions along with one or more electrically conductive portions. In one embodiment,nonconductive portions second electrodes contacts - Through appropriate electrical coupling, for example, by way of
leads more contacts 815 may be configured as an anode or a cathode, whileother contacts 825 may respectively be configured as a cathode or an anode to facilitate bipolar and/or unipolar stimulation as further described below. For example, a combinedelectrode assembly 800 may be implanted into a patient such that a local contact portion, which may comprise a distal portion of ashaft 816, resides at, upon, or proximate to a stimulation site; while a remote contact portion, which may comprise adistal portion 826 of anelongate member 822, provides a remote or distant circuit completion site. - In general, the applicability of one or more intracranial electrode embodiments to any given neural stimulation and/or monitoring situation may depend upon the location, depth, and/or spatial boundaries of target neural structures and/or target neural populations under consideration, which may depend upon the nature of a patient's neurological condition or disorder. The extent to which an electric field reaches, penetrates, and/or travels into and/or through target neural structures and/or a target neural population may affect neural stimulation efficiency and/or efficacy. Various intracranial electrode embodiments in accordance with the invention, for example, those described above with reference to
FIGS. 27-31 , may have conducting portions in various positions or locations, which may facilitate establishment of particular types of electric field distributions at one or more times. - C. Systems Employing Intracranial Electrodes
-
FIG. 19 is a schematic illustration of aneurostimulation system 1000 in accordance with one embodiment of the invention. Thisneurostimulation system 1000 includes anarray 1010 of intracranial electrodes and an internallyimplantable pulse system 1050. Thearray 1010 of electrodes may employ one or more electrodes in accordance with any one or more of the embodiments described above in connection withFIGS. 2-18 and/or 27-31 and/or any other suitable design. In the particular implementation depicted inFIG. 19 , the array 1010 (shown schematically inFIG. 20 ) includes a first implantableintracranial electrode 100 a and a second implantableintracranial electrode 100 b, each of which may be substantially the same as theelectrode 100 shown in FIGS. 2A-B. Theseelectrodes skull 10 into contact with thedura mater 20 at two spaced-apart locations. - The
pulse system 1050 may be implanted in the body of the patient P at a location remote from thearray 1010 ofelectrodes 100. In the embodiment shown inFIG. 19 , thepulse system 1050 is adapted to be implanted subclavicularly. In the alternative embodiment shown inFIG. 20 , thepulse system 1050 is adapted to be implanted in a recess formed in the patient'sskull 10. In either embodiment, each of theelectrodes 100 in thearray 1010 is electrically coupled to thepulse system 1050 by means of a separate lead (120 in FIGS. 2A-B) having an elongate, subcutaneouslyimplantable body 124. Hence,electrode 100 a is coupled to thepulse system 1050 by theelongate body 124 a of a first lead and theother electrode 100 b is coupled to thepulse system 1050 by theelongate body 124 b of another lead. In one embodiment, theelongate bodies 124 a-b are combined into a single subcutaneously implantable cable or ribbon. -
FIG. 21 schematically illustrates onepulse system 1050 suitable for use in theneurostimulation system 1000 shown inFIG. 19 . Thepulse system 1050 generally includes apower supply 1055, anintegrated controller 1060, apulse generator 1065, and apulse transmitter 1070. Thepower supply 1055 can be a primary battery, such as a rechargeable battery or other suitable device for storing electrical energy. In alternative embodiments, thepower supply 1055 can be an RF transducer or a magnetic transducer that receives broadcast energy emitted from an external power source and converts the broadcast energy into power for the electrical components of thepulse system 1050. - In one embodiment, the
controller 1060 includes a processor, a memory, and a programmable computer medium. Thecontroller 1060, for example, can be a computer, and the programmable computer medium can be software loaded into the memory of the computer and/or hardware that performs the requisite control functions. In an alternative embodiment suggested by dashed lines inFIG. 21 , thecontroller 1060 may include an integrated RF ormagnetic controller 1064 that communicates with anexternal controller 1062 via an RF or magnetic link. In such a circumstance, many of the functions of thecontroller 1060 may be resident in theexternal controller 1062 and theintegrated portion 1064 of thecontroller 1060 may comprise a wireless communication system. - The
controller 1060 is operatively coupled to and provides control signals to thepulse generator 1065, which may include a plurality of channels that send appropriate electrical pulses to thepulse transmitter 1070. Thepulse generator 1065 may have N channels, with at least one channel associated with each ofN electrodes 100 in thearray 1010. Thepulse generator 1065 sends appropriate electrical pulses to thepulse transmitter 1070, which is coupled to a plurality ofelectrodes 1080. In one embodiment, each of these electrodes is adapted to be physically connected to thebody 124 of a separate lead, allowing eachelectrode 1080 to electrically communicate with asingle electrode 100 in thearray 1010 on a dedicated channel of thepulse generator 1065. Suitable components for thepower supply 1055, theintegrated controller 1060, thepulse generator 1065, and thepulse transmitter 1070 are known to persons skilled in the art of implantable medical devices. - As shown in
FIG. 20 , thearray 1010 ofelectrodes 100 inFIG. 19 comprises a simple pair ofelectrodes FIGS. 23-26 illustrate alternative arrays that may be useful in other embodiments. InFIG. 23 , the array 1010 a includes fourelectrodes 100 arranged in a rectangular array. Thearray 1010 b ofFIG. 24 includes sixteenelectrodes 100, also arranged in a rectangular array. Thearray 1010 c shown inFIG. 25 includes nineelectrodes 100 arranged in a radial array.FIG. 26 illustrates anarray 1010 d that includes fourelectrodes 100×arranged in a rectangular pattern and afifth electrode 100 y at a location spaced from the other fourelectrodes 100 x. In using such an array, the fourproximate electrodes 100×may be provided with the same polarity and thefifth electrode 100 y may have a different polarity. In some embodiments, the housing (1052 inFIG. 19 ) of thepulse system 1050 may serve the function of thefifth electrode 100 y. The precise shape, size, and location of thearray 1010 and the number ofelectrodes 100 in thearray 110 can be optimized to meet the requirements of any particular application. - One or
more electrodes 100 ofarrays 1010 such as those described herein may be provided with electrical signals in a variety of spatially and/or temporally different manners. In some circumstances, oneelectrode 100 or a subset of theelectrodes 100 may have one electrical potential and adifferent electrode 100 or subset of the electrodes 100 (or, in some embodiments, thehousing 1052 of the pulse system 1050) may have a different electrical potential. U.S. patent application Ser. No. 09/978,134, entitled “Systems and Methods for Automatically Optimizing Stimulus Parameters and Electrode Configurations for Neuro-Stimulators” and filed 15 Oct. 2001 (the entirety of which is incorporated herein by reference), suggests ways for optimizing the control of the electrical pulses delivered to theelectrodes 100 in anarray 1010. The methods and apparatus disclosed therein may be used to automatically determine the configuration of therapy electrodes and/or the parameters for the stimulus to treat or otherwise effectuate a change in neural function of a patient. - In general, neural stimulation efficiency and/or efficacy may be influenced by an extent to and/or manner in which neural stimulation reaches and/or travels into and/or through target neural structures and/or a target neural population, which may be affected by stimulation signal polarity, electrode configuration, and/or electrical contact configuration considerations. The particular neural structures and/or neural populations targeted at any time in a neural stimulation situation, and hence such considerations, may depend upon the nature, severity, and/or spatial boundaries of a patient's neurologic dysfunction.
- Various embodiments in accordance with the present invention may be configured to provide bipolar and/or unipolar stimulation at one or more times. Neural stimulation in which both an anode and a cathode are positioned, located, or situated within, essentially across, or proximate to a stimulation site may be defined as bipolar stimulation. Neural stimulation in which one of an anode and a cathode is positioned, located, or situated within or proximate to a stimulation site while a respective corresponding cathode or anode is positioned, located, or situated remote from the stimulation site to provide electrical continuity may be defined as unipolar, monopolar, or isopolar stimulation. Unipolar stimulation may alternatively or additionally be characterized by a biasing configuration in which an anode and a cathode are positioned, located, or situated in different neurofunctional areas or functionally distinct anatomical regions. Those skilled in the art will understand that an anode and a cathode may be defined in accordance with a first phase polarity of a biphasic or polyphasic signal.
- In a unipolar configuration, a
pulse system 1050 may apply an identical polarity signal to each electrode or electrical contact positioned upon or proximate to one or more stimulation sites. Unipolar stimulation may be defined as anodal unipolar stimulation when an anode is positioned upon or proximate to a stimulation site or a target neural population; and as cathodal unipolar stimulation when a cathode is positioned upon or proximate to a stimulation site or a target neural population. - In various situations, neural stimulation having particular stimulation signal and/or spatial and/or temporal characteristics (e.g., bipolar stimulation, cathodal or anodal unipolar stimulation, mixed-polarity stimulation, varying duty cycle stimulation, varying frequency stimulation, varying amplitude stimulation, spatially or topographically varying stimulation, theta burst stimulation, and/or other types of stimulation applied or delivered in a predetermined, pseudo-random, and/or aperiodic manner at one or more times and/or locations), possibly in association or conjunction with one or more adjunctive or synergistic therapies, may facilitate enhanced symptomatic relief and/or at least partial recovery from neurologic dysfunction.
- An adjunctive or synergistic therapy may comprise a behavioral therapy such as a physical therapy activity, a movement and/or balance exercise, an activity of daily living (ADL), a vision exercise, a reading task, a speech task, a memory or concentration task, a visualization or imagination exercise, an auditory activity, an olfactory activity, a relaxation activity, and/or another type of behavior, task, or activity; a drug or chemical substance therapy; and/or another therapy that may be relevant to a patient's functional state, development, and/or recovery.
- Neurologic dysfunction to which various embodiments of the present invention may be directed may correspond to, for example, motor, sensory, language, visual, cognitive, neuropsychiatric, auditory, and/or other types of deficits or symptoms associated with stroke, traumatic brain injury, cerebral palsy, Multiple Sclerosis, Parkinson's Disease, essential tremor, a memory disorder, dementia, Alzheimer's disease, depression, bipolar disorder, anxiety, obsessive/compulsive disorder, Post Traumatic Stress Disorder, an eating disorder, schizophrenia, Tourette's Syndrome, Attention Deficit Disorder, a drug addiction, autism, epilepsy, a sleep disorder, a hearing disorder, and/or one or more other states, conditions, and/or disorders. Depending upon embodiment details and/or the nature of a patient's neurologic dysfunction, at least partial symptomatic relief, functional recovery, and/or functional development may occur through mechanisms corresponding or analogous to Long Term Potentiation (LTP), Long Term Depression (LTD), neuroplastic change, and/or compensatory processes.
-
FIG. 32 is a schematic illustration of an exemplary implantation configuration for aneural stimulation system 1000 according to an embodiment of the invention. In one embodiment, aneural stimulation system 1000 may comprise a set of intracranial electrodes 100 c and 100 d coupled bylead wires 124 c and 124 d to apulse system 1050. The intracranial electrodes 100 c and 100 d may be surgically implanted at or relative to a set of target sites, and thepulse system 1050 may be implanted beneath thescalp 30 and adjacent to and/or partially within theskull 10. In certain configurations, a particular separation between and/or relative positioning of two or more intracranial electrodes 100 c and 100 d may be established, such that target electrode implantation or stimulation sites may correspond to anatomically remote and/or distinct regions. This may facilitate unipolar stimulation and/or stimulation of neural populations in different neural association areas, for example, different neurofunctional areas associated with motor skills or abilities; neurofunctional areas associated with motor and language skills; and/or neurofunctional areas associated with other skills. -
FIG. 33 is a schematic illustration of another exemplary implantation configuration for aneural stimulation system 1000 according to an embodiment of the invention. Relative toFIG. 32 , like reference numbers may indicate like, corresponding, and/or analogous elements. As inFIG. 32 , a set of intracranial electrodes 100 e and 100 f may be implanted or positioned relative to particular neurofunctional areas. In one embodiment, the set of electrodes 100 e and 100 f may exhibit multiple types of electrical contact configurations, orientations, and/or geometries. For example, a particular electrode 100 e may carry an electrical contact Ce that is distinctly different from one or more contacts Cf carried by another electrode 100 f. Depending upon embodiment details, differences in contact configuration may facilitate establishment of particular types of electric field distributions, which may influence neural stimulation efficiency and/or efficacy. - Various portions of the discussion herein focus on use of intracranial electrodes (e.g.,
electrodes neurostimulation system 1000 shown inFIG. 19 , but a sensing unit (not shown) may be used in place of thepulse system 1050. Suitable components for such a sensing unit are known to those skilled in the art of electroencephalography. -
FIG. 34A illustrates anintracranial electrode system 900 in accordance with an embodiment of the invention. In one embodiment, theelectrode system 900 comprises an electrical energy transfer mechanism (ETM) 910 externally placed adjacent to a patient'sscalp 30 to couple electrical energy from apulse generator 1050 to anintracranial electrode 920. Alead wire 915 may couple theETM 910 to thepulse generator 1050. Thepulse generator 1050 may be of an identical, essentially identical, analogous, or different type relative to apulse generator 1050 shown inFIGS. 19-21 . - In some embodiments, the
ETM 910 may comprise a conventional adhesive patch electrode commonly used for providing an electrical coupling to a particular location on a patient. Theintracranial electrode 920 may comprise a head 922 coupled to ashaft 924. The head 922 andshaft 924 may be integrally formed of an electrically conductive material forming aconductive core 925 that forms an electrical energy conduit. Theconductive core 925 may extend throughout a portion or along the entire length of theelectrode 920. Theconductive core 925 may be carried by or encased in an electrically insulating material orcladding 921. Theconductive core 925 may extend from an upper orproximal contact surface 925 a to a lower or distal contact surface 925 b. Contact surfaces 925 a and 925 b provide a signal exchange interface of theconductive core 925. Theconductive core 925 and the insulatingmaterial 921 may vary in proportionate dimensions with one another accordingly. -
FIG. 34B is a cross sectional illustration of anETM 910 according to an embodiment of the invention. In one embodiment, theETM 910 comprises anenergy transfer patch 912 that may have several layers. In general, anETM 910 may comprise an outer flexible, insulating, and/or articulatedlayer 916, an electricallyconductive layer 914, and agel layer 912. Theconductive layer 914 may be comprised of a conductive material, such as aluminum for example, for carrying or conveying an electrical signal. Theconductive layer 914 may be appropriately shaped (e.g., oval or elliptical) for conforming to a portion of the skull's rounded surface, and may be coupled to thelead wire 915. Theconductive layer 914 forms a portion of a conductive circuit between thelead wire 915 and the conductive core 925 (FIG. 34A ). - The
outer layer 916 may be comprised of essentially any appropriate insulating nonconductive material as is known in the art (e.g., foam). Theouter layer 916 may be smooth and flexible to facilitate contouring to the patient'sskin surface 30. Thegel layer 912, which may be placed in contact withscalp 30, may comprise one or more of an electrically conductive coupling gel 912 a (such as a hydrogel or wet gel), an adhesive gel 912 b, and/or an anesthetic gel 912 c. Electrical coupling gel 912 a may be comprised of a saline composition for enhancing electrical conductivity and decreasing losses between theconductive layer 914 andscalp 30. The adhesive gel 912 b aids in keeping theETM 910 in place. An anesthetic gel 912 c may be incorporated to possibly reduce or retard sensations that may result from the transfer of electrical signals from theETM 910 throughscalp tissues 30 to theelectrode 920. -
FIG. 35 illustrates yet another embodiment of portions of anintracranial electrode system 900. In one embodiment, an intracranial electrode 930 comprises ahead 932 and a shaft 934 forming a body of the electrode 930. The electrode 930 may contain aconductive core 925 having contact surfaces 935 a and 935 b for conducting electrical energy through thescalp 30 to a stimulation site such as thedura 20. The conductive core 935 may be clad with an electrically insulatingmaterial 931. A portion of the insulatingmaterial 931 may form one or more portions of the shaft 934, which may contain threads 935 for tapping into the cancellous 18. As in certain previous embodiments having threads, intracranial electrode 930 may be tapped into theskull 10 to a desired depth. A bore, notch or groove 933 may be formed in a proximal portion of thehead 932 to facilitate tapping the electrode 930 into place. -
FIG. 36 is an illustration of anintracranial electrode system 900 according to an embodiment of the invention. A set of intracranial electrodes 920 (shown aselectrodes 920 a and 920 b) may be implanted relative to one or more target sites withincancellous 18. For purposes of simplicity, only twoelectrodes 920 are shown; however, it is to be appreciated that additional orfewer electrodes 920 may be employed. In some embodiments, ETMs 910 (shown as ETMs 910 a, 910 b) may be placed proximate to eachelectrode 920 a and 920 b, external to the body and adjacent thescalp 30. Such a set ofETMs 910 may be coupled to thepulse generator 1050 vialeads 915 a and 915 b. Depending upon embodiment details and/or a type of neurologic dysfunction under consideration, theintracranial electrode system 900 may be configured to provide bipolar stimulation, as afirst electrode 920 a may have a first polarity and a second electrode 920 b may have an opposing polarity as determined by electrical signals transmitted via correspondinglead wires 915 a and 915 b, respectively. Alternatively, each of theelectrodes 920 may be biased with the same polarity in a unipolar configuration. In such a situation, a return electrode (not shown) may be placed in another location upon the patient's body; or one or more portions of the pulse generator's case may serve as a return electrode. The leads 915 a, 915 b can be generally continuous (e.g., they can extend from the corresponding ETM 910 a, 910 b to thepulse generator 1050 without a break, except for an optional releasable connection at the pulse generator 1050). -
FIG. 37 is an illustration of a set of implantedintracranial electrodes 940 a and 940 b according to an embodiment of the invention. In one embodiment, theintracranial electrodes 940 a and 940 b may compriseheads 942 a and 942 b that are eccentrically offset relative to a center axis A1 and A2 of an electrode shaft 944 a and 944 b, respectively. A first offset may be defined for afirst electrode 940 a by a first radius L1 and a second radius R1, where L1>R1. Likewise, a second offset may be defined for a second electrode 940 b having a head 942 b with radii L2 and R2 where R2>L2. The offset radii may facilitate the placement ofintracranial electrodes 940 a and 940 b in close or generally close proximity to one another at a distance D, while keeping D at a minimum due to the shorter radii R1 and L2. The offset radii provide maximum distancing between the ETMs 910 a and 910 b. In a situation wherein several sets of electrodes may be needed for treatment, having electrodes with off center heads 942 a and 942 b may provide better and/or more placement options when a plurality of electrodes are to be placed in close proximity to one another. Although a set of twointracranial electrodes 940 a and 940 b are shown, it is to be understood that larger sets may be employed depending on electrode dimensions and/or a number of stimulation sites under consideration. In any of these embodiments, theelectrodes 940 a, 940 b can be secured relative to theskull 10 by inserting each of theelectrodes 940 a, 940 b into a corresponding collar, e.g., acollar 540 generally similar to that described above with reference toFIG. 14 . The collar can be secured to the skull with one or more securement elements (e.g., threads). -
FIG. 38 illustrates anintracranial electrode 950 according to another embodiment of the invention. In one aspect of this embodiment,electrode 950 comprises a body formed of a head 952 andshaft 954, wherein the head 952 and theshaft 954 are formed with an obtuse angle θ at their juncture. The obtuse angle θ provides the body of the electrode with a tapered, frustoconical shape that facilitates a more contoured, conformal implant within the cancellous 18. The head 952 may also be formed with a protrusion or protruded upper portion E. The protrusion E may be rounded for a more contoured abutment withscalp tissues 30 to enhance patient comfort. The head 952 may be contoured and/or tapered, and may be at least partially recessed within theskull 10 to facilitate a more conformal positioning within the patient'sskull 10. Furthermore, a recessed, contoured placement within theskull 10 may provide a more aesthetically pleasing implant. - An outer portion of the
electrode 950 may be comprised of an insulatingcladding 956 disposed around aconductive core 955. Theconductive core 955 can include a first electrical contact portion 955 a and a second conductive contact portion 955 b. It is to be appreciated by those of ordinary skill in the art that thecladding 956 may be comprised of any suitable biocompatible electrically insulating material, such as, but not limited to, polymers and/or ceramic materials. Thecladding 956 may contain a plurality ofpores 957.Pores 957 may encourage bone regeneration within and about the pores for a more friction enhanced and/or lasting placement within theskull 10. In lieu ofpores 957, an exterior portion of thecladding 956 in contact with body tissues may also be formed with a roughened surface (not shown) that may encourage bone growth and/or regeneration. Such enhanced friction and intergrowth between thecladding 956 and the cancellous 18 may provide for a more secure and/or conformal placement, which may reduce or minimize positional migration of the implantedelectrodes 950. Other embodiments (not shown) may include variations of thecladding 957 having combinations of compatible insulative materials comprising the exterior; such as for example, an upper proximal portion of thecladding 967 being comprised of a ring-like polymer insulator; and/or a distal or generally distal portion of thecladding 967 being comprised of a ceramic insulator. -
FIG. 39 illustrates yet anotherintracranial electrode 960 according to an embodiment of the invention. In one embodiment, theintracranial electrode 960 comprises a body having ahead 962 and ashaft 964. One or more portions of thehead 962 and/or theshaft 964 may form a tapered transition region, such that a juncture of thehead 962 and theshaft 964 form an obtuse angle 0. Theintracranial electrode 960 may be surgically implanted within a patient'sskull 10 such that a proximal portion (e.g., an end surface) of thehead 962 is flush or substantially flush with an outer portion orlayer 12 of theskull 10. The entirety of theelectrode 960 may be countersunk into a recess formed through theouter skull 12 and cancellous 18. - The
intracranial electrode 960 may also comprise acladding 966 surrounding a conductive core 965. Thecladding 966, comprised of any suitable biocompatible material, may in some embodiments includerecesses 967 which may encourage surroundingcancellous tissue 18 to grow within and/or around therecesses 967, thus forming an enhanced bonding between the implantedelectrode 960 and theskull 10. This modified bonding may discourage migration of theelectrode 960. -
FIG. 40 illustrates anintracranial electrode system 900 according to another embodiment of the invention. In one aspect of this embodiment, theintracranial electrode system 900 comprises at least one intracranial electrode 970 that includes a radio frequency identification (RFID) element, tag, or transponder 971 and/or another type of proximity sensing and/or detecting device. The RFID element 971 may be embedded within or carried by a portion of thehead 972 and/orshaft 974, for example, within an insulatingnon-conductive material 973 forming a portion of thehead 972. Insulatingmaterial 973 may electrically insulate the RFID element 971 from aconductive core 975. Theconductive core 975 may includecontact surface areas 975 a and 975 b that couple to and/or comprise a portion of an electrical conduit that facilitates signal transfer or electrical communication between anETM 910 and intended target tissues. TheETM 910 is electrically coupled to apulse generator 1050. In this embodiment, thepulse generator 1050 may include an RFID unit 1063 comprising an RFID reader configured to identify one or more RFID elements 971 to either allow/enable or disallow/disable electrical signal transmissions to particular intracranial electrodes 970 at one or more times. - The RFID unit 1063 may comprise an RFID reader that may include a transmitter and a receive module, a control unit, and a coupling element (e.g., an antenna). The reader may have three functions: energizing, demodulating, and decoding. In addition, a reader can include or be fitted with an interface that converts RF signals returned from an RFID element 971 into a form that can be passed on to and/or processed by other elements (e.g., a controller 1060) associated with the
system 900. - The RFID element 971 may comprise an integrated circuit that is activated when placed in a transmitting field of the RFID unit 1063. The transmitting field may vary depending on specifications of the RFID element 971 and/or RFID unit 1063. When an
ETM 910 is placed proximate to the intracranial electrode 970, the RFID unit 1063 may emit an RF signal that may used to power up the electrode's RFID element 971. In one embodiment, in the event that an RFID element 971 corresponds to or provides a particular code and/or other information, electrical signal transmission between thepulse generator 1050 and theETM 910, and hence to the electrode 970, may be allowed. Such an embodiment may facilitate enhanced security neural stimulation. - The above descriptions of embodiments of the invention are not exhaustive and it is to be appreciated that, although not detailed in every instance, certain characteristics of some embodiments may be applicable to other embodiments. Various embodiments may include characteristics that are identical, essentially identical, or analogous to those described in relation to other embodiments. For example, regarding various embodiments of
FIGS. 27-40 , one or more of the following may be incorporated therewith in a manner that is identical, essentially identical, and/or analogous to that described above: an adjunct sleeve may serve as an anchor surrounding an electrode as discussed with reference toFIG. 4B ; a dielectric member may be included with an insulating layer as discussed with reference toFIGS. 3A, 4A , and 14; one or more mechanisms for adjusting the overall length of the electrode as discussed with reference toFIGS. 6-13 may be included; an electrode may have a compressible retaining collar as discussed with reference toFIG. 14 ; an electrode may have a sharper contact surface as discussed with reference toFIGS. 14 and 15 ; and/or thesecond electrode 820 of the intracranial electrode system ofFIGS. 30 and 31 may have a gimbal type fitting, as discussed with reference toFIG. 18 . - D. Methods
- As noted above, other embodiments of the invention provide methods of implanting an intracranial electrode and/or methods of installing a neurostimulation system including an implantable intracranial electrode. In the following discussion, reference is made to the particular
intracranial electrode 100 illustrated in FIGS. 2A-B and to theneurostimulation system 1000 shown inFIG. 19 . It should be understood, though, that reference to this particular embodiment is solely for purposes of illustration and that the methods outlined below are not limited to any particular apparatus shown in the drawings or discussed in detail above. - As noted above, implanting conventional cortical electrodes typically requires a full craniotomy under general anesthesia to remove a relatively large (e.g., thumbnail-sized or larger) window in the skull. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
- In accordance with one embodiment of the present invention, however, the diameter of the
electrode shaft 110 is sufficiently small to permit implantation under local anesthetic without requiring a craniotomy. In this embodiment, a relatively small (e.g., 4 mm or smaller) pilot hole may be formed through at least part of the thickness of the patient's skull adjacent a selected stimulation or monitoring site of the brain. When implanting theelectrode 100 of FIGS. 2A-B, it may be advantageous to extend the pilot hole through the entire thickness of the skull. Care should be taken to avoid undue trauma to the brain in forming the pilot hole. In one embodiment, an initial estimate of skull thickness can be made from MRI, CT, or other imaging information. A hand-held drill may be used to form a bore shallow enough to avoid extending through the entire skull. A stylus may be inserted into the pilot hole to confirm that it strikes relatively rigid bone. The drill may then be used to deepen the pilot hole in small increments, checking with the stylus after each increment to detect when the hole passes through the thickness of theinner cortex 14 of theskull 10. If so desired, the stylus may be graduated to allow a physician to measure the distance to the springy dura mater and this information can be used to select anelectrode 100 of appropriate length or, if an adjustable-length electrode (e.g.,electrode 300 of FIGS. 6A-B) is used, to adjust the electrode to an appropriate length. - The location of the pilot hole (and, ultimately the
electrode 100 received therein) can be selected in a variety of fashions. U.S. Patent Application Publication No. US 2002/0087201 and U.S. application Ser. No. 09/978,134 (both of which are incorporated hereinabove), for example, suggest approaches for selecting an appropriate stimulation site. When the desired site has been identified, the physician can bore the pilot hole to guide thecontact surface 115 of theelectrode 100 to that site. In one embodiment, the physician may use anatomical landmarks, e.g., cranial landmarks such as the bregma or the sagittal suture, to guide placement and orientation of the pilot hole. In another embodiment, a surgical navigation system may be employed to inform the physician during the procedure. Briefly, such systems may employ real-time imaging and/or proximity detection to guide a physician in placing the pilot hole and in placing theelectrode 100 in the pilot hole. In some systems, fiducials are positioned on the patient's scalp or skull prior to imaging and those fiducials are used as reference points in subsequent implantation. In other systems, real-time MRI or the like may be employed instead of or in conjunction with such fiducials. A number of suitable navigation systems are commercially available, such as the STEALTHSTATION TREON TGS sold by Medtronic Surgical Navigation Technologies of Louisville, Colo., US. - Once the pilot hole is formed, the threaded
electrode 100 may be advanced along the pilot hole until thecontact surface 115 electrically contacts a desired portion of the patient's brain. If theelectrode 100 is intended to be positioned epidurally, this may comprise relatively atraumatically contacting thedura mater 20; if the electrode is to contact a site on the cerebral cortex, the electrode will be advanced to extend through the dura mater. Theelectrodes 100 may also be implanted to a selected depth within the cerebral cortex or at a deeper location in the brain. - In one embodiment, the length of the
electrode 100 is selected (or adjusted forelectrode 300, for example) to achieve the desired level of contact and the electrode will be advanced until a known relationship with the skull is achieved, e.g., when thehead 102 compresses thecontact ring 122 of thelead 120 against the exterior of theskull 10. In another embodiment, the thickness of theskull 10 need not be known to any significant accuracy before theelectrode 100 is implanted. Instead, theelectrode 100 may be connected, e.g., via thelead 120, to an impedance monitor and the impedance may be monitored as theelectrode 100 is being implanted. It is anticipated that the measured impedance will change when theelectrode 100 contacts thedura mater 20. Once this contact is detected, the physician may advance the electrode a small, fixed distance to ensure reliable electrical contact over time. - As noted above, the
electrode 100 may be coupled to alead 120. The timing of this coupling may vary with the nature of the coupling. For a lead 120 employing acontact ring 122 or the like positioned below thehead 102, the lead may be coupled to the electrode before the electrode is introduced into the skull. In other embodiments, the lead (e.g., lead 160 of FIGS. 3A-B) may be coupled to the electrode after the electrode is properly positioned with respect to the selected site of the brain. The lead, or at least a length thereof, may be implanted subcutaneously, e.g., by guiding it through a tunnel formed between the implant site and the intended site of a subclavicularly implantedpulse system 1050. The patient's scalp may then be closed over thehead 102 of theelectrode 100 so the electrode is completely enclosed. This can materially improve patient comfort compared to more conventional systems wherein epilepsy monitoring electrodes or the like extend through the scalp to an extracorporeal connection. - Additionally or alternatively, implant depth may be measured, estimated, or indicated through the use of a depth measurement device or apparatus.
FIG. 41 is a schematic illustration of a depth measurement apparatus 175 (e.g., a depth acquisition stick or DAS) and a set of intracranial electrodes I1-I4. In one embodiment, an appropriate electrode length may be determined by performing a depth measurement procedure using thedevice 175. Thedevice 175 may be inserted into a surgically formedpilot hole 11. Thedevice 175 may contain indicia comprising a plurality of calibrated indicators d1-d4, which provide linear measurements as to the depth of thepilot hole 11. Thedevice 175 may have a retainer cuff and/or sleeve 176 that aids in keeping thedevice 175 in an upright position for accurate depth measurements. - Depending on the depth of the
pilot hole 11, intracranial electrodes 11-14 may have shafts of varying lengths S1-S4 that correspond to the demarcated indicators d1-d4. For example, the shaft of intracranial electrode I1, may have a length S1 associated with a distance d, indicated on thedevice 175. Likewise, intracranial electrodes I2, I3 and I4 may be associated with distances d2, d3, and d4, respectively. The depths of the pilot holes 11 may vary from patient to patient depending on such variables as the age of the patient and/or an implant location in theskull 10. -
FIG. 42 is a flowchart illustrating adepth acquisition procedure 2000 according to an embodiment of the invention. In one embodiment, adepth acquisition procedure 2000 may comprise an accessingprocedure 2010 that involves surgically accessing an implantation or stimulation site. An accessing procedure may utilize a surgical navigational system and/or anatomical landmarks, as discussed above, to aid in making apilot hole 11 in one or more appropriate locations. Thedepth acquisition procedure 2000 may further comprise aninsertion procedure 2020 that may involve insertion of a depth acquisition apparatus such as device 175 (FIG. 41 ) into apilot hole 11. As discussed above, thedevice 175 may be provided with indicia corresponding to demarcations or units of length (e.g., millimeters). Thedepth acquisition procedure 2000 may additionally comprise ameasurement procedure 2030 that involves measuring or comparing the depth of ahole 11 relative to a calibrated indicia on a measurement device, e.g., thedevice 175. As discussed above, thedevice 175 may have calibrations corresponding to a set of shaft lengths of a series of electrodes. Thedepth acquisition procedure 2000 may also comprise amapping procedure 2040 that involves mapping or correlating a measurement depth associated with apilot hole 11 to a corresponding electrode, for example, one of intracranial electrodes I1-I4. Adepth acquisition procedure 2000 may additionally comprise aselection procedure 2050 that involves selecting an electrode characterized by an appropriate length or dimension for implantation. - Once an
electrode 100 is in place, an electrical stimulus may be delivered from apulse system 1050 to the patient's brain via alead 120 and theelectrode 100. In certain embodiments of the invention discussed previously, a plurality ofelectrodes 100 may be implanted in an array (e.g.,array electrodes 100 may be coupled to thepulse system 1050 by an electricallyseparate lead 120. The precise nature of the stimulus delivered via the electrode(s) 100 can be varied as desired to diagnose or treat a variety of conditions. The type, pattern, and/or frequency of stimulus may be selected in a manner identical, essentially identical, or analogous to or different from that outlined in U.S. Patent Application Publication No. US 2002/0087201, for example, and/or may be optimized in a manner described in U.S. application Ser. No. 09/978,134. - Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense, that is to say, in a sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number, respectively. When the claims use the word “or” in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list, and any combination of the items in the list.
- The above-detailed descriptions of embodiments of the invention are not intended to be exhaustive or to limit the invention to the precise form disclosed above. While specific embodiments of, and examples for, the invention are described above for illustrative purposes, various equivalent modifications are possible within the scope of the invention, as those skilled in the relevant art will recognize. For example, whereas steps are presented in a given order, alternative embodiments may perform steps in a different order. Aspects of the invention described in the context of particular embodiments can be combined or eliminated in other embodiments.
- In general, the terms used in the following claims should not be construed to limit the invention to the specific embodiments disclosed in the specification, unless the above-detailed description explicitly defines such terms. While certain aspects of the invention are presented below in certain claim forms, the inventors contemplate the various aspects of the invention in any number of claim forms. Accordingly, the inventors reserve the right to add additional claims after filing the application to pursue such additional claim forms for other aspects of the invention.
Claims (58)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/891,834 US20050075680A1 (en) | 2003-04-18 | 2004-07-15 | Methods and systems for intracranial neurostimulation and/or sensing |
PCT/US2005/024768 WO2006019766A2 (en) | 2004-07-15 | 2005-07-15 | Methods and systems for intracranial neurostimulation and/or sensing |
EP05773623A EP1786508A4 (en) | 2004-07-15 | 2005-07-15 | Methods and systems for intracranial neurostimulation and/or sensing |
US12/509,110 US8718777B2 (en) | 2002-11-27 | 2009-07-24 | Methods and systems for intracranial neurostimulation and/or sensing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/418,796 US7302298B2 (en) | 2002-11-27 | 2003-04-18 | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography |
US10/891,834 US20050075680A1 (en) | 2003-04-18 | 2004-07-15 | Methods and systems for intracranial neurostimulation and/or sensing |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/418,796 Continuation-In-Part US7302298B2 (en) | 2002-11-27 | 2003-04-18 | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/509,110 Continuation US8718777B2 (en) | 2002-11-27 | 2009-07-24 | Methods and systems for intracranial neurostimulation and/or sensing |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050075680A1 true US20050075680A1 (en) | 2005-04-07 |
Family
ID=35907867
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/891,834 Abandoned US20050075680A1 (en) | 2002-11-27 | 2004-07-15 | Methods and systems for intracranial neurostimulation and/or sensing |
US12/509,110 Expired - Fee Related US8718777B2 (en) | 2002-11-27 | 2009-07-24 | Methods and systems for intracranial neurostimulation and/or sensing |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/509,110 Expired - Fee Related US8718777B2 (en) | 2002-11-27 | 2009-07-24 | Methods and systems for intracranial neurostimulation and/or sensing |
Country Status (3)
Country | Link |
---|---|
US (2) | US20050075680A1 (en) |
EP (1) | EP1786508A4 (en) |
WO (1) | WO2006019766A2 (en) |
Cited By (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020091419A1 (en) * | 2000-07-13 | 2002-07-11 | Firlik Andrew D. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US20030074032A1 (en) * | 2001-10-15 | 2003-04-17 | Gliner Bradford Evan | Neural stimulation system and method responsive to collateral neural activity |
US20030088274A1 (en) * | 2001-09-28 | 2003-05-08 | Vertis Neuroscience, Inc. | Method and apparatus for electrically stimulating cells implanted in the nervous system |
US20030097161A1 (en) * | 2000-07-13 | 2003-05-22 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20030125786A1 (en) * | 2000-07-13 | 2003-07-03 | Gliner Bradford Evan | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20030130706A1 (en) * | 2000-07-13 | 2003-07-10 | Sheffield W. Douglas | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20030187490A1 (en) * | 2002-03-28 | 2003-10-02 | Gliner Bradford Evan | Electrode geometries for efficient neural stimulation |
US20040088024A1 (en) * | 2001-03-08 | 2004-05-06 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20040102828A1 (en) * | 2002-11-27 | 2004-05-27 | Lowry David Warren | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography |
US20040111127A1 (en) * | 2002-12-10 | 2004-06-10 | Gliner Bradford Evan | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders |
US20040158298A1 (en) * | 2000-07-13 | 2004-08-12 | Gliner Bradford Evan | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US20040181263A1 (en) * | 2001-03-08 | 2004-09-16 | Jeffrey Balzer | System and method for treating Parkinson's Disease and other movement disorders |
US20050274589A1 (en) * | 2004-05-07 | 2005-12-15 | Vanderlande Industries Nederland B.V. | Device for sorting products |
US20060069415A1 (en) * | 2003-11-20 | 2006-03-30 | Advanced Neuromodulation Systems, Inc. | Electrical stimulation system, lead, and method providing modified reduced neuroplasticity effect |
US20060106431A1 (en) * | 2004-11-12 | 2006-05-18 | Allen Wyler | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US20070043392A1 (en) * | 2000-07-13 | 2007-02-22 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US20070043268A1 (en) * | 2005-06-16 | 2007-02-22 | Russell Michael J | Guided Electrical Transcranial Stimulation (GETS) Technique |
US20070179557A1 (en) * | 2006-01-27 | 2007-08-02 | Maschino Steven E | Controlling neuromodulation using stimulus modalities |
US20070225773A1 (en) * | 2005-09-28 | 2007-09-27 | Yang Shen | Implantable transcranial pulse generator having a collapsible portion |
US20070255338A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Cranial implant |
US20080243204A1 (en) * | 2007-03-28 | 2008-10-02 | University Of Florida Research Foundation, Inc. | Variational parameter neurostimulation paradigm for treatment of neurologic disease |
US20080249591A1 (en) * | 2007-04-06 | 2008-10-09 | Northstar Neuroscience, Inc. | Controllers for implantable medical devices, and associated methods |
US20080255582A1 (en) * | 2007-04-11 | 2008-10-16 | Harris John F | Methods and Template Assembly for Implanting an Electrode Array in a Patient |
US20080312716A1 (en) * | 2005-06-16 | 2008-12-18 | Russell Michael J | Methods and Systems for Using Intracranial Electrodes |
US20090018571A1 (en) * | 2005-09-28 | 2009-01-15 | Sean Tremaine Whalen | System, method and apparatus for applying air pressure on a portion of the body of an individual |
WO2009051965A1 (en) * | 2007-10-14 | 2009-04-23 | Board Of Regents, The University Of Texas System | A wireless neural recording and stimulating system for pain management |
US20090112279A1 (en) * | 2007-10-30 | 2009-04-30 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US20090112278A1 (en) * | 2007-10-30 | 2009-04-30 | Neuropace, Inc. | Systems, Methods and Devices for a Skull/Brain Interface |
US20090118804A1 (en) * | 2007-11-05 | 2009-05-07 | Advanced Bionics Corporation | Method of mounting minimally invasive plug electrodes within cranium of patient |
US20090118787A1 (en) * | 2007-11-02 | 2009-05-07 | Advanced Bionics Corporation | Closed-loop feedback for steering stimulation energy within tissue |
US20090192569A1 (en) * | 2008-01-30 | 2009-07-30 | New York University | Cortical electrode array and method for stimulating and recording brain activity |
US20090248165A1 (en) * | 2008-03-28 | 2009-10-01 | National Cheng Kung University | Skull endosseous implant and kit containing the same |
US20100023100A1 (en) * | 2008-07-24 | 2010-01-28 | Boston Scientific Neoromodulation Corporation | Cam lock burr hole plug for securing stimulation lead |
US20100023020A1 (en) * | 2008-07-24 | 2010-01-28 | Boston Scientific Neuromodulation Corporation | Cam lock burr hole plug for securing retainer/plug base |
US20100036233A1 (en) * | 2008-08-08 | 2010-02-11 | Michigan State University | Automatic Methods for Combining Human Facial Information with 3D Magnetic Resonance Brain Images |
US7684866B2 (en) | 2003-08-01 | 2010-03-23 | Advanced Neuromodulation Systems, Inc. | Apparatus and methods for applying neural stimulation to a patient |
WO2010035203A1 (en) * | 2008-09-24 | 2010-04-01 | Dr. Langer Medical Gmbh | Electrode for intraoperative nerve stimulation |
US20100100151A1 (en) * | 2008-10-20 | 2010-04-22 | Terry Jr Reese S | Neurostimulation with signal duration determined by a cardiac cycle |
US7729773B2 (en) | 2005-10-19 | 2010-06-01 | Advanced Neuromodualation Systems, Inc. | Neural stimulation and optical monitoring systems and methods |
US20100280585A1 (en) * | 2009-04-29 | 2010-11-04 | Medtronic, Inc. | Method and Apparatus for Securing an Electrode |
US7869867B2 (en) | 2006-10-27 | 2011-01-11 | Cyberonics, Inc. | Implantable neurostimulator with refractory stimulation |
US7869885B2 (en) | 2006-04-28 | 2011-01-11 | Cyberonics, Inc | Threshold optimization for tissue stimulation therapy |
US20110098615A1 (en) * | 2007-10-15 | 2011-04-28 | Alterg, Inc. | Systems, methods and apparatus for differential air pressure devices |
US20110120567A1 (en) * | 2009-05-15 | 2011-05-26 | Alterg, Inc. | Differential air pressure systems |
US7974701B2 (en) | 2007-04-27 | 2011-07-05 | Cyberonics, Inc. | Dosing limitation for an implantable medical device |
US7974697B2 (en) | 2006-01-26 | 2011-07-05 | Cyberonics, Inc. | Medical imaging feedback for an implantable medical device |
US7983762B2 (en) | 2004-07-15 | 2011-07-19 | Advanced Neuromodulation Systems, Inc. | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US20120046531A1 (en) * | 2009-12-21 | 2012-02-23 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US8145319B1 (en) * | 2005-10-11 | 2012-03-27 | Ebi, Llc | Methods and devices for treatment of osteonecrosis of the femoral head with core decompression |
US8150508B2 (en) | 2006-03-29 | 2012-04-03 | Catholic Healthcare West | Vagus nerve stimulation method |
US8204603B2 (en) | 2008-04-25 | 2012-06-19 | Cyberonics, Inc. | Blocking exogenous action potentials by an implantable medical device |
US8565867B2 (en) | 2005-01-28 | 2013-10-22 | Cyberonics, Inc. | Changeable electrode polarity stimulation by an implantable medical device |
WO2014001501A3 (en) * | 2012-06-28 | 2014-04-03 | Plugmed Heart | Percutaneous connection device with a socket and with an extension member |
US8718777B2 (en) | 2002-11-27 | 2014-05-06 | Advanced Neuromodulation Systems, Inc. | Methods and systems for intracranial neurostimulation and/or sensing |
US8929991B2 (en) | 2005-10-19 | 2015-01-06 | Advanced Neuromodulation Systems, Inc. | Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits |
WO2015138459A1 (en) * | 2014-03-12 | 2015-09-17 | The Nielsen Company (Us), Llc | Methods and apparatus to gather and analyze electroencephalographic data |
WO2016001261A1 (en) * | 2014-06-30 | 2016-01-07 | Sooma Ltd | An implantable stimulation device |
US9259591B2 (en) | 2007-12-28 | 2016-02-16 | Cyberonics, Inc. | Housing for an implantable medical device |
WO2016025406A1 (en) * | 2014-08-11 | 2016-02-18 | Medtronic, Inc. | Mechanical feedthroughs for implantable medical device |
US9307925B2 (en) | 2005-06-16 | 2016-04-12 | Aaken Laboratories | Methods and systems for generating electrical property maps of biological structures |
US9314633B2 (en) | 2008-01-25 | 2016-04-19 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US9339651B2 (en) | 2009-11-10 | 2016-05-17 | Imthera Medical, Inc. | System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US9492660B2 (en) | 2014-12-09 | 2016-11-15 | Pacesetter, Inc. | Implantable neurostimulation systems and methods thereof |
US20170049398A1 (en) * | 2010-11-09 | 2017-02-23 | Osaka University | Casing of implantable device and implantable device, method for manufacturing casing of implantable device, and method for supporting treatment using implantable device |
US9579505B2 (en) | 2008-10-09 | 2017-02-28 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US9597499B2 (en) | 2006-06-19 | 2017-03-21 | Highland Instruments | Apparatus and method for stimulation of biological tissue |
US9656083B2 (en) | 2014-07-22 | 2017-05-23 | Imthera Medical, Inc. | Method for adjusting a system for stimulating a hypoglossal nerve |
US9662496B2 (en) | 2012-05-15 | 2017-05-30 | Imthera Medical, Inc | Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue |
US20170216017A1 (en) * | 2010-03-10 | 2017-08-03 | Smith & Nephew, Inc. | Composite interference screws and drivers |
US20170281927A1 (en) * | 2016-03-29 | 2017-10-05 | Boston Scientific Neuromodulation Corporation | Skull-Mounted Optical Implant |
JP2017531483A (en) * | 2014-10-03 | 2017-10-26 | ウッドウェルディング・アクチェンゲゼルシャフト | Medical device, apparatus, and surgical method |
US9849288B2 (en) | 2007-10-09 | 2017-12-26 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
US9913976B2 (en) | 2006-06-19 | 2018-03-13 | Highland Instruments, Inc. | Systems and methods for stimulating and monitoring biological tissue |
US20180132961A1 (en) * | 2016-11-15 | 2018-05-17 | Medtronic, Inc. | Medical device anchoring |
US10004904B2 (en) | 2013-03-07 | 2018-06-26 | Imthera Medical, Inc | Lead splitter for neurostimulation systems |
WO2018136999A1 (en) | 2017-01-25 | 2018-08-02 | The Bionics Institute Of Australia | Electrode device for monitoring and/or stimulating activity in a subject |
US10232169B2 (en) | 2015-07-23 | 2019-03-19 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
US10342461B2 (en) | 2007-10-15 | 2019-07-09 | Alterg, Inc. | Method of gait evaluation and training with differential pressure system |
EP2914160B1 (en) * | 2012-10-30 | 2019-07-10 | Leibniz-Institut für Neurobiologie Magdeburg | Microelectrode array for an electrocorticogram (ecog) |
US10426555B2 (en) * | 2015-06-03 | 2019-10-01 | Covidien Lp | Medical instrument with sensor for use in a system and method for electromagnetic navigation |
US10610681B2 (en) * | 2017-08-29 | 2020-04-07 | Medtronic Inc. | Medical device anchoring |
CN111050689A (en) * | 2017-09-06 | 2020-04-21 | 美敦力公司 | Shift drill cap subassembly |
US10653883B2 (en) | 2009-01-23 | 2020-05-19 | Livanova Usa, Inc. | Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation |
US11013913B2 (en) | 2018-03-16 | 2021-05-25 | Boston Scientific Neuromodulation Corporation | Kits and methods for securing a burr hole plugs for stimulation systems |
US20210205623A1 (en) * | 2020-01-07 | 2021-07-08 | Medtronic, Inc. | Burr cap-mounted electrodes |
US11058870B2 (en) | 2018-03-09 | 2021-07-13 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
US11103716B2 (en) | 2017-11-13 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
US11160580B2 (en) | 2019-04-24 | 2021-11-02 | Spine23 Inc. | Systems and methods for pedicle screw stabilization of spinal vertebrae |
CN114447725A (en) * | 2021-12-24 | 2022-05-06 | 上海脑虎科技有限公司 | Brain-computer interface fixing and interconnecting device |
US11406317B2 (en) | 2007-12-28 | 2022-08-09 | Livanova Usa, Inc. | Method for detecting neurological and clinical manifestations of a seizure |
US11497914B2 (en) | 2018-01-16 | 2022-11-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system with a case-neutral battery |
US11517781B1 (en) | 2017-06-22 | 2022-12-06 | Boost Treadmills, LLC | Unweighting exercise equipment |
US11654327B2 (en) | 2017-10-31 | 2023-05-23 | Alterg, Inc. | System for unweighting a user and related methods of exercise |
US11752058B2 (en) | 2011-03-18 | 2023-09-12 | Alterg, Inc. | Differential air pressure systems and methods of using and calibrating such systems for mobility impaired users |
US11759238B2 (en) | 2008-10-01 | 2023-09-19 | Sherwin Hua | Systems and methods for pedicle screw stabilization of spinal vertebrae |
US11806564B2 (en) | 2013-03-14 | 2023-11-07 | Alterg, Inc. | Method of gait evaluation and training with differential pressure system |
US11872433B2 (en) | 2020-12-01 | 2024-01-16 | Boost Treadmills, LLC | Unweighting enclosure, system and method for an exercise device |
US11883713B2 (en) | 2021-10-12 | 2024-01-30 | Boost Treadmills, LLC | DAP system control and related devices and methods |
US11957954B2 (en) | 2017-10-18 | 2024-04-16 | Alterg, Inc. | Gait data collection and analytics system and methods for operating unweighting training systems |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8116875B2 (en) | 2006-06-16 | 2012-02-14 | Neuropoint Medical, Inc. | Implantable neurostimulation systems |
EP2152363A4 (en) * | 2007-05-28 | 2010-12-08 | St Jude Medical | Implantable medical device |
US8396558B2 (en) * | 2009-02-11 | 2013-03-12 | University Of Maryland, Baltimore | Methods for treating central pain syndrome and other pain related pathologies |
US10838406B2 (en) | 2013-02-11 | 2020-11-17 | The Aerospace Corporation | Systems and methods for the patterning of material substrates |
US8679189B1 (en) * | 2013-02-11 | 2014-03-25 | Amendia Inc. | Bone growth enhancing implant |
US9872996B2 (en) | 2014-10-01 | 2018-01-23 | James William Phillips | System and method for transcranial current loop brain stimulation |
US10292831B2 (en) | 2015-03-20 | 2019-05-21 | Intelligent Implants Limited | System and method for dynamically stimulating bone growth |
US10617880B2 (en) | 2015-12-08 | 2020-04-14 | Intelligent Implants Limited | System and method for an electrical implant device with increased patient compliance |
US20180085573A1 (en) * | 2016-09-27 | 2018-03-29 | National Guard Health Affairs | Skull implanted electrode assembly for brain stimulation |
US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
US10955918B1 (en) * | 2018-08-20 | 2021-03-23 | Facebook, Inc. | Head-coupled optode assembly |
CN113382683A (en) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | System and method for improving sleep |
US11576789B2 (en) | 2018-10-03 | 2023-02-14 | Intelligent Implants Limited | System and method to alter bone growth in a targeted spatial region for the use with implants |
US11600093B1 (en) | 2019-01-28 | 2023-03-07 | Meta Platforms, Inc. | Increased dynamic range sensor with fast readout |
US11844706B2 (en) | 2019-03-20 | 2023-12-19 | Grabango Co. | System and method for positioning and orienting an orthopedic implant |
CN114364432A (en) * | 2019-07-31 | 2022-04-15 | 诺沃库勒有限责任公司 | Applying a tumor treatment field (TTfield) via electrodes embedded in a cranial implant |
CN115135376A (en) | 2019-11-01 | 2022-09-30 | 智能植入有限公司 | System and method for embedding electronic components within an implant |
WO2022256385A1 (en) * | 2021-06-01 | 2022-12-08 | EPIC Neuro, Inc. | Subcutaneous transcranial cortical electrotherapy stimulation method and device |
Citations (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3650276A (en) * | 1969-03-26 | 1972-03-21 | Inst Demedicina Si Farmacie | Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder |
US4019518A (en) * | 1975-08-11 | 1977-04-26 | Medtronic, Inc. | Electrical stimulation system |
US4140133A (en) * | 1977-04-26 | 1979-02-20 | Moskovsky Oblastnoi Nauchno-Issledovatelsky Institut Akusherstva I Ginekolog Ii | Device for pulse current action on central nervous system |
US4245645A (en) * | 1977-09-28 | 1981-01-20 | Arseneault Pierre Michel | Self-locking cerebral electrical probe |
US4308868A (en) * | 1980-05-27 | 1982-01-05 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Implantable electrical device |
US4328813A (en) * | 1980-10-20 | 1982-05-11 | Medtronic, Inc. | Brain lead anchoring system |
US4431000A (en) * | 1978-11-29 | 1984-02-14 | Gatron Corporation | Transcutaneous nerve stimulator with pseusorandom pulse generator |
US4590946A (en) * | 1984-06-14 | 1986-05-27 | Biomed Concepts, Inc. | Surgically implantable electrode for nerve bundles |
US4646744A (en) * | 1984-06-29 | 1987-03-03 | Zion Foundation | Method and treatment with transcranially applied electrical signals |
US4817634A (en) * | 1987-06-18 | 1989-04-04 | Medtronic, Inc. | Epicardial patch electrode |
US5002053A (en) * | 1989-04-21 | 1991-03-26 | University Of Arkansas | Method of and device for inducing locomotion by electrical stimulation of the spinal cord |
US5092835A (en) * | 1990-07-06 | 1992-03-03 | Schurig Janet L S | Brain and nerve healing power apparatus and method |
US5184620A (en) * | 1991-12-26 | 1993-02-09 | Marquette Electronics, Inc. | Method of using a multiple electrode pad assembly |
US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5282468A (en) * | 1990-06-07 | 1994-02-01 | Medtronic, Inc. | Implantable neural electrode |
US5299569A (en) * | 1991-05-03 | 1994-04-05 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
US5303705A (en) * | 1992-05-01 | 1994-04-19 | Nenov Valeriy I | Evoked 23NA MR imaging of sodium currents in the brain |
US5304206A (en) * | 1991-11-18 | 1994-04-19 | Cyberonics, Inc. | Activation techniques for implantable medical device |
US5314458A (en) * | 1990-06-01 | 1994-05-24 | University Of Michigan | Single channel microstimulator |
US5405375A (en) * | 1994-01-21 | 1995-04-11 | Incontrol, Inc. | Combined mapping, pacing, and defibrillating catheter |
US5406957A (en) * | 1992-02-05 | 1995-04-18 | Tansey; Michael A. | Electroencephalic neurofeedback apparatus for training and tracking of cognitive states |
US5411540A (en) * | 1993-06-03 | 1995-05-02 | Massachusetts Institute Of Technology | Method and apparatus for preferential neuron stimulation |
US5417719A (en) * | 1993-08-25 | 1995-05-23 | Medtronic, Inc. | Method of using a spinal cord stimulation lead |
US5591216A (en) * | 1995-05-19 | 1997-01-07 | Medtronic, Inc. | Method for treatment of sleep apnea by electrical stimulation |
US5593432A (en) * | 1993-06-23 | 1997-01-14 | Neuroware Therapy International, Inc. | Method for neurostimulation for pain alleviation |
US5601611A (en) * | 1994-08-05 | 1997-02-11 | Ventritex, Inc. | Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same |
US5611350A (en) * | 1996-02-08 | 1997-03-18 | John; Michael S. | Method and apparatus for facilitating recovery of patients in deep coma |
US5618531A (en) * | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
US5707334A (en) * | 1995-08-21 | 1998-01-13 | Young; Robert B. | Method of treating amygdala related transitory disorders |
US5711316A (en) * | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5713922A (en) * | 1996-04-25 | 1998-02-03 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain |
US5713923A (en) * | 1996-05-13 | 1998-02-03 | Medtronic, Inc. | Techniques for treating epilepsy by brain stimulation and drug infusion |
US5716377A (en) * | 1996-04-25 | 1998-02-10 | Medtronic, Inc. | Method of treating movement disorders by brain stimulation |
US5722401A (en) * | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
US5735814A (en) * | 1996-04-30 | 1998-04-07 | Medtronic, Inc. | Techniques of treating neurodegenerative disorders by brain infusion |
US5865842A (en) * | 1996-08-29 | 1999-02-02 | Medtronic, Inc. | System and method for anchoring brain stimulation lead or catheter |
US5871517A (en) * | 1997-01-15 | 1999-02-16 | Somatics, Inc. | Convulsive therapy apparatus to stimulate and monitor the extent of therapeutic value of the treatment |
US5885976A (en) * | 1995-05-08 | 1999-03-23 | Sandyk; Reuven | Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions |
US5886769A (en) * | 1998-05-18 | 1999-03-23 | Zolten; A. J. | Method of training and rehabilitating brain function using hemi-lenses |
US5893883A (en) * | 1997-04-30 | 1999-04-13 | Medtronic, Inc. | Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user |
US6011996A (en) * | 1998-01-20 | 2000-01-04 | Medtronic, Inc | Dual electrode lead and method for brain target localization in functional stereotactic brain surgery |
US6016449A (en) * | 1997-10-27 | 2000-01-18 | Neuropace, Inc. | System for treatment of neurological disorders |
US6018682A (en) * | 1998-04-30 | 2000-01-25 | Medtronic, Inc. | Implantable seizure warning system |
US6021352A (en) * | 1996-06-26 | 2000-02-01 | Medtronic, Inc, | Diagnostic testing methods and apparatus for implantable therapy devices |
US6024702A (en) * | 1997-09-03 | 2000-02-15 | Pmt Corporation | Implantable electrode manufactured with flexible printed circuit |
US6026326A (en) * | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US6035236A (en) * | 1998-07-13 | 2000-03-07 | Bionergy Therapeutics, Inc. | Methods and apparatus for electrical microcurrent stimulation therapy |
US6038480A (en) * | 1996-04-04 | 2000-03-14 | Medtronic, Inc. | Living tissue stimulation and recording techniques with local control of active sites |
US6040180A (en) * | 1996-05-23 | 2000-03-21 | Neuralstem Biopharmaceuticals, Ltd. | In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells |
US6042579A (en) * | 1997-04-30 | 2000-03-28 | Medtronic, Inc. | Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain |
US6052624A (en) * | 1999-01-07 | 2000-04-18 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6055456A (en) * | 1999-04-29 | 2000-04-25 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
US6176242B1 (en) * | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
US6190893B1 (en) * | 1998-09-18 | 2001-02-20 | Massachusetts Institute Of Technology | Electroactive materials for stimulation of biological activity of bone marrow stromal cells |
US6198958B1 (en) * | 1998-06-11 | 2001-03-06 | Beth Israel Deaconess Medical Center, Inc. | Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation |
US6205361B1 (en) * | 1998-02-10 | 2001-03-20 | Advanced Bionics Corporation | Implantable expandable multicontact electrodes |
US6205360B1 (en) * | 1995-09-07 | 2001-03-20 | Cochlear Limited | Apparatus and method for automatically determining stimulation parameters |
US6210417B1 (en) * | 1999-04-29 | 2001-04-03 | Medtronic, Inc. | Medical lead positioning and anchoring system |
US6221908B1 (en) * | 1998-03-12 | 2001-04-24 | Scientific Learning Corporation | System for stimulating brain plasticity |
US6339725B1 (en) * | 1996-05-31 | 2002-01-15 | The Board Of Trustees Of Southern Illinois University | Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation |
US6353754B1 (en) * | 2000-04-24 | 2002-03-05 | Neuropace, Inc. | System for the creation of patient specific templates for epileptiform activity detection |
US6356786B1 (en) * | 2000-01-20 | 2002-03-12 | Electrocore Techniques, Llc | Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain |
US6356792B1 (en) * | 2000-01-20 | 2002-03-12 | Electro Core Technologies, Llc | Skull mounted electrode lead securing assembly |
US6354299B1 (en) * | 1997-10-27 | 2002-03-12 | Neuropace, Inc. | Implantable device for patient communication |
US6366813B1 (en) * | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
US6375666B1 (en) * | 1999-12-09 | 2002-04-23 | Hans Alois Mische | Methods and devices for treatment of neurological disorders |
US6505075B1 (en) * | 1999-05-29 | 2003-01-07 | Richard L. Weiner | Peripheral nerve stimulation method |
US6507755B1 (en) * | 1998-12-01 | 2003-01-14 | Neurometrix, Inc. | Apparatus and method for stimulating human tissue |
US6529774B1 (en) * | 2000-11-09 | 2003-03-04 | Neuropace, Inc. | Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation |
US6539263B1 (en) * | 1999-06-11 | 2003-03-25 | Cornell Research Foundation, Inc. | Feedback mechanism for deep brain stimulation |
US6684105B2 (en) * | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US6687525B2 (en) * | 2000-06-07 | 2004-02-03 | New York University | Method and system for diagnosing and treating thalamocortical dysrhythmia |
US6690974B2 (en) * | 2000-04-05 | 2004-02-10 | Neuropace, Inc. | Stimulation signal generator for an implantable device |
US6708064B2 (en) * | 2000-02-24 | 2004-03-16 | Ali R. Rezai | Modulation of the brain to affect psychiatric disorders |
US6725094B2 (en) * | 1999-03-24 | 2004-04-20 | Lloyd R. Saberski | Apparatus and methods for reducing pain and/or retraining muscles |
US6839594B2 (en) * | 2001-04-26 | 2005-01-04 | Biocontrol Medical Ltd | Actuation and control of limbs through motor nerve stimulation |
US20050004620A1 (en) * | 2002-12-09 | 2005-01-06 | Medtronic, Inc. | Implantable medical device with anti-infection agent |
US20050015129A1 (en) * | 1999-12-09 | 2005-01-20 | Mische Hans A. | Methods and devices for the treatment of neurological and physiological disorders |
US20050021118A1 (en) * | 2000-07-13 | 2005-01-27 | Chris Genau | Apparatuses and systems for applying electrical stimulation to a patient |
US20050021105A1 (en) * | 2000-07-13 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US20050021104A1 (en) * | 1998-08-05 | 2005-01-27 | Dilorenzo Daniel John | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US20050021107A1 (en) * | 2001-03-08 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20050021106A1 (en) * | 2000-07-13 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US6850802B2 (en) * | 1998-04-30 | 2005-02-01 | Medtronic, Inc. | Selective brain stimulation using conditioning pulses |
US20050033378A1 (en) * | 2002-12-09 | 2005-02-10 | Sheffield Warren Douglas | Methods for treating and/or collecting information regarding neurological disorders, including language disorders |
US6873872B2 (en) * | 1999-12-07 | 2005-03-29 | George Mason University | Adaptive electric field modulation of neural systems |
US20050070971A1 (en) * | 2003-08-01 | 2005-03-31 | Brad Fowler | Apparatus and methods for applying neural stimulation to a patient |
US20050075679A1 (en) * | 2002-09-30 | 2005-04-07 | Gliner Bradford E. | Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system |
US20060004423A1 (en) * | 2002-05-09 | 2006-01-05 | Boveja Birinder R | Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves |
US20060015153A1 (en) * | 2004-07-15 | 2006-01-19 | Gliner Bradford E | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US6990377B2 (en) * | 2003-04-24 | 2006-01-24 | Northstar Neuroscience, Inc. | Systems and methods for facilitating and/or effectuating development, rehabilitation, restoration, and/or recovery of visual function through neural stimulation |
US7006859B1 (en) * | 2002-07-20 | 2006-02-28 | Flint Hills Scientific, L.L.C. | Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes |
US7010351B2 (en) * | 2000-07-13 | 2006-03-07 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7024247B2 (en) * | 2001-10-15 | 2006-04-04 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US7187968B2 (en) * | 2003-10-23 | 2007-03-06 | Duke University | Apparatus for acquiring and transmitting neural signals and related methods |
US20070088404A1 (en) * | 2005-10-19 | 2007-04-19 | Allen Wyler | Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders |
Family Cites Families (195)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2716226A (en) | 1951-06-22 | 1955-08-23 | Reiner Electronics Co Inc | Electrical solderless connector |
US2721316A (en) | 1953-06-09 | 1955-10-18 | Joseph D Shaw | Method and means for aiding the blind |
US3628193A (en) | 1969-02-19 | 1971-12-21 | Inst Of Medical Sciences The | Tactile image projection system |
US3918461A (en) | 1974-01-31 | 1975-11-11 | Irving S Cooper | Method for electrically stimulating the human brain |
US4030509A (en) | 1975-09-30 | 1977-06-21 | Mieczyslaw Mirowski | Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization |
US4125116A (en) | 1977-02-14 | 1978-11-14 | The Johns Hopkins University | Human tissue stimulation electrode structure |
US4214804A (en) | 1978-09-25 | 1980-07-29 | Daig Corporation | Press fit electrical connection apparatus |
US4474186A (en) | 1979-07-17 | 1984-10-02 | Georgetown University | Computerized electro-oculographic (CEOG) system with feedback control of stimuli |
US4340038A (en) * | 1980-12-15 | 1982-07-20 | Pacesetter Systems, Inc. | Magnetic field concentration means and method for an implanted device |
US4487210A (en) | 1982-11-15 | 1984-12-11 | Minnesota Mining And Manufacturing Company | Anchor for anchoring electrode leads used in cochlear implantation |
CA1215128A (en) | 1982-12-08 | 1986-12-09 | Pedro Molina-Negro | Electric nerve stimulator device |
US4542752A (en) | 1983-04-22 | 1985-09-24 | Cordis Corporation | Implantable device having porous surface with carbon coating |
US4702254A (en) | 1983-09-14 | 1987-10-27 | Jacob Zabara | Neurocybernetic prosthesis |
US4844075A (en) | 1984-01-09 | 1989-07-04 | Pain Suppression Labs, Inc. | Transcranial stimulation for the treatment of cerebral palsy |
US4607639A (en) | 1984-05-18 | 1986-08-26 | Regents Of The University Of California | Method and system for controlling bladder evacuation |
US4936306A (en) | 1985-02-15 | 1990-06-26 | Doty James R | Device and method for monitoring evoked potentials and electroencephalograms |
CA1292285C (en) | 1985-08-21 | 1991-11-19 | Paul H. Stypulkowski | External ear canal electrode to be placed proximate the tympanic membrane and method of stimulating/recording utilizing external ear canal electrode placed proximate the tympanic membrane |
US5054906A (en) | 1986-01-17 | 1991-10-08 | Brimfield Precision, Inc. | Indirectly illuminating ophthalmological speculum |
US4969468A (en) | 1986-06-17 | 1990-11-13 | Alfred E. Mann Foundation For Scientific Research | Electrode array for use in connection with a living body and method of manufacture |
US4869255A (en) | 1987-12-04 | 1989-09-26 | Ad-Tech Medical Instrument Corp. | Electrical connection device |
US4865048A (en) | 1987-12-31 | 1989-09-12 | Eckerson Harold D | Method and apparatus for drug free neurostimulation |
DE3914662A1 (en) | 1989-05-03 | 1990-11-08 | Alt Eckhard | DEVICE FOR TRANSMITTING ELECTRICAL SIGNALS BETWEEN AN IMPLANTABLE MEDICAL DEVICE AND ELECTRICALLY EXPENSIBLE HUMAN TISSUE |
US5024226A (en) | 1989-08-17 | 1991-06-18 | Critikon, Inc. | Epidural oxygen sensor |
US5063932A (en) | 1989-10-03 | 1991-11-12 | Mieczyslaw Mirowski | Controlled discharge defibrillation electrode |
US5215088A (en) | 1989-11-07 | 1993-06-01 | The University Of Utah | Three-dimensional electrode device |
US5271417A (en) * | 1990-01-23 | 1993-12-21 | Cardiac Pacemakers, Inc. | Defibrillation electrode having smooth current distribution |
US5031618A (en) | 1990-03-07 | 1991-07-16 | Medtronic, Inc. | Position-responsive neuro stimulator |
US5713926A (en) | 1990-04-25 | 1998-02-03 | Cardiac Pacemakers, Inc. | Implantable intravenous cardiac stimulation system with pulse generator housing serving as optional additional electrode |
US5121754A (en) | 1990-08-21 | 1992-06-16 | Medtronic, Inc. | Lateral displacement percutaneously inserted epidural lead |
US5224491A (en) | 1991-01-07 | 1993-07-06 | Medtronic, Inc. | Implantable electrode for location within a blood vessel |
US5215086A (en) | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
US5255678A (en) | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5750376A (en) | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
US5169384A (en) | 1991-08-16 | 1992-12-08 | Bosniak Stephen L | Apparatus for facilitating post-traumatic, post-surgical, and/or post-inflammatory healing of tissue |
US5358514A (en) | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5282252A (en) * | 1992-02-27 | 1994-01-25 | Akg Acoustics, Inc. | Audio equalizer providing reciprocal equalization plus infinite-depth notch |
US5263967B1 (en) | 1992-05-15 | 2000-12-19 | Brimfield Prec Inc | Medical instrument with dual action drive |
US5476494A (en) * | 1992-09-11 | 1995-12-19 | Massachusetts Institute Of Technology | Low pressure neural contact structure |
US5370672A (en) | 1992-10-30 | 1994-12-06 | The Johns Hopkins University | Computer-controlled neurological stimulation system |
US5358513A (en) * | 1992-12-09 | 1994-10-25 | Medtronic, Inc. | Parameter selection and electrode placement of neuromuscular electrical stimulation apparatus |
SE9203734D0 (en) | 1992-12-11 | 1992-12-11 | Siemens Elema Ab | defibrillation |
US5292252A (en) | 1992-12-14 | 1994-03-08 | Impla-Med, Inc. | Stimulator healing cap |
US5358541A (en) * | 1993-01-08 | 1994-10-25 | The Boc Group, Inc. | Forehearth temperature control system |
US5537512A (en) | 1993-05-26 | 1996-07-16 | Northrop Grumman Corporation | Neural network elements |
US5540736A (en) | 1993-08-02 | 1996-07-30 | Haimovich; Yechiel | Transcranial electrostimulation apparatus having two electrode pairs and independent current generators |
US5464446A (en) * | 1993-10-12 | 1995-11-07 | Medtronic, Inc. | Brain lead anchoring system |
US5697975A (en) | 1994-02-09 | 1997-12-16 | The University Of Iowa Research Foundation | Human cerebral cortex neural prosthetic for tinnitus |
US6129685A (en) | 1994-02-09 | 2000-10-10 | The University Of Iowa Research Foundation | Stereotactic hypothalamic obesity probe |
US5843093A (en) | 1994-02-09 | 1998-12-01 | University Of Iowa Research Foundation | Stereotactic electrode assembly |
US5562708A (en) * | 1994-04-21 | 1996-10-08 | Medtronic, Inc. | Method and apparatus for treatment of atrial fibrillation |
US5769778A (en) * | 1994-04-22 | 1998-06-23 | Somatics, Inc. | Medical magnetic non-convulsive stimulation therapy |
US5464448A (en) | 1994-05-02 | 1995-11-07 | Empi, Inc. | Electrode and method of making neuromuscular stimulator |
US6152143A (en) | 1994-05-09 | 2000-11-28 | Somnus Medical Technologies, Inc. | Method for treatment of air way obstructions |
US5685313A (en) | 1994-05-31 | 1997-11-11 | Brain Monitor Ltd. | Tissue monitor |
DE59506078D1 (en) * | 1994-07-19 | 1999-07-08 | Bat Cigarettenfab Gmbh | Tobacco cartridge |
US5549655A (en) * | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US5540734A (en) | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
US5522864A (en) | 1994-10-25 | 1996-06-04 | Wallace; Larry B. | Apparatus and method for ocular treatment |
US5520190A (en) | 1994-10-31 | 1996-05-28 | Ventritex, Inc. | Cardiac blood flow sensor and method |
US5545186A (en) | 1995-03-30 | 1996-08-13 | Medtronic, Inc. | Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias |
US5772591A (en) * | 1995-06-06 | 1998-06-30 | Patient Comfort, Inc. | Electrode assembly for signaling a monitor |
US6057846A (en) | 1995-07-14 | 2000-05-02 | Sever, Jr.; Frank | Virtual reality psychophysiological conditioning medium |
US5649936A (en) | 1995-09-19 | 1997-07-22 | Real; Douglas D. | Stereotactic guide apparatus for use with neurosurgical headframe |
US5782873A (en) | 1995-10-11 | 1998-07-21 | Trustees Of Boston University | Method and apparatus for improving the function of sensory cells |
US6944501B1 (en) | 2000-04-05 | 2005-09-13 | Neurospace, Inc. | Neurostimulator involving stimulation strategies and process for using it |
US6480743B1 (en) | 2000-04-05 | 2002-11-12 | Neuropace, Inc. | System and method for adaptive brain stimulation |
US20020169485A1 (en) | 1995-10-16 | 2002-11-14 | Neuropace, Inc. | Differential neurostimulation therapy driven by physiological context |
US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
DE19544750A1 (en) * | 1995-11-30 | 1997-06-05 | Christoph Rehberg | Implantable device with internal electrode to promote tissue growth |
AU731837B2 (en) | 1995-12-01 | 2001-04-05 | Cochlear Limited | A feedback system to control electrode voltages in a cochlear stimulator and the like |
NL1001890C2 (en) | 1995-12-13 | 1997-06-17 | Cordis Europ | Catheter with plate-shaped electrode array. |
US5824030A (en) | 1995-12-21 | 1998-10-20 | Pacesetter, Inc. | Lead with inter-electrode spacing adjustment |
US6066163A (en) | 1996-02-02 | 2000-05-23 | John; Michael Sasha | Adaptive brain stimulation method and system |
US6463328B1 (en) | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
US6126657A (en) | 1996-02-23 | 2000-10-03 | Somnus Medical Technologies, Inc. | Apparatus for treatment of air way obstructions |
US5724377A (en) * | 1996-02-29 | 1998-03-03 | Lucent Technologies Inc. | Method and apparatus for improving the instability of a laser |
US5904916A (en) | 1996-03-05 | 1999-05-18 | Hirsch; Alan R. | Use of odorants to alter learning capacity |
US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
DE59712479D1 (en) | 1996-03-21 | 2005-12-22 | Biotronik Gmbh & Co Kg | Implantable stimulation electrode |
US5725377A (en) | 1996-03-29 | 1998-03-10 | Lemler; Jeffrey Richard | Dental implant apparatus |
US5628317A (en) | 1996-04-04 | 1997-05-13 | Medtronic, Inc. | Ultrasonic techniques for neurostimulator control |
US5702429A (en) | 1996-04-04 | 1997-12-30 | Medtronic, Inc. | Neural stimulation techniques with feedback |
US5925070A (en) | 1996-04-04 | 1999-07-20 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of electrically excitable tissue |
US5683422A (en) | 1996-04-25 | 1997-11-04 | Medtronic, Inc. | Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation |
US5824021A (en) | 1996-04-25 | 1998-10-20 | Medtronic Inc. | Method and apparatus for providing feedback to spinal cord stimulation for angina |
US5782798A (en) | 1996-06-26 | 1998-07-21 | Medtronic, Inc. | Techniques for treating eating disorders by brain stimulation and drug infusion |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5738521A (en) | 1996-07-19 | 1998-04-14 | Biolectron, Inc. | Method for accelerating osseointegration of metal bone implants using electrical stimulation |
US5797970A (en) | 1996-09-04 | 1998-08-25 | Medtronic, Inc. | System, adaptor and method to provide medical electrical stimulation |
US5843148A (en) | 1996-09-27 | 1998-12-01 | Medtronic, Inc. | High resolution brain stimulation lead and method of use |
US5735521A (en) * | 1996-10-18 | 1998-04-07 | Meyer/Glass Design, Ltd. | Puzzle with textured surface |
US5752979A (en) * | 1996-11-01 | 1998-05-19 | Medtronic, Inc. | Method of controlling epilepsy by brain stimulation |
US6057847A (en) | 1996-12-20 | 2000-05-02 | Jenkins; Barry | System and method of image generation and encoding using primitive reprojection |
US6432070B1 (en) | 1999-05-11 | 2002-08-13 | Exogen, Inc. | Method and apparatus for ultrasonic treatment of reflex sympathetic dystrophy |
US5948007A (en) | 1997-04-30 | 1999-09-07 | Medtronic, Inc. | Dual channel implantation neurostimulation techniques |
US5975085A (en) * | 1997-05-01 | 1999-11-02 | Medtronic, Inc. | Method of treating schizophrenia by brain stimulation and drug infusion |
US6128537A (en) | 1997-05-01 | 2000-10-03 | Medtronic, Inc | Techniques for treating anxiety by brain stimulation and drug infusion |
US5861017A (en) * | 1997-06-06 | 1999-01-19 | Shriners Hospitals For Children | Portable functional electrical stimulation (FES) system for upper or lower extremity applications |
US5843150A (en) | 1997-10-08 | 1998-12-01 | Medtronic, Inc. | System and method for providing electrical and/or fluid treatment within a patient's brain |
US5941906A (en) | 1997-10-15 | 1999-08-24 | Medtronic, Inc. | Implantable, modular tissue stimulator |
US5938688A (en) | 1997-10-22 | 1999-08-17 | Cornell Research Foundation, Inc. | Deep brain stimulation method |
US6647296B2 (en) | 1997-10-27 | 2003-11-11 | Neuropace, Inc. | Implantable apparatus for treating neurological disorders |
US6230049B1 (en) | 1999-08-13 | 2001-05-08 | Neuro Pace, Inc. | Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes |
US6597954B1 (en) | 1997-10-27 | 2003-07-22 | Neuropace, Inc. | System and method for controlling epileptic seizures with spatially separated detection and stimulation electrodes |
US6427086B1 (en) | 1997-10-27 | 2002-07-30 | Neuropace, Inc. | Means and method for the intracranial placement of a neurostimulator |
US6459936B2 (en) | 1997-10-27 | 2002-10-01 | Neuropace, Inc. | Methods for responsively treating neurological disorders |
DE19750043A1 (en) | 1997-11-12 | 1999-05-20 | Johann W Prof Dr Bartha | Novel cuff electrode and method for producing it |
US6128527A (en) | 1997-12-03 | 2000-10-03 | University Of Iowa Research Foundation | Apparatus and method of analyzing electrical brain activity |
US6631295B2 (en) | 1998-02-13 | 2003-10-07 | University Of Iowa Research Foundation | System and method for diagnosing and/or reducing tinnitus |
US6058331A (en) | 1998-04-27 | 2000-05-02 | Medtronic, Inc. | Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6319241B1 (en) | 1998-04-30 | 2001-11-20 | Medtronic, Inc. | Techniques for positioning therapy delivery elements within a spinal cord or a brain |
US5938689A (en) | 1998-05-01 | 1999-08-17 | Neuropace, Inc. | Electrode configuration for a brain neuropacemaker |
US6006124A (en) * | 1998-05-01 | 1999-12-21 | Neuropace, Inc. | Means and method for the placement of brain electrodes |
US7890176B2 (en) | 1998-07-06 | 2011-02-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating chronic pelvic pain |
US6104960A (en) | 1998-07-13 | 2000-08-15 | Medtronic, Inc. | System and method for providing medical electrical stimulation to a portion of the nervous system |
US6949081B1 (en) | 1998-08-26 | 2005-09-27 | Non-Invasive Technology, Inc. | Sensing and interactive drug delivery |
CA2341695C (en) | 1998-08-27 | 2009-02-10 | Novavision Ag | Process and device for the training of human vision |
US6149612A (en) | 1998-09-14 | 2000-11-21 | Schnapp; Moacir | Rehabilitative apparatus for treating reflex sympathetic dystrophy |
US6569654B2 (en) | 1998-09-18 | 2003-05-27 | Massachusetts Institute Of Technology | Electroactive materials for stimulation of biological activity of stem cells |
USRE45616E1 (en) | 1998-10-13 | 2015-07-21 | Covidien Lp | Multi-channel non-invasive tissue oximeter |
US20060217782A1 (en) | 1998-10-26 | 2006-09-28 | Boveja Birinder R | Method and system for cortical stimulation to provide adjunct (ADD-ON) therapy for stroke, tinnitus and other medical disorders using implantable and external components |
US7062330B1 (en) | 1998-10-26 | 2006-06-13 | Boveja Birinder R | Electrical stimulation adjunct (Add-ON) therapy for urinary incontinence and urological disorders using implanted lead stimulus-receiver and an external pulse generator |
US6253109B1 (en) | 1998-11-05 | 2001-06-26 | Medtronic Inc. | System for optimized brain stimulation |
US6161044A (en) | 1998-11-23 | 2000-12-12 | Synaptic Corporation | Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation |
US6214016B1 (en) | 1999-04-29 | 2001-04-10 | Medtronic, Inc. | Medical instrument positioning device internal to a catheter or lead and method of use |
US6161045A (en) | 1999-06-01 | 2000-12-12 | Neuropace, Inc. | Method for determining stimulation parameters for the treatment of epileptic seizures |
US6633780B1 (en) | 1999-06-07 | 2003-10-14 | The Johns Hopkins University | Cardiac shock electrode system and corresponding implantable defibrillator system |
US6301493B1 (en) | 1999-07-10 | 2001-10-09 | Physiometrix, Inc. | Reservoir electrodes for electroencephalograph headgear appliance |
US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US6236892B1 (en) | 1999-10-07 | 2001-05-22 | Claudio A. Feler | Spinal cord stimulation lead |
US6499488B1 (en) | 1999-10-28 | 2002-12-31 | Winchester Development Associates | Surgical sensor |
US6764498B2 (en) | 1999-12-09 | 2004-07-20 | Hans Alois Mische | Methods and devices for treatment of neurological disorders |
AU1618401A (en) | 1999-12-06 | 2001-06-12 | Advanced Bionics Corporation | Implantable device programmer |
JP2003516206A (en) | 1999-12-07 | 2003-05-13 | クラスノウ インスティテュート | Adaptive electric field regulation of the nervous system |
US6658299B1 (en) | 2000-01-04 | 2003-12-02 | William H. Dobelle | Artificial system for vision and the like |
US6907296B1 (en) | 2000-02-15 | 2005-06-14 | Pacesetter, Inc. | Implantable cardiac lead having convenient implant location identification and method of manufacture |
US6609030B1 (en) | 2000-02-24 | 2003-08-19 | Electrocore Techniques, Llc | Method of treating psychiatric diseases by neuromodulation within the dorsomedial thalamus |
US6418344B1 (en) | 2000-02-24 | 2002-07-09 | Electrocore Techniques, Llc | Method of treating psychiatric disorders by electrical stimulation within the orbitofrontal cerebral cortex |
US6487450B1 (en) | 2000-02-24 | 2002-11-26 | Cedars-Sinai Medical Center | System and method for preventing Sudden Cardiac Death by nerve sprouting from right stellate ganglion |
US6473639B1 (en) | 2000-03-02 | 2002-10-29 | Neuropace, Inc. | Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures |
US6810286B2 (en) | 2000-03-06 | 2004-10-26 | Medtronic, Inc | Stimulation for delivery of molecular therapy |
US6549814B1 (en) | 2000-06-09 | 2003-04-15 | Juergen Strutz | Blade electrode array for insertion under soft tissue of lateral wall of cochlea |
US6782292B2 (en) | 2000-06-20 | 2004-08-24 | Advanced Bionics Corporation | System and method for treatment of mood and/or anxiety disorders by electrical brain stimulation and/or drug infusion |
US20030125786A1 (en) * | 2000-07-13 | 2003-07-03 | Gliner Bradford Evan | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20040176831A1 (en) | 2000-07-13 | 2004-09-09 | Gliner Bradford Evan | Apparatuses and systems for applying electrical stimulation to a patient |
US7756584B2 (en) | 2000-07-13 | 2010-07-13 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7831305B2 (en) | 2001-10-15 | 2010-11-09 | Advanced Neuromodulation Systems, Inc. | Neural stimulation system and method responsive to collateral neural activity |
US7305268B2 (en) | 2000-07-13 | 2007-12-04 | Northstar Neurscience, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US6497699B1 (en) | 2000-08-09 | 2002-12-24 | The Research Foundation Of State University Of New York | Hybrid neuroprosthesis for the treatment of brain disorders |
DE10039240A1 (en) | 2000-08-11 | 2002-02-28 | Hans Ulrich May | Electrotherapeutic device |
US6591138B1 (en) | 2000-08-31 | 2003-07-08 | Neuropace, Inc. | Low frequency neurostimulator for the treatment of neurological disorders |
JP2002072309A (en) | 2000-09-01 | 2002-03-12 | Canon Inc | Camera and camera system |
US6405079B1 (en) | 2000-09-22 | 2002-06-11 | Mehdi M. Ansarinia | Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions |
US6898464B2 (en) | 2000-10-05 | 2005-05-24 | Innersea Technology | Optical telemetry of data and power for wireless biomedical sensors and actuators |
US6788975B1 (en) | 2001-01-30 | 2004-09-07 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy |
US6735475B1 (en) | 2001-01-30 | 2004-05-11 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain |
US7149586B2 (en) | 2002-03-28 | 2006-12-12 | Second Sight Medical Products, Inc. | Variable pitch electrode array |
US7299096B2 (en) | 2001-03-08 | 2007-11-20 | Northstar Neuroscience, Inc. | System and method for treating Parkinson's Disease and other movement disorders |
WO2002073526A2 (en) | 2001-03-13 | 2002-09-19 | Wide Horizon Holdings Inc. | Cerebral programming |
US7010856B2 (en) | 2001-03-16 | 2006-03-14 | Nihon Kohden Corporation | Lead wire attachment method, electrode, and spot welder |
US20060241717A1 (en) | 2001-08-30 | 2006-10-26 | Whitehurst Todd K | Treatment of movement disorders by extra dural motor cortex stimulation |
WO2003026738A1 (en) | 2001-09-28 | 2003-04-03 | Northstar Neuroscience, Inc. | Methods and apparatus for electrically stimulating cells implanted in the nervous system |
AU2002334749A1 (en) | 2001-09-28 | 2003-04-07 | Northstar Neuroscience, Inc. | Methods and implantable apparatus for electrical therapy |
US6944497B2 (en) | 2001-10-31 | 2005-09-13 | Medtronic, Inc. | System and method of treating stuttering by neuromodulation |
US7050856B2 (en) | 2002-01-11 | 2006-05-23 | Medtronic, Inc. | Variation of neural-stimulation parameters |
US7110820B2 (en) | 2002-02-05 | 2006-09-19 | Tcheng Thomas K | Responsive electrical stimulation for movement disorders |
US7221981B2 (en) | 2002-03-28 | 2007-05-22 | Northstar Neuroscience, Inc. | Electrode geometries for efficient neural stimulation |
US7146222B2 (en) | 2002-04-15 | 2006-12-05 | Neurospace, Inc. | Reinforced sensing and stimulation leads and use in detection systems |
US7184840B2 (en) | 2002-04-22 | 2007-02-27 | Medtronic, Inc. | Implantable lead with isolated contact coupling |
US20050154426A1 (en) | 2002-05-09 | 2005-07-14 | Boveja Birinder R. | Method and system for providing therapy for neuropsychiatric and neurological disorders utilizing transcranical magnetic stimulation and pulsed electrical vagus nerve(s) stimulation |
US20050182453A1 (en) | 2002-05-24 | 2005-08-18 | Whitehurst Todd K. | Treatment of epilepsy by high frequency electrical stimulation and/or drug stimulation |
US6934580B1 (en) | 2002-07-20 | 2005-08-23 | Flint Hills Scientific, L.L.C. | Stimulation methodologies and apparatus for control of brain states |
US20040092809A1 (en) | 2002-07-26 | 2004-05-13 | Neurion Inc. | Methods for measurement and analysis of brain activity |
US7471974B2 (en) | 2002-09-13 | 2008-12-30 | Brainlab Ag | Method for planning stimulation of hyper/hypometabolic cortical areas |
US20040082847A1 (en) | 2002-10-23 | 2004-04-29 | Mcdermott Kathleen B. | System and methods for identifying brain regions supporting language |
US7236830B2 (en) | 2002-12-10 | 2007-06-26 | Northstar Neuroscience, Inc. | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders |
US7302298B2 (en) * | 2002-11-27 | 2007-11-27 | Northstar Neuroscience, Inc | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography |
US20050075680A1 (en) | 2003-04-18 | 2005-04-07 | Lowry David Warren | Methods and systems for intracranial neurostimulation and/or sensing |
US6959215B2 (en) | 2002-12-09 | 2005-10-25 | Northstar Neuroscience, Inc. | Methods for treating essential tremor |
US7065412B2 (en) | 2003-04-25 | 2006-06-20 | Medtronic, Inc. | Implantable trial neurostimulation device |
US7107104B2 (en) | 2003-05-30 | 2006-09-12 | Medtronic, Inc. | Implantable cortical neural lead and method |
EP1694403A2 (en) | 2003-11-20 | 2006-08-30 | Advanced Neuromodulation Systems, Inc. | Electrical stimulation system, lead, and method providing reduced neuroplasticity effects |
US8093205B2 (en) | 2003-12-01 | 2012-01-10 | Medtronic, Inc. | Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis |
US7981119B2 (en) | 2003-12-11 | 2011-07-19 | Advanced Neuromodulation Systems, Inc. | Electrical stimulation system and associated apparatus for securing an electrical stimulation lead in position in a person's brain |
US7993352B2 (en) | 2003-12-11 | 2011-08-09 | Advanced Neuromodulation Systems, Inc. | Electrical stimulation system and associated apparatus for securing an electrical stimulation lead in position in a person's brain |
US7107097B2 (en) | 2004-01-14 | 2006-09-12 | Northstar Neuroscience, Inc. | Articulated neural electrode assembly |
US20060004422A1 (en) | 2004-03-11 | 2006-01-05 | Dirk De Ridder | Electrical stimulation system and method for stimulating tissue in the brain to treat a neurological condition |
US20050154425A1 (en) | 2004-08-19 | 2005-07-14 | Boveja Birinder R. | Method and system to provide therapy for neuropsychiatric disorders and cognitive impairments using gradient magnetic pulses to the brain and pulsed electrical stimulation to vagus nerve(s) |
US20060106430A1 (en) | 2004-11-12 | 2006-05-18 | Brad Fowler | Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods |
US7565200B2 (en) | 2004-11-12 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US20060173522A1 (en) | 2005-01-31 | 2006-08-03 | Medtronic, Inc. | Anchoring of a medical device component adjacent a dura of the brain or spinal cord |
US7664610B2 (en) | 2005-09-28 | 2010-02-16 | Rosemount Inc. | Steam trap monitoring |
US7856264B2 (en) | 2005-10-19 | 2010-12-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for patient interactive neural stimulation and/or chemical substance delivery |
-
2004
- 2004-07-15 US US10/891,834 patent/US20050075680A1/en not_active Abandoned
-
2005
- 2005-07-15 EP EP05773623A patent/EP1786508A4/en not_active Withdrawn
- 2005-07-15 WO PCT/US2005/024768 patent/WO2006019766A2/en active Application Filing
-
2009
- 2009-07-24 US US12/509,110 patent/US8718777B2/en not_active Expired - Fee Related
Patent Citations (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3650276A (en) * | 1969-03-26 | 1972-03-21 | Inst Demedicina Si Farmacie | Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder |
US4019518A (en) * | 1975-08-11 | 1977-04-26 | Medtronic, Inc. | Electrical stimulation system |
US4140133A (en) * | 1977-04-26 | 1979-02-20 | Moskovsky Oblastnoi Nauchno-Issledovatelsky Institut Akusherstva I Ginekolog Ii | Device for pulse current action on central nervous system |
US4245645A (en) * | 1977-09-28 | 1981-01-20 | Arseneault Pierre Michel | Self-locking cerebral electrical probe |
US4431000A (en) * | 1978-11-29 | 1984-02-14 | Gatron Corporation | Transcutaneous nerve stimulator with pseusorandom pulse generator |
US4308868A (en) * | 1980-05-27 | 1982-01-05 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Implantable electrical device |
US4328813A (en) * | 1980-10-20 | 1982-05-11 | Medtronic, Inc. | Brain lead anchoring system |
US4590946A (en) * | 1984-06-14 | 1986-05-27 | Biomed Concepts, Inc. | Surgically implantable electrode for nerve bundles |
US4646744A (en) * | 1984-06-29 | 1987-03-03 | Zion Foundation | Method and treatment with transcranially applied electrical signals |
US4817634A (en) * | 1987-06-18 | 1989-04-04 | Medtronic, Inc. | Epicardial patch electrode |
US5002053A (en) * | 1989-04-21 | 1991-03-26 | University Of Arkansas | Method of and device for inducing locomotion by electrical stimulation of the spinal cord |
US5314458A (en) * | 1990-06-01 | 1994-05-24 | University Of Michigan | Single channel microstimulator |
US5282468A (en) * | 1990-06-07 | 1994-02-01 | Medtronic, Inc. | Implantable neural electrode |
US5092835A (en) * | 1990-07-06 | 1992-03-03 | Schurig Janet L S | Brain and nerve healing power apparatus and method |
US5618531A (en) * | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
US5299569A (en) * | 1991-05-03 | 1994-04-05 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
US5304206A (en) * | 1991-11-18 | 1994-04-19 | Cyberonics, Inc. | Activation techniques for implantable medical device |
US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5184620A (en) * | 1991-12-26 | 1993-02-09 | Marquette Electronics, Inc. | Method of using a multiple electrode pad assembly |
US5406957A (en) * | 1992-02-05 | 1995-04-18 | Tansey; Michael A. | Electroencephalic neurofeedback apparatus for training and tracking of cognitive states |
US5303705A (en) * | 1992-05-01 | 1994-04-19 | Nenov Valeriy I | Evoked 23NA MR imaging of sodium currents in the brain |
US5411540A (en) * | 1993-06-03 | 1995-05-02 | Massachusetts Institute Of Technology | Method and apparatus for preferential neuron stimulation |
US5593432A (en) * | 1993-06-23 | 1997-01-14 | Neuroware Therapy International, Inc. | Method for neurostimulation for pain alleviation |
US5417719A (en) * | 1993-08-25 | 1995-05-23 | Medtronic, Inc. | Method of using a spinal cord stimulation lead |
US5405375A (en) * | 1994-01-21 | 1995-04-11 | Incontrol, Inc. | Combined mapping, pacing, and defibrillating catheter |
US5601611A (en) * | 1994-08-05 | 1997-02-11 | Ventritex, Inc. | Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same |
US5722401A (en) * | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
US5885976A (en) * | 1995-05-08 | 1999-03-23 | Sandyk; Reuven | Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions |
US5591216A (en) * | 1995-05-19 | 1997-01-07 | Medtronic, Inc. | Method for treatment of sleep apnea by electrical stimulation |
US5707334A (en) * | 1995-08-21 | 1998-01-13 | Young; Robert B. | Method of treating amygdala related transitory disorders |
US6205360B1 (en) * | 1995-09-07 | 2001-03-20 | Cochlear Limited | Apparatus and method for automatically determining stimulation parameters |
US5611350A (en) * | 1996-02-08 | 1997-03-18 | John; Michael S. | Method and apparatus for facilitating recovery of patients in deep coma |
US6038480A (en) * | 1996-04-04 | 2000-03-14 | Medtronic, Inc. | Living tissue stimulation and recording techniques with local control of active sites |
US5716377A (en) * | 1996-04-25 | 1998-02-10 | Medtronic, Inc. | Method of treating movement disorders by brain stimulation |
US5713922A (en) * | 1996-04-25 | 1998-02-03 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain |
US5735814A (en) * | 1996-04-30 | 1998-04-07 | Medtronic, Inc. | Techniques of treating neurodegenerative disorders by brain infusion |
US5711316A (en) * | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5713923A (en) * | 1996-05-13 | 1998-02-03 | Medtronic, Inc. | Techniques for treating epilepsy by brain stimulation and drug infusion |
US6040180A (en) * | 1996-05-23 | 2000-03-21 | Neuralstem Biopharmaceuticals, Ltd. | In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells |
US6339725B1 (en) * | 1996-05-31 | 2002-01-15 | The Board Of Trustees Of Southern Illinois University | Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation |
US6556868B2 (en) * | 1996-05-31 | 2003-04-29 | The Board Of Trustees Of Southern Illinois University | Methods for improving learning or memory by vagus nerve stimulation |
US6021352A (en) * | 1996-06-26 | 2000-02-01 | Medtronic, Inc, | Diagnostic testing methods and apparatus for implantable therapy devices |
US5865842A (en) * | 1996-08-29 | 1999-02-02 | Medtronic, Inc. | System and method for anchoring brain stimulation lead or catheter |
US6026326A (en) * | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US5871517A (en) * | 1997-01-15 | 1999-02-16 | Somatics, Inc. | Convulsive therapy apparatus to stimulate and monitor the extent of therapeutic value of the treatment |
US5893883A (en) * | 1997-04-30 | 1999-04-13 | Medtronic, Inc. | Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user |
US6042579A (en) * | 1997-04-30 | 2000-03-28 | Medtronic, Inc. | Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain |
US6024702A (en) * | 1997-09-03 | 2000-02-15 | Pmt Corporation | Implantable electrode manufactured with flexible printed circuit |
US6360122B1 (en) * | 1997-10-27 | 2002-03-19 | Neuropace, Inc. | Data recording methods for an implantable device |
US6354299B1 (en) * | 1997-10-27 | 2002-03-12 | Neuropace, Inc. | Implantable device for patient communication |
US6016449A (en) * | 1997-10-27 | 2000-01-18 | Neuropace, Inc. | System for treatment of neurological disorders |
US6011996A (en) * | 1998-01-20 | 2000-01-04 | Medtronic, Inc | Dual electrode lead and method for brain target localization in functional stereotactic brain surgery |
US6205361B1 (en) * | 1998-02-10 | 2001-03-20 | Advanced Bionics Corporation | Implantable expandable multicontact electrodes |
US6221908B1 (en) * | 1998-03-12 | 2001-04-24 | Scientific Learning Corporation | System for stimulating brain plasticity |
US6018682A (en) * | 1998-04-30 | 2000-01-25 | Medtronic, Inc. | Implantable seizure warning system |
US6850802B2 (en) * | 1998-04-30 | 2005-02-01 | Medtronic, Inc. | Selective brain stimulation using conditioning pulses |
US5886769A (en) * | 1998-05-18 | 1999-03-23 | Zolten; A. J. | Method of training and rehabilitating brain function using hemi-lenses |
US6198958B1 (en) * | 1998-06-11 | 2001-03-06 | Beth Israel Deaconess Medical Center, Inc. | Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation |
US6035236A (en) * | 1998-07-13 | 2000-03-07 | Bionergy Therapeutics, Inc. | Methods and apparatus for electrical microcurrent stimulation therapy |
US20050021104A1 (en) * | 1998-08-05 | 2005-01-27 | Dilorenzo Daniel John | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US6366813B1 (en) * | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
US6190893B1 (en) * | 1998-09-18 | 2001-02-20 | Massachusetts Institute Of Technology | Electroactive materials for stimulation of biological activity of bone marrow stromal cells |
US6507755B1 (en) * | 1998-12-01 | 2003-01-14 | Neurometrix, Inc. | Apparatus and method for stimulating human tissue |
US6052624A (en) * | 1999-01-07 | 2000-04-18 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6725094B2 (en) * | 1999-03-24 | 2004-04-20 | Lloyd R. Saberski | Apparatus and methods for reducing pain and/or retraining muscles |
US6210417B1 (en) * | 1999-04-29 | 2001-04-03 | Medtronic, Inc. | Medical lead positioning and anchoring system |
US6055456A (en) * | 1999-04-29 | 2000-04-25 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
US6176242B1 (en) * | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
US6505075B1 (en) * | 1999-05-29 | 2003-01-07 | Richard L. Weiner | Peripheral nerve stimulation method |
US6539263B1 (en) * | 1999-06-11 | 2003-03-25 | Cornell Research Foundation, Inc. | Feedback mechanism for deep brain stimulation |
US6873872B2 (en) * | 1999-12-07 | 2005-03-29 | George Mason University | Adaptive electric field modulation of neural systems |
US6375666B1 (en) * | 1999-12-09 | 2002-04-23 | Hans Alois Mische | Methods and devices for treatment of neurological disorders |
US20050015129A1 (en) * | 1999-12-09 | 2005-01-20 | Mische Hans A. | Methods and devices for the treatment of neurological and physiological disorders |
US6356786B1 (en) * | 2000-01-20 | 2002-03-12 | Electrocore Techniques, Llc | Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain |
US6356792B1 (en) * | 2000-01-20 | 2002-03-12 | Electro Core Technologies, Llc | Skull mounted electrode lead securing assembly |
US6708064B2 (en) * | 2000-02-24 | 2004-03-16 | Ali R. Rezai | Modulation of the brain to affect psychiatric disorders |
US6690974B2 (en) * | 2000-04-05 | 2004-02-10 | Neuropace, Inc. | Stimulation signal generator for an implantable device |
US6353754B1 (en) * | 2000-04-24 | 2002-03-05 | Neuropace, Inc. | System for the creation of patient specific templates for epileptiform activity detection |
US6687525B2 (en) * | 2000-06-07 | 2004-02-03 | New York University | Method and system for diagnosing and treating thalamocortical dysrhythmia |
US20050021106A1 (en) * | 2000-07-13 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20050021118A1 (en) * | 2000-07-13 | 2005-01-27 | Chris Genau | Apparatuses and systems for applying electrical stimulation to a patient |
US20050021105A1 (en) * | 2000-07-13 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US7010351B2 (en) * | 2000-07-13 | 2006-03-07 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US6529774B1 (en) * | 2000-11-09 | 2003-03-04 | Neuropace, Inc. | Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation |
US20050021107A1 (en) * | 2001-03-08 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US6839594B2 (en) * | 2001-04-26 | 2005-01-04 | Biocontrol Medical Ltd | Actuation and control of limbs through motor nerve stimulation |
US6684105B2 (en) * | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US7024247B2 (en) * | 2001-10-15 | 2006-04-04 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US20060004423A1 (en) * | 2002-05-09 | 2006-01-05 | Boveja Birinder R | Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves |
US7006859B1 (en) * | 2002-07-20 | 2006-02-28 | Flint Hills Scientific, L.L.C. | Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes |
US20050075679A1 (en) * | 2002-09-30 | 2005-04-07 | Gliner Bradford E. | Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system |
US20050033378A1 (en) * | 2002-12-09 | 2005-02-10 | Sheffield Warren Douglas | Methods for treating and/or collecting information regarding neurological disorders, including language disorders |
US20050004620A1 (en) * | 2002-12-09 | 2005-01-06 | Medtronic, Inc. | Implantable medical device with anti-infection agent |
US6990377B2 (en) * | 2003-04-24 | 2006-01-24 | Northstar Neuroscience, Inc. | Systems and methods for facilitating and/or effectuating development, rehabilitation, restoration, and/or recovery of visual function through neural stimulation |
US20050070971A1 (en) * | 2003-08-01 | 2005-03-31 | Brad Fowler | Apparatus and methods for applying neural stimulation to a patient |
US7187968B2 (en) * | 2003-10-23 | 2007-03-06 | Duke University | Apparatus for acquiring and transmitting neural signals and related methods |
US20060015153A1 (en) * | 2004-07-15 | 2006-01-19 | Gliner Bradford E | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US20070088404A1 (en) * | 2005-10-19 | 2007-04-19 | Allen Wyler | Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders |
Cited By (221)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7756584B2 (en) | 2000-07-13 | 2010-07-13 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20030125786A1 (en) * | 2000-07-13 | 2003-07-03 | Gliner Bradford Evan | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20060195155A1 (en) * | 2000-07-13 | 2006-08-31 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20030097161A1 (en) * | 2000-07-13 | 2003-05-22 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20020091419A1 (en) * | 2000-07-13 | 2002-07-11 | Firlik Andrew D. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US20030130706A1 (en) * | 2000-07-13 | 2003-07-10 | Sheffield W. Douglas | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US8412335B2 (en) | 2000-07-13 | 2013-04-02 | Advanced Neuromodulation Systems, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US20040158298A1 (en) * | 2000-07-13 | 2004-08-12 | Gliner Bradford Evan | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US8433414B2 (en) | 2000-07-13 | 2013-04-30 | Advanced Neuromodulation Systems, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US20080161881A1 (en) * | 2000-07-13 | 2008-07-03 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20070043392A1 (en) * | 2000-07-13 | 2007-02-22 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US8195300B2 (en) | 2000-07-13 | 2012-06-05 | Advanced Neuromodulation Systems, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US20080161882A1 (en) * | 2000-07-13 | 2008-07-03 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20050021105A1 (en) * | 2000-07-13 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US8073546B2 (en) | 2000-07-13 | 2011-12-06 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20060200206A1 (en) * | 2000-07-13 | 2006-09-07 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US8065012B2 (en) | 2000-07-13 | 2011-11-22 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20050021107A1 (en) * | 2001-03-08 | 2005-01-27 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20110208263A1 (en) * | 2001-03-08 | 2011-08-25 | Jeffrey Balzer | System and method for treating parkinson's disease and other movement disorders |
US7672730B2 (en) | 2001-03-08 | 2010-03-02 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20040181263A1 (en) * | 2001-03-08 | 2004-09-16 | Jeffrey Balzer | System and method for treating Parkinson's Disease and other movement disorders |
US20040088024A1 (en) * | 2001-03-08 | 2004-05-06 | Firlik Andrew D. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US20030088274A1 (en) * | 2001-09-28 | 2003-05-08 | Vertis Neuroscience, Inc. | Method and apparatus for electrically stimulating cells implanted in the nervous system |
US7831305B2 (en) | 2001-10-15 | 2010-11-09 | Advanced Neuromodulation Systems, Inc. | Neural stimulation system and method responsive to collateral neural activity |
US20030074032A1 (en) * | 2001-10-15 | 2003-04-17 | Gliner Bradford Evan | Neural stimulation system and method responsive to collateral neural activity |
US8126568B2 (en) | 2002-03-28 | 2012-02-28 | Advanced Neuromodulation Systems, Inc. | Electrode geometries for efficient neural stimulation |
US20030187490A1 (en) * | 2002-03-28 | 2003-10-02 | Gliner Bradford Evan | Electrode geometries for efficient neural stimulation |
US20070179584A1 (en) * | 2002-03-28 | 2007-08-02 | Northstar Neuroscience, Inc. | Electrode geometries for efficient neural stimulation |
US9427585B2 (en) | 2002-11-01 | 2016-08-30 | Advanced Neuromodulation Systems, Inc. | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of parkinsons disease and or other movement disorders |
US8718777B2 (en) | 2002-11-27 | 2014-05-06 | Advanced Neuromodulation Systems, Inc. | Methods and systems for intracranial neurostimulation and/or sensing |
US20040102828A1 (en) * | 2002-11-27 | 2004-05-27 | Lowry David Warren | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography |
US20080071323A1 (en) * | 2002-11-27 | 2008-03-20 | Lowry David W | Methods and Systems Employing Intracranial Electrodes for Neurostimulation and/or Electroencephalography |
US20040111127A1 (en) * | 2002-12-10 | 2004-06-10 | Gliner Bradford Evan | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders |
US20070112393A1 (en) * | 2002-12-10 | 2007-05-17 | Northstar Neuroscience, Inc. | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of parkinson's disease and/or other movement disorders |
US7684866B2 (en) | 2003-08-01 | 2010-03-23 | Advanced Neuromodulation Systems, Inc. | Apparatus and methods for applying neural stimulation to a patient |
US20060069415A1 (en) * | 2003-11-20 | 2006-03-30 | Advanced Neuromodulation Systems, Inc. | Electrical stimulation system, lead, and method providing modified reduced neuroplasticity effect |
US20050274589A1 (en) * | 2004-05-07 | 2005-12-15 | Vanderlande Industries Nederland B.V. | Device for sorting products |
US8606361B2 (en) | 2004-07-15 | 2013-12-10 | Advanced Neuromodulation Systems, Inc. | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US7983762B2 (en) | 2004-07-15 | 2011-07-19 | Advanced Neuromodulation Systems, Inc. | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US11786729B2 (en) | 2004-07-15 | 2023-10-17 | Advanced Neuromodulation Systems, Inc. | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US7742820B2 (en) | 2004-11-12 | 2010-06-22 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects |
US20060106431A1 (en) * | 2004-11-12 | 2006-05-18 | Allen Wyler | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US7917225B2 (en) | 2004-11-12 | 2011-03-29 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects |
US20060253170A1 (en) * | 2004-11-12 | 2006-11-09 | Northstar Neuroscience, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects |
US7908009B2 (en) | 2004-11-12 | 2011-03-15 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US20060259095A1 (en) * | 2004-11-12 | 2006-11-16 | Northstar Neuroscience, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US9586047B2 (en) | 2005-01-28 | 2017-03-07 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US8565867B2 (en) | 2005-01-28 | 2013-10-22 | Cyberonics, Inc. | Changeable electrode polarity stimulation by an implantable medical device |
US9307925B2 (en) | 2005-06-16 | 2016-04-12 | Aaken Laboratories | Methods and systems for generating electrical property maps of biological structures |
US8068892B2 (en) * | 2005-06-16 | 2011-11-29 | Aaken Labs | Methods and systems for using intracranial electrodes |
US20080312716A1 (en) * | 2005-06-16 | 2008-12-18 | Russell Michael J | Methods and Systems for Using Intracranial Electrodes |
US20070043268A1 (en) * | 2005-06-16 | 2007-02-22 | Russell Michael J | Guided Electrical Transcranial Stimulation (GETS) Technique |
US20090014004A1 (en) * | 2005-09-28 | 2009-01-15 | Sean Tremaine Whalen | System, method and apparatus for applying air pressure on a portion of the body of an individual |
US8840572B2 (en) | 2005-09-28 | 2014-09-23 | Alterg, Inc. | System, method and apparatus for applying air pressure on a portion of the body of an individual |
US20090082700A1 (en) * | 2005-09-28 | 2009-03-26 | Sean Tremaine Whalen | System, method and apparatus for applying air pressure on a portion of the body of an individual |
US20090018571A1 (en) * | 2005-09-28 | 2009-01-15 | Sean Tremaine Whalen | System, method and apparatus for applying air pressure on a portion of the body of an individual |
US20070225773A1 (en) * | 2005-09-28 | 2007-09-27 | Yang Shen | Implantable transcranial pulse generator having a collapsible portion |
US8145319B1 (en) * | 2005-10-11 | 2012-03-27 | Ebi, Llc | Methods and devices for treatment of osteonecrosis of the femoral head with core decompression |
US8929991B2 (en) | 2005-10-19 | 2015-01-06 | Advanced Neuromodulation Systems, Inc. | Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits |
US7729773B2 (en) | 2005-10-19 | 2010-06-01 | Advanced Neuromodualation Systems, Inc. | Neural stimulation and optical monitoring systems and methods |
US7974697B2 (en) | 2006-01-26 | 2011-07-05 | Cyberonics, Inc. | Medical imaging feedback for an implantable medical device |
WO2007089394A2 (en) * | 2006-01-27 | 2007-08-09 | Cyberonics, Inc. | Controlling neuromodulation using stimulus modalities |
US7801601B2 (en) | 2006-01-27 | 2010-09-21 | Cyberonics, Inc. | Controlling neuromodulation using stimulus modalities |
WO2007089394A3 (en) * | 2006-01-27 | 2007-11-29 | Cyberonics Inc | Controlling neuromodulation using stimulus modalities |
US20070179557A1 (en) * | 2006-01-27 | 2007-08-02 | Maschino Steven E | Controlling neuromodulation using stimulus modalities |
US8615309B2 (en) | 2006-03-29 | 2013-12-24 | Catholic Healthcare West | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US9533151B2 (en) | 2006-03-29 | 2017-01-03 | Dignity Health | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US8660666B2 (en) | 2006-03-29 | 2014-02-25 | Catholic Healthcare West | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US8738126B2 (en) | 2006-03-29 | 2014-05-27 | Catholic Healthcare West | Synchronization of vagus nerve stimulation with the cardiac cycle of a patient |
US8280505B2 (en) | 2006-03-29 | 2012-10-02 | Catholic Healthcare West | Vagus nerve stimulation method |
US8219188B2 (en) | 2006-03-29 | 2012-07-10 | Catholic Healthcare West | Synchronization of vagus nerve stimulation with the cardiac cycle of a patient |
US8150508B2 (en) | 2006-03-29 | 2012-04-03 | Catholic Healthcare West | Vagus nerve stimulation method |
US9289599B2 (en) | 2006-03-29 | 2016-03-22 | Dignity Health | Vagus nerve stimulation method |
US9108041B2 (en) | 2006-03-29 | 2015-08-18 | Dignity Health | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US9504402B2 (en) | 2006-04-28 | 2016-11-29 | Medtronic, Inc. | Cranial implant |
US7869885B2 (en) | 2006-04-28 | 2011-01-11 | Cyberonics, Inc | Threshold optimization for tissue stimulation therapy |
US9084901B2 (en) * | 2006-04-28 | 2015-07-21 | Medtronic, Inc. | Cranial implant |
US20070255338A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Cranial implant |
US9597499B2 (en) | 2006-06-19 | 2017-03-21 | Highland Instruments | Apparatus and method for stimulation of biological tissue |
US9913976B2 (en) | 2006-06-19 | 2018-03-13 | Highland Instruments, Inc. | Systems and methods for stimulating and monitoring biological tissue |
US7869867B2 (en) | 2006-10-27 | 2011-01-11 | Cyberonics, Inc. | Implantable neurostimulator with refractory stimulation |
US20080243204A1 (en) * | 2007-03-28 | 2008-10-02 | University Of Florida Research Foundation, Inc. | Variational parameter neurostimulation paradigm for treatment of neurologic disease |
US20080249591A1 (en) * | 2007-04-06 | 2008-10-09 | Northstar Neuroscience, Inc. | Controllers for implantable medical devices, and associated methods |
US20080255582A1 (en) * | 2007-04-11 | 2008-10-16 | Harris John F | Methods and Template Assembly for Implanting an Electrode Array in a Patient |
US8306627B2 (en) | 2007-04-27 | 2012-11-06 | Cyberonics, Inc. | Dosing limitation for an implantable medical device |
US7974701B2 (en) | 2007-04-27 | 2011-07-05 | Cyberonics, Inc. | Dosing limitation for an implantable medical device |
US10646714B2 (en) | 2007-10-09 | 2020-05-12 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
US9849288B2 (en) | 2007-10-09 | 2017-12-26 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
US9884191B2 (en) | 2007-10-09 | 2018-02-06 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
US11351364B2 (en) | 2007-10-09 | 2022-06-07 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
WO2009051965A1 (en) * | 2007-10-14 | 2009-04-23 | Board Of Regents, The University Of Texas System | A wireless neural recording and stimulating system for pain management |
US9031658B2 (en) | 2007-10-14 | 2015-05-12 | Board Of Regents, The University Of Texas System | Wireless neural recording and stimulating system |
US20090157141A1 (en) * | 2007-10-14 | 2009-06-18 | Board Of Regents, The University Of Texas System | Wireless neural recording and stimulating system |
US10342461B2 (en) | 2007-10-15 | 2019-07-09 | Alterg, Inc. | Method of gait evaluation and training with differential pressure system |
US20110098615A1 (en) * | 2007-10-15 | 2011-04-28 | Alterg, Inc. | Systems, methods and apparatus for differential air pressure devices |
US10004656B2 (en) | 2007-10-15 | 2018-06-26 | Alterg, Inc. | Systems, methods and apparatus for differential air pressure devices |
US20090112277A1 (en) * | 2007-10-30 | 2009-04-30 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US11406824B2 (en) | 2007-10-30 | 2022-08-09 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US10188860B2 (en) | 2007-10-30 | 2019-01-29 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9387320B2 (en) | 2007-10-30 | 2016-07-12 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US20090112278A1 (en) * | 2007-10-30 | 2009-04-30 | Neuropace, Inc. | Systems, Methods and Devices for a Skull/Brain Interface |
US9375564B2 (en) | 2007-10-30 | 2016-06-28 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US20090112279A1 (en) * | 2007-10-30 | 2009-04-30 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9179850B2 (en) | 2007-10-30 | 2015-11-10 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US8761889B2 (en) | 2007-10-30 | 2014-06-24 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9289143B2 (en) | 2007-10-30 | 2016-03-22 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US20090112280A1 (en) * | 2007-10-30 | 2009-04-30 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9440064B2 (en) | 2007-10-30 | 2016-09-13 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9167976B2 (en) | 2007-10-30 | 2015-10-27 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9167977B2 (en) | 2007-10-30 | 2015-10-27 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US8938290B2 (en) | 2007-10-30 | 2015-01-20 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US8965513B2 (en) | 2007-10-30 | 2015-02-24 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9597493B2 (en) | 2007-10-30 | 2017-03-21 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9167978B2 (en) | 2007-10-30 | 2015-10-27 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US9597494B2 (en) | 2007-10-30 | 2017-03-21 | Neuropace, Inc. | Systems, methods and devices for a skull/brain interface |
US20090118787A1 (en) * | 2007-11-02 | 2009-05-07 | Advanced Bionics Corporation | Closed-loop feedback for steering stimulation energy within tissue |
US9248280B2 (en) | 2007-11-02 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Closed-loop feedback for steering stimulation energy within tissue |
US20090118804A1 (en) * | 2007-11-05 | 2009-05-07 | Advanced Bionics Corporation | Method of mounting minimally invasive plug electrodes within cranium of patient |
US11406317B2 (en) | 2007-12-28 | 2022-08-09 | Livanova Usa, Inc. | Method for detecting neurological and clinical manifestations of a seizure |
US9259591B2 (en) | 2007-12-28 | 2016-02-16 | Cyberonics, Inc. | Housing for an implantable medical device |
US9314633B2 (en) | 2008-01-25 | 2016-04-19 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US20090192569A1 (en) * | 2008-01-30 | 2009-07-30 | New York University | Cortical electrode array and method for stimulating and recording brain activity |
US8315686B2 (en) | 2008-01-30 | 2012-11-20 | New York University | Cortical electrode array and method for stimulating and recording brain activity |
TWI384963B (en) * | 2008-03-28 | 2013-02-11 | Univ Nat Cheng Kung | Kit for providing an access channel in or sensing the intracranial status of the skull of a subject |
US20090248165A1 (en) * | 2008-03-28 | 2009-10-01 | National Cheng Kung University | Skull endosseous implant and kit containing the same |
US8182540B2 (en) * | 2008-03-28 | 2012-05-22 | National Cheng Kung University | Skull endosseous implant |
US8204603B2 (en) | 2008-04-25 | 2012-06-19 | Cyberonics, Inc. | Blocking exogenous action potentials by an implantable medical device |
US8043304B2 (en) * | 2008-07-24 | 2011-10-25 | Boston Scientific Neuromodulation Corporation | Cam lock burr hole plug for securing retainer/plug base |
US20100023020A1 (en) * | 2008-07-24 | 2010-01-28 | Boston Scientific Neuromodulation Corporation | Cam lock burr hole plug for securing retainer/plug base |
US20100023100A1 (en) * | 2008-07-24 | 2010-01-28 | Boston Scientific Neoromodulation Corporation | Cam lock burr hole plug for securing stimulation lead |
US8764767B2 (en) | 2008-07-24 | 2014-07-01 | Boston Scientific Neuromodulation Corporation | Cam lock burr hole plug for securing stimulation lead |
US8425534B2 (en) | 2008-07-24 | 2013-04-23 | Boston Scientific Neuromodulation Corporation | Cam lock burr hole plug for securing stimulation lead |
US20100036233A1 (en) * | 2008-08-08 | 2010-02-11 | Michigan State University | Automatic Methods for Combining Human Facial Information with 3D Magnetic Resonance Brain Images |
WO2010035203A1 (en) * | 2008-09-24 | 2010-04-01 | Dr. Langer Medical Gmbh | Electrode for intraoperative nerve stimulation |
US11759238B2 (en) | 2008-10-01 | 2023-09-19 | Sherwin Hua | Systems and methods for pedicle screw stabilization of spinal vertebrae |
US10279185B2 (en) | 2008-10-09 | 2019-05-07 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US9895541B2 (en) | 2008-10-09 | 2018-02-20 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patients tongue |
US9579505B2 (en) | 2008-10-09 | 2017-02-28 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US8874218B2 (en) | 2008-10-20 | 2014-10-28 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
US20100100151A1 (en) * | 2008-10-20 | 2010-04-22 | Terry Jr Reese S | Neurostimulation with signal duration determined by a cardiac cycle |
US8457747B2 (en) | 2008-10-20 | 2013-06-04 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
US10653883B2 (en) | 2009-01-23 | 2020-05-19 | Livanova Usa, Inc. | Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation |
US20100280585A1 (en) * | 2009-04-29 | 2010-11-04 | Medtronic, Inc. | Method and Apparatus for Securing an Electrode |
US8417353B2 (en) | 2009-04-29 | 2013-04-09 | Medtronic, Inc. | Method and apparatus for securing an electrode |
US8805539B2 (en) | 2009-04-29 | 2014-08-12 | Medtronic, Inc. | Method and apparatus for securing an electrode |
US8464716B2 (en) | 2009-05-15 | 2013-06-18 | Alterg, Inc. | Differential air pressure systems |
US9642764B2 (en) | 2009-05-15 | 2017-05-09 | Alterg, Inc. | Differential air pressure systems |
US20110120567A1 (en) * | 2009-05-15 | 2011-05-26 | Alterg, Inc. | Differential air pressure systems |
US9662497B2 (en) | 2009-11-10 | 2017-05-30 | Imthera Medical, Inc | System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US9339651B2 (en) | 2009-11-10 | 2016-05-17 | Imthera Medical, Inc. | System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US10195436B2 (en) | 2009-11-10 | 2019-02-05 | Imthera Medical, Inc. | System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
JP2013514870A (en) * | 2009-12-21 | 2013-05-02 | フア,シャーウィン | Insertion and use of medical devices through non-orthogonal and orthogonal pathways within the skull |
US20180153429A1 (en) * | 2009-12-21 | 2018-06-07 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US10736533B2 (en) * | 2009-12-21 | 2020-08-11 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US9820668B2 (en) | 2009-12-21 | 2017-11-21 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US20120046531A1 (en) * | 2009-12-21 | 2012-02-23 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US9642552B2 (en) | 2009-12-21 | 2017-05-09 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US9179875B2 (en) * | 2009-12-21 | 2015-11-10 | Sherwin Hua | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
CN102791185A (en) * | 2009-12-21 | 2012-11-21 | S·华 | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
US20170216017A1 (en) * | 2010-03-10 | 2017-08-03 | Smith & Nephew, Inc. | Composite interference screws and drivers |
US9949820B2 (en) * | 2010-03-10 | 2018-04-24 | Smith & Nephew, Inc. | Composite interference screws and drivers |
US20170049398A1 (en) * | 2010-11-09 | 2017-02-23 | Osaka University | Casing of implantable device and implantable device, method for manufacturing casing of implantable device, and method for supporting treatment using implantable device |
US10617361B2 (en) * | 2010-11-09 | 2020-04-14 | Osaka University | Casing of implantable device and implantable device, method for manufacturing casing of implantable device, and method for supporting treatment using implantable device |
US11752058B2 (en) | 2011-03-18 | 2023-09-12 | Alterg, Inc. | Differential air pressure systems and methods of using and calibrating such systems for mobility impaired users |
US9662496B2 (en) | 2012-05-15 | 2017-05-30 | Imthera Medical, Inc | Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue |
US9987491B2 (en) | 2012-05-15 | 2018-06-05 | Imthera Medical, Inc. | Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue |
US10751538B2 (en) | 2012-05-15 | 2020-08-25 | Imthera Medical, Inc. | Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue |
US20150320991A1 (en) * | 2012-06-28 | 2015-11-12 | Plugmed Heart | Percutaneous connection device with a socket and with an extension member |
WO2014001501A3 (en) * | 2012-06-28 | 2014-04-03 | Plugmed Heart | Percutaneous connection device with a socket and with an extension member |
US10220197B2 (en) * | 2012-06-28 | 2019-03-05 | Plugmed Heart | Percutaneous connection device with a socket and with an extension member |
CN104428032A (en) * | 2012-06-28 | 2015-03-18 | 普卢格梅德哈特公司 | Percutaneous connection device with a socket and with an extension member |
EP2914160B1 (en) * | 2012-10-30 | 2019-07-10 | Leibniz-Institut für Neurobiologie Magdeburg | Microelectrode array for an electrocorticogram (ecog) |
US10857350B2 (en) | 2013-03-07 | 2020-12-08 | Imthera Medical, Inc. | Lead splitter for neurostimulation systems |
US10004904B2 (en) | 2013-03-07 | 2018-06-26 | Imthera Medical, Inc | Lead splitter for neurostimulation systems |
US11806564B2 (en) | 2013-03-14 | 2023-11-07 | Alterg, Inc. | Method of gait evaluation and training with differential pressure system |
US11357433B2 (en) | 2014-03-12 | 2022-06-14 | Nielsen Consumer Llc | Methods and apparatus to gather and analyze electroencephalographic data |
US9398864B2 (en) | 2014-03-12 | 2016-07-26 | The Nielsen Company (Us), Llc | Methods and apparatus to gather and analyze electroencephalographic data |
WO2015138459A1 (en) * | 2014-03-12 | 2015-09-17 | The Nielsen Company (Us), Llc | Methods and apparatus to gather and analyze electroencephalographic data |
US20170136239A1 (en) * | 2014-06-30 | 2017-05-18 | Sooma Ltd. | An Implantable Stimulation Device |
WO2016001261A1 (en) * | 2014-06-30 | 2016-01-07 | Sooma Ltd | An implantable stimulation device |
US10434310B2 (en) * | 2014-06-30 | 2019-10-08 | Sooma Ltd. | Implantable stimulation device |
US9656083B2 (en) | 2014-07-22 | 2017-05-23 | Imthera Medical, Inc. | Method for adjusting a system for stimulating a hypoglossal nerve |
US10631779B2 (en) | 2014-07-22 | 2020-04-28 | Imthera Medical, Inc. | Method for adjusting a system for stimulating a hypoglossal nerve |
US11647947B2 (en) | 2014-07-22 | 2023-05-16 | Imthera Medical, Inc. | Method for adjusting a system for stimulating a hypoglossal nerve |
WO2016025406A1 (en) * | 2014-08-11 | 2016-02-18 | Medtronic, Inc. | Mechanical feedthroughs for implantable medical device |
US20180153474A1 (en) * | 2014-10-03 | 2018-06-07 | Woodwelding Ag | Medical device, apparatus, and surgical method |
JP2017531483A (en) * | 2014-10-03 | 2017-10-26 | ウッドウェルディング・アクチェンゲゼルシャフト | Medical device, apparatus, and surgical method |
US11317869B2 (en) * | 2014-10-03 | 2022-05-03 | Woodwelding Ag | Medical device, apparatus, and surgical method |
US9492660B2 (en) | 2014-12-09 | 2016-11-15 | Pacesetter, Inc. | Implantable neurostimulation systems and methods thereof |
US10426555B2 (en) * | 2015-06-03 | 2019-10-01 | Covidien Lp | Medical instrument with sensor for use in a system and method for electromagnetic navigation |
US10232169B2 (en) | 2015-07-23 | 2019-03-19 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
US10213596B2 (en) * | 2016-03-29 | 2019-02-26 | Boston Scientific Neuromodulation Corporation | Skull-mounted optical implant |
US20170281927A1 (en) * | 2016-03-29 | 2017-10-05 | Boston Scientific Neuromodulation Corporation | Skull-Mounted Optical Implant |
US20180132961A1 (en) * | 2016-11-15 | 2018-05-17 | Medtronic, Inc. | Medical device anchoring |
US10588710B2 (en) * | 2016-11-15 | 2020-03-17 | Medtronic, Inc. | Medical device anchoring |
US11602409B2 (en) | 2016-11-15 | 2023-03-14 | Medtronic, Inc. | Medical device anchoring |
JP2020506757A (en) * | 2017-01-25 | 2020-03-05 | ザ・バイオニクス・インスティテュート・オブ・オーストラリア | Electrode device for monitoring and / or stimulating activity in a treatment subject |
US10980440B2 (en) | 2017-01-25 | 2021-04-20 | Epi-Minder Pty Ltd | Electrode device for monitoring and/or stimulating activity in a subject |
EP3573700A4 (en) * | 2017-01-25 | 2020-07-01 | The Bionics Institute of Australia | Electrode device for monitoring and/or stimulating activity in a subject |
CN110234388A (en) * | 2017-01-25 | 2019-09-13 | 澳大利亚仿生学研究所 | For monitoring and/or stimulating the intracorporal movable electrode assembly of subject |
WO2018136999A1 (en) | 2017-01-25 | 2018-08-02 | The Bionics Institute Of Australia | Electrode device for monitoring and/or stimulating activity in a subject |
JP7144425B2 (en) | 2017-01-25 | 2022-09-29 | イーピーアイ-マインダー・ピーティーワイ・リミテッド | Electrode device for monitoring and/or stimulating activity in a subject |
US20190053730A1 (en) * | 2017-01-25 | 2019-02-21 | The Bionics Institute Of Australia | Electrode device for monitoring and/or stimulating activity in a subject |
US11794051B1 (en) | 2017-06-22 | 2023-10-24 | Boost Treadmills, LLC | Unweighting exercise equipment |
US11517781B1 (en) | 2017-06-22 | 2022-12-06 | Boost Treadmills, LLC | Unweighting exercise equipment |
US11819686B2 (en) | 2017-08-29 | 2023-11-21 | Medtronic, Inc. | Medical device anchoring |
US10610681B2 (en) * | 2017-08-29 | 2020-04-07 | Medtronic Inc. | Medical device anchoring |
CN111050689A (en) * | 2017-09-06 | 2020-04-21 | 美敦力公司 | Shift drill cap subassembly |
US11957954B2 (en) | 2017-10-18 | 2024-04-16 | Alterg, Inc. | Gait data collection and analytics system and methods for operating unweighting training systems |
US11654327B2 (en) | 2017-10-31 | 2023-05-23 | Alterg, Inc. | System for unweighting a user and related methods of exercise |
US11103716B2 (en) | 2017-11-13 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
US11497914B2 (en) | 2018-01-16 | 2022-11-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system with a case-neutral battery |
US11058870B2 (en) | 2018-03-09 | 2021-07-13 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
US11013913B2 (en) | 2018-03-16 | 2021-05-25 | Boston Scientific Neuromodulation Corporation | Kits and methods for securing a burr hole plugs for stimulation systems |
US11160580B2 (en) | 2019-04-24 | 2021-11-02 | Spine23 Inc. | Systems and methods for pedicle screw stabilization of spinal vertebrae |
WO2021141814A1 (en) * | 2020-01-07 | 2021-07-15 | Medtronic, Inc. | Burr cap-mounted electrodes |
US20210205623A1 (en) * | 2020-01-07 | 2021-07-08 | Medtronic, Inc. | Burr cap-mounted electrodes |
US11633603B2 (en) * | 2020-01-07 | 2023-04-25 | Medtronic, Inc. | Burr cap-mounted electrodes |
US11872433B2 (en) | 2020-12-01 | 2024-01-16 | Boost Treadmills, LLC | Unweighting enclosure, system and method for an exercise device |
US11883713B2 (en) | 2021-10-12 | 2024-01-30 | Boost Treadmills, LLC | DAP system control and related devices and methods |
CN114447725A (en) * | 2021-12-24 | 2022-05-06 | 上海脑虎科技有限公司 | Brain-computer interface fixing and interconnecting device |
Also Published As
Publication number | Publication date |
---|---|
EP1786508A4 (en) | 2013-01-16 |
WO2006019766A2 (en) | 2006-02-23 |
US20090292344A1 (en) | 2009-11-26 |
US8718777B2 (en) | 2014-05-06 |
EP1786508A2 (en) | 2007-05-23 |
WO2006019766A3 (en) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8718777B2 (en) | Methods and systems for intracranial neurostimulation and/or sensing | |
US7302298B2 (en) | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography | |
US8068892B2 (en) | Methods and systems for using intracranial electrodes | |
US7277758B2 (en) | Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder | |
US7974696B1 (en) | Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease | |
US7231254B2 (en) | Closed-loop feedback-driven neuromodulation | |
US7853329B2 (en) | Monitoring efficacy of neural modulation therapy | |
US9042988B2 (en) | Closed-loop vagus nerve stimulation | |
US8755906B2 (en) | Devices with cannula and electrode lead for brain stimulation and methods of use and manufacture | |
US9421373B2 (en) | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease | |
US7565199B2 (en) | Methods for treating and/or collecting information regarding neurological disorders, including language disorders | |
US20120078327A1 (en) | Microdevice-based electrode assemblies and associated neural stimulation systems, devices, and methods | |
US20050119703A1 (en) | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease | |
WO2009052480A2 (en) | Miniature wireless system for deep brain stimulation | |
US20220226638A1 (en) | Methods and Devices for Wireless Deep Brain Stimulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NORTHSTAR NEUROSCIENCE, INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOWRY, DAVID W.;FOWLER, BRAD;THOMPSON, GENE;REEL/FRAME:016086/0167;SIGNING DATES FROM 20041118 TO 20041124 |
|
AS | Assignment |
Owner name: ADVANCED NEUROMODULATION SYSTEMS, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORTHSTAR NEUROSCIENCE, INC.;REEL/FRAME:022813/0542 Effective date: 20090521 Owner name: ADVANCED NEUROMODULATION SYSTEMS, INC.,TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORTHSTAR NEUROSCIENCE, INC.;REEL/FRAME:022813/0542 Effective date: 20090521 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |